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Nervous System. (Under the direction of Dr. Gregory J. Cole). 
The nervous system contains hundreds of different cell-types which arise in a precise 
temporal and spatial developmental pattern. The complex pattern of neural development is 
characterized by a distinct series of events, which include cell proliferation, migration, 
differentiation, neurite extension, and synaptagenesis (Jacobson, 1978). Proteoglycans have 
been implicated in being involved in many of these processes, but have been poorly 
characterized in the developing vertebrate nervous system (Margolis and Margolis, 1989a; 
1989b; 1993; Herndon and Lander, 1989). The studies outlined in this thesis have focussed 
on the identification, biochemical characterization, and developmental regulation of the major 
proteoglycan species in the developing chick nervous system. This analysis has provided 
insight into the different functions mediated by nervous system HSPGs and CSPGs\KSPGs, 
and have enabled us to produce specific proteoglycan antisera that can be used to elucidate 
specific proteoglycan functions. 
We have also described the molecular cloning, sequence analysis, and in situ mRNA 
localization, of a nervous system keratan sulfate proteoglycan, claustrin. These analyses have 
determined that claustrin is highly homologous to the mouse MAP1B protein, and 
furthermore, suggest that MAP1B itself may be a keratan sulfate proteoglycan. In situ 
localization of claustrin mRNA during chick development has reinforced previous studies 
(Cole and McCabe, 1991; McCabe and Cole, 1992; McCabe et ai, 1991) s~ggesting that 
cJaustrin may be an inhibitory growth molecule localized to many of the proposed glial barrier 
structures in the developing chick eNS. 
TABLE OF CONTENTS 
ABSTRACT 
I. INTRODUCTION 1 
LIST OF FIGURES 21 
II. CHARACTERIZATION OF PROTEOGLYCANS IN THE 
EMBRYONIC CHICK RETINA 
ABSTRACT 25 
INTRODUCTION 26 
MATERIALS AND METHODS 29 
RESULTS 33 
DISCUSSION 38 
LIST OF FIGURES 43 
III. ANALYSIS OF THE MAJOR PROTEOGL YCANS 
OF CHICK BRAIN DURING DEVELOPMENT 
ABSTRACT 61 
INTRODUCTION 62 
MATERIALS AND METHODS 65 
RESULTS 69 
DISCUSSION 76 
LIST OF FIGURES 82 
IV. CLAUSTRIN, AN ANTI-ADHESIVE NEURAL KERATAN SULFATE 
PROTEOGLYCAN, IS STRUCTURALLY RELATED TO MAP1B 
ABSTRACT 104 
INTRODUCTION 105 
MATERIALS AND METHODS 108 
RESULTS 113 
DISCUSSION 123 
LIST OF FIGURES 129 
V. IN srru LOCALIZATION OF A KERATAN SULFATE PROTEOGLYCAN, 
CLAUSTRIN, IN THE DEVELOPING CHICK NERVOUS SYSTEM 
ABSTRACT 157 
INTRODUCTION 158 
MATERIALS AND METHODS 161 
RESULTS 165 
DISCUSSION 171 
LIST OF FIGURES 175 
VI. GENERAL DISCUSSION 193 
VII. LIST OF REFERENCES 198 
I. INTRODUCTION 
1 
Proteoglycans represent a diverse class of macromolecules whose defining feature is the 
addition of one or more glycosaminoglycan (GAG) sugar chains. Characterization of this group of 
molecules has expanded in recent years, and has revealed an enormous diversity in number, 
structure, and function (for reviews see Ruoslahti, 1988; Margolis and Margolis, 1989a; 1989b; 
Kjellen and Lindahl, 1991; Jackson et aI., 1991; Hardingham and Fosang, 1992). While early 
studies depicted proteoglycans as large, highly-glycosylated aggregates serving mainly structural 
roles, it is now clear that proteoglycans are highly variable in size and glycosylation, with a 
growing list of functions, which include cell adhesion and recognition (Cole et ai, 1985a; 1985b; 
1986; Schubert and Lacorbiere, 1985; Perkins et ai, 1989; Bernfield et ai, 1992), control of cell 
growth and differentiation (Ruoslahti, 1989; Ruoslahti and Yamaguchi, 1991), as well as regulation 
of gene transcription (Busch et ai, 1992). 
Proteoglycans vary in size from 10 kOa to over 1 million kOa, and contain from one to 
greater than 100 GAG chains attached to them. Protein cores of proteoglycans vary in MW from 
10K to greater than 500 kOa. Sequence information gained from the limited number of cloned 
proteoglycans reveals little sequence similarity to one another, and in fact, reveals that they 
contain many domains common to other nonproteoglycan proteins (Goetinck, 1991; Kjellen and 
Lindahl, 1991; Hardingham and Fosang, 1992). Proteoglycan homogeneity has been further 
complicated by the identification of "part-timell proteoglycans; proteins which are expressed in 
both GAG-substituted and GAG-unsubstituted variations (Sant et ai, 1985; Bourin et ai, 1986; 
Jalkanen et ai, 1988; Yada et ai, 1990; Kugelman et ai, 1992). 
Proteoglycans are ubiquitously expressed in all tissues, and are particularly abundant in 
mesenchymal connective tissues, epithelial basement membranes, and the cell surfaces of a 
wide range of cell-types including epithelial cells, liver hepatocytes, endothelial cells, as well as 
neuronal and glial cell surfaces ( Fransson, 1987; Kjellen and Lindahl, 1991; Jackson et ai, 1991). 
In general, chondroitin sulfate proteoglycans (CSPGs) are enriched in the extracellular matrix, 
while heparan sulfate proteoglycans (HSPGs) have been shown to be enriched in plasma 
membranes and basement membranes of various tissues. Keratan sulfate proteoglycans (KSPGs) 
have been generally localized to areas where CSPGs reside (Snow et ai, 1990a; Snow et ai, 
1990b), and in fact, many hybrid proteoglycans, which contain both keratan sulfate and 
chondroitin sulfate GAG chains have been characterized (Zimmerman et ai, 1989; Doege et ai, 
1990). 
Glycosaminoglycan Structure and Function 
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The GAG chains of proteoglycans consist of a repeating disaccharide structure, most 
commonly being an amino sugar linked to an uronic acid. The various classes of proteoglycans, 
which include heparan sulfate proteoglycans (HSPG), chondroitin sulfate proteoglycans (CSPG), 
and keratan sulfate proteoglycans (KSPG), are defined by the particular structure of these GAG 
chains. The GAG chains themselves are highly negatively-charged, due to numerous sulfation 
and\or carboxylation substitutions along their length. Many of the known functions of 
proteoglycans appear, in fact, to be mediated by these unusual sugar groups (for reviews see 
Ruoslahti, 1988; Kjellen and Lindahl, 1991; Jackson et ai, 1991). GAG chains differ from most 
other glycoprotein oligosaccharides in that they are much larger, unbranched, and highly 
charged. Because of these features, proteoglycans found in extracellular matrices exhibit a very 
high hydrodynamic volume and are capable of becoming highly-hydrated. This serves to aid in 
cell migration, proper cell spacing, and allow developing cells contained within the ECM access 
to a variety of soluble growth factors (Wright and Mayne, 1988; Hardingham and Bayliss, 1990; 
Oldberg et ai, 1990; Ruoslahti and Yamaguchi, 1991). 
The GAG chains of proteoglycans appear to mediate many of the known functions of 
proteoglycans by ionic interaction with a diverse list of ligands which include extracellular matrix 
components such as laminin (Rogers et ai, 1983; Lander et ai, 1985), collagens (Oldperg and 
Ruc)slahti, 1982; Vogel et ai, 1984; Smith et ai, 1985; Bidanset et ai, 1992) and fibronectin 
(Rogers et ai, 1983; Rogers et ai, 1985; Hermans et ai, 1990), growth factors (Kiefer et ai, 1990; 
Andres et ai, 1989; Ruoslahti and Yamaguchi, 1991), protease inhibitors (Thunberg et ai, 1982; 
Atha et ai, 1984; Ragg, 1986), as well as cell surface proteins such as the neural cell adhesion 
molecule, NCAM (Cole et ai, 1985a; 1985b; 1986; Cole and Akeson, 1989; KalJappur and Akeson, 
1992). Recent evidence also have demonstrated GAG-binding to nuclear transcription factors 
(Busch et ai, 1991). 
Very little is known concerning how specific modification of GAG sugar chains affects 
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binding to their ligands. One exception is a specific pentasaccharide region of heparin which 
has been shown to specifically interact with antithrombin III (Atha et ai, 1984; Pejler et ai, 1987). 
Abolishment of a specific 3-0 sulfated group prevents heparin binding to antithrombin III, and 
subsequent mediation of its antithrombotic effects (Atha et ai, 1984). While other specific GAG 
sequences of this type may be found, much of the interaction between GAGs and their ligands 
appear to involve more general ionic interactions. This can be demonstrated by the ability of 
many commercially available preparations of heparin and chondroitin sulfate to bind a number of 
different GAG-binding proteins in vitro (see Jackson et ai, 1991, and references within). However, 
caution must be used, since the in vivo binding interactions may be substantially different than in 
vitro conditions, and may require specific modifications. In general, heparin/heparan sulfate 
binds with a greater affinity to its ligands than chondroitin/dermatan sulfate. This is due, in part, 
to the greater charge density found in the former group, as well as a greater percentage of 
iduronic acid, which has been proposed to convey the molecule with a greater conformational 
flexibility and greater binding capabilities (Casu et ai, 1988). 
While specific GAG sequences, such as described for heparan binding to antithrombin III, 
are largely unknown, several studies have demonstrated that many proteoglycans modulate the 
length, number, type, and/or sulfation of their GAG chains, thereby modifying proteoglycan 
function. The abundant cartilage proteoglycan, aggrecan, expresses altered forms of chondroitin 
sulfate chains at different stages of development (Caterson et ai, 1990). The CSPG expresses 
longer chondroitin sulfate chains containing distinctly different epitopes in the developing growth 
plates at times corresponding to rapid bone growth and development. These distinc~ive GAG 
chains are also expressed in cartilage undergoing osteoarthritis. While the exact function is not 
known, it is theorized that the altered chondroitin sulfate chains may increase affinity for growth 
factors or other cytokines which will assist in rapid cartilage growth and repair. Collagen type IX 
found in developing cornea contains a much larger (10-fold) chondroitin sulfate chain than found 
in developing cartilage (Wright and Mayne, 1988; Yada et ai, 1990). The increased length is 
thought to optimize the proper spatial arrangement in the developing vitreous in order to optimize 
light transmission. 
Changes in sulfation patterns of GAGs offer a second mechanism to control proteoglycan 
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function. In general, higher sulfation of GAG chains has been linked to higher antiproliferative 
potency (Chiarugi and Vannaucchi, 1976). While HSPGs secreted by endothelial cells have been 
shown to inhibit smooth muscle proliferation, HSPGs isolated from hypertensive rats contain 
heparan sulfate chains with a lower degree of sulfation, and exhibit corresponding lower 
antiprolferative effects (Scott-Burden and Buhler, 1988; Scott-Burden et ai, 1989). Similarly, HSPG 
GAG chains derived from postconfluent cultured arterial smooth muscle cells contained a higher 
proportion of hydrophobic (N-acetyl) groups and a lower proportion of sulfate groups than those 
isolated from preconfluent dividing cells. These postconfluent GAG chains were found to have a 
10-fold higher antiproliferative potency than their preconfluent counterparts (Schmidt and 
Buddecke, 1990). Cultured artery smooth muscle cells from atherosclerosis-susceptible pigeons 
produce an oversulfated variety of CSPG (Edwards and Wagner, 1988). This modification may 
lead to increased binding and accumulation of LDL. Changes in sulfation have also been linked 
to differentiation of cells, with highly sulfated GAGs being associated with greater differentiation 
(Chiarugi and Vannucchi, 1976). Accordingly, transformed cells typically display undersulfated 
GAG chains (Keller et ai, 1980;Winterbourne and Mora, 1981; Robinson et ai, 1984; Esko et ai, 
1988) . 
The number and type of GAG chains attached to a proteoglycan is also variable. The 
cell-surface proteoglycan, syndecan, contains both heparan sulfate and chondroitin sulfate GAG 
chains (Mali et ai, 1990). The relative percentage of the two types of GAG chains differs in 
different tissues (Rapraeger, 1989; Elenius et ai, 1990). While uterine epithelial cells express 
syndecan containing two chains each of chondroitin sulfate and heparan sulfate, stratifi~d vaginal 
epithelial cells contain only one heparan sulfate chain and either one or no chondroitin sulfate 
chains. Syndecan of TGFJ3-treated mouse mammary cells is enriched in chondroitin sulfate 
chains. The altered GAG composition presumably reflects syndecan's different functions within 
these different cell-types. 
The "part-timeN proteoglycans, which include the lymphocyte homing receptor (Jalkanen 
et al J 1988), the invariant chain of the class II antigen (Sant et ai, 1985), thrombomodulin (Sourin 
et ai, 1986), the transferrin receptor (Schmidtchen et ai, 1990), and CD44 (Kugelman et ai, 1992), 
are proteins in which both GAG-substituted and unsubstituted variations have been isolated, 
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emphasizing the dynamic role GAG substitution plays in modulating protein function. 
Thus, although the repeating disaccharide structure of GAGs give them a certain 
homogeneity, variations in number, type, length, sulfation, and carboxylation create an enormous 
diversity in structures. This diversity enables proteoglycans to perform a dynamic array of 
functions in a cell-specific and developmentally-controlled manner, and help explains their 
ubiquitous expression and involvement in diverse cellular processes throughout development. 
Proteoglycan Protein Cores 
While an immense number of different proteoglycans have been identified (Kjellen and 
Lindahl, 1991; Hardingham and Fosang, 1992), very little is known about the primary structure of 
the protein cores of these proteoglycans. This is due largely to the difficulty in purifying 
individual proteoglycans, as well as the relative inaccessibility of the protein core due to extensive 
glycosylation. Early studies grouped proteoglycans into several protein core families based 
mainly upon size similarity and immunological cross-reactivity (Hassel et ai, 1986). Recently, a 
number of proteoglycan cores have been cloned (Kjellen and Lindahl, 1991 for review). In 
general, sequence information has strengthened the validity of the earlier groupings (Fig. 1.1). 
The extracellular matrix contains three major families of related proteoglycans. These are the 
large aggregating CSPGs, typified by the proteoglycan aggrecan; small CSPGs\DSPGs abundant 
in various connective tissues, which include decorin and biglycan; and the basement membrane 
abundant HSPGs, represented by perlecan. Intracellular granule proteoglycans possess similar 
protein cores. Serglycin is a typical proteoglycan of this group. Finally, cell-surface 
proteoglycans form a very diverse family. The best characterized cell-surface proteoglycans are 
the syndecans. 
There appears to be little information contained within the primary sequence of 
proteoglycan core proteins which distinguish them from other proteins, and in fact, proteoglycans 
contain many domains common to a number of other proteins. Indeed, the existence of "part-
timeN proteoglycans support this idea. The protein data does suggest that the protein cores 
themselves mediate many proteoglycan functions, and do not just serve as a structural support 
for the GAG chains. Several representative examples will serve to illustrate this: 
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Aggrecan 
Aggrecan is a large CSPG found in developing cartilage (Heinegard and Oldberg, 1989; 
Hardingham and Bayliss, 1990). It is capable of binding hyaluronic acid and forming huge 
aggregates. Aggrecan's core protein is organized into several distinct modules (Doege et ai, 
1987; Doege at ai, 1991; Upholt et ai, 1993). The amino terminus contains a immunoglobulin-like 
module and two tandemly repeating sequences. Together, these three modules form the G1 
domain of aggrecan. This domain is homologous to a region of the hyaluronate-binding link 
protein (Goetinck et ai, 1987; Neame and Barry, 1993), as well as the hyaluronate-binding celJ-
surface proteoglycan, CD44 (Culty et ai, 1990; Kugelman et ai, 1992), and has been shown to 
mediate hyaluronate-aggrecan interaction (Paulsson et ai, 1987). The fibroblast proteoglycan, 
versican, also contains a similar G1 domain and is capable of hyaluronate aggregation (Krusius 
et ai, 1987; Zimmermann and Ruoslahti, 1989». 
The central portion of aggrecan's core contains the numerous ser-gly repeats which serve 
as the GAG attachment sites for the numerous chondroitin sulfate and keratan sulfate chains 
(Doege et ai, 1987; Doege et ai, 1990). Analysis of the residues surrounding the ser-gly repeats 
reveal no clear consensus sequence for GAG attachment, although a number of acidic residues 
followed by a hydrophobic residue often precedes the ser-gly repeat in aggrecan, as well as 
some other proteoglycans (Bourdon et ai, 1987). Exceptions to this are numerous, however, and 
no universal consensus sequence is known (Bourdon et ai, 1985; Saunders et ai, 1989; 
Zimmermann and Ruoslahti, 1989). In addition, it is not known what determines which type of 
GAG chain will be attached. 
The amino terminus of aggrecan contains an epidermal growth factor-like domain, a 
lectin-like domain, and a complement regulatory protein-like domain (Doege et ai, 1987; Doege 
et ai, 1990). Similar domains are found on versican (Zimmermann and Ruoslahti, 1989). These 
domains have also been found on other proteoglycan core proteins, which include perlecan 
(Noonan and Hassel, 1993; Timpl, 1993», and the neural CSPG, neurocan (Rauch et ai, 1992). 
The exact function of these domains has not been determined, but they may represent potential 
binding sites and cytokine activities that proteoglycan protein cores may themselves mediate. 
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Decorin 
Decorin, along with biglycan and fibromodulin, are members of a leucine-rich family of connective 
tissue proteoglycans (Heinegard and Oldberg, 1989; Fisher et ai, 1989; Kresse et ai, 1993). 
These core proteins contain a central portion containing repeating modules, characterized by 24 
amino acid repeats which contain numerous conserved leucine residues. These leucine-rich 
domains are found in some other proteins such as a 2-glycoprotein, the platelet-surface protein 
GP1 b, and several Drosophila proteins, and are thought to mediate cell binding (see Hardingham 
and Fosang, 1992). Decorin binds collagen type I and II, as well as, fibronectin, thrombospondin, 
and TGF-,8 (Kresse et ai, 1993). Fibromodulin also binds collagen types I and II, and biglycan 
can bind TGF-/3 (Kresse et ai, 1993). Interestingly, binding of these ligands are mediated by 
protein core interactions instead of the GAG chains, although the precise binding regions have 
not been determined. 
Syndecan 
The syndecan family of proteoglycans is a group of cell-surface membrane-intercalated 
proteins found in numerous epithelial, fibroblast, endothelial, and neural cells (Saunders et ai, 
1987; Bernfield et ai, 1992 for review). The core protein contains a large extracellular N-terminal 
region containing the GAG attachment sites for both heparan sulfate and chondroitin sulfate 
chains. Syndecan is capable of binding a number of different ligands including matrix 
components, adhesion molecules, growth factors, enzymes, and protease inhibitors (Bernfield 
and Sanderson, 1990; Elenius et ai, 1990). A highly-conserved protease-susceptible site is found 
adjacent to the putative membrane spanning region of the molecule (Jalkanen et ai, 1987). 
Cleavage of syndecans at this site is thought to be important for many of syndecans 
developmental functions (see below). The cytoplasmic domain includes a basic region capable of 
interacting with the actin cytoskeleton, and a number of tyrosine residues contained in a 
consensus region for tyrosine phosphorylation. Providing a linking mechanism between the ECM 
and cytoskeleton, and involvement in signal transduction have been included in the proposed 
functions of the syndecans (Bernfield et ai, 1992). 
Very few other membrane-spanning proteoglycans have been cloned, so it is difficult to 
ascertain the conserved homology between these proteoglycans and the syndecans. In all 
cases, however, the core protein provides an effective anchor for the proteoglycan and its 
associated ligands to the cell, thus effectively modulating cell-cell and cell-ECM interactions, as 
well as providing the cell with local stores of various growth factors. In the more elaborate 
instances, such as with the syndecans, these functions may extend to affecting cytoskeletal and 
other cytoplasmic elements. 
In conclusion, the sequence information gained from the limited number of proteoglycan 
core proteins sequenced suggest that the protein cores are not just a scaffold for the GAG 
chains, and are capable of interacting with a number of different ligands, and serve to mediate 
many proteoglycan functions 
Proteoglycan Functions 
Much of the early characterization of proteoglycan function focused on the structural 
functions mediated by these molecules. As more proteoglycans have been characterized, the 
various functions attributed to proteoglycans have greatly expanded. 
Matrix Assembly 
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Proteoglycans play an integral role in matrix assembly and maintenance in cartilage, and 
other mesenchymal tissues. Proteoglycans and collagens are the major ECM molecules found in 
cartilage. The large, hyaluronate-binding proteoglycan, aggrecan, forms huge aggregates in the 
cartilage matrix creating a highly hydrated structure possessing high osmotic strength. This 
swelling pressure enables cartilage to withstand compressive forces and distribute load 
(Hardingham and Bayliss, 1990). Furthermore, the supply of nutrients to the chondrocytes are 
largely controlled by the hydration of the cartilage matrix (Oldberg et ai, 1990). Homologous 
hyaluronate-binding proteoglycans, such as versican, found in other mesenchymal tissues, such 
as the developing limb bud or skin, contain fewer GAG chains than aggrecan (Zimmermann and 
Ruoslahti, 1989). In these tissues, the matrix proteoglycan aggregates primarily appear to be 
providing a hydrated matrix facilitating nutrient and growth factor transport, as well as providing 
an environment suitable for cell migration. 
The smaller ECM proteoglycans, such as decorin, biglycan, and fibromodulin, participate 
in matrix assembly by bindings of ECM proteins such as the collagens and fibronectin (Vogel et 
ai, 1984; Scott and Haigh, 1988; Plass et ai, 1990). The interaction of these PGs with collagen is 
very specific, and help determine the spacing, thickness, and number of collagen fibrils in the 
matrix. These proteoglycans also serve to link various ECM components to one another in 
formation of the matrix. Altered proteoglycan composition found in tumor stroma may be linked 
to tumor growth and invasion (Iozzo and Cohen, 1993). 
Cell Adhesion 
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Cell-surface proteoglycans have been shown to mediate cell-cell and cell-ECM interactions 
(Gallagher et ai, 1986; Fransson, 1987; Yanagishita and Hascall, 1992). In most cases, these 
represent HSPGs. Binding of cell-surface HSPG to ECM components such as collagen, 
fibronectin, thrombospondin, and laminin is well established (Reichardt and Tomaselli, 1991). 
Cell-cell interactions are less clear. Cell-cell associations appear to result from self-association of 
GAG heparan chains (Petitou et ai, 1988), as well as enhancement of the function of cell 
adhesion molecules such as NCAM (Cole and Glaser, 1986; Cole et ai, 1986; Cole and Akeson, 
1989; Cole and Burg, 1989). These adhesive functions help maintain proper cell contacts and 
morphology in developing solid tissue structures (Chiarugi and Vannucchi, 1976). Cells 
undergoing migration or neoplastic transformation typically express lower levels of cellular HSPG 
(Underhill and Keller, 1975; Chiarugi and Vannucchi, 1976), as well as, adhesion molecules such 
as E-cadherin (Nagafuchi et ai, 1987). Experiments utilizing syndecan antisense constructs have 
demonstrated that transfected epithelial cells lose their epithelial morphology and lose their E-
cadherin and J31-integrin expression (Kato and Bernfield, 1990). Conversely, mouse mammary 
tumor cells transfected with a syndecan cDNA transform their fibroblastic phenotype into an 
epithelial one (Saunders et ai, 1989b). 
Conversely, CSPGs have generally been found to diminish cellular interactions, possibly 
be sterically hindering interaction between normal cell-cell and cell-ECM contacts (cf. Ruoslahti, 
1988). This is similar to the proposed role of polysialic acid as a modulator of cellular contact 
(Rutishausser and Landmesser, 1991) 
Growth Factor Interactions 
Proteoglycans are capable of binding many growth factors which include FGF, TGF-J3, interleukin-
3, and platelet factor 4 (Ruoslahti, 1989; Ruoslahti and Yamaguchi, 1991; Vlodavsky et ai, 1991). 
Proteoglycans are thought to help direct the activities of these growth factors by providing a 
matrix-bound or cell surface-bound reservoir of the growth factor, which is capable of being 
released via proteolysis or degradation of the proteoglycan GAG sugar chains. Thus, 
proteoglycans may serve to both spatially and temporally restrict growth factor activities. 
Recently, it has been demonstrated that bFGF binding to a HSPG is required for subsequent 
binding of bFGF to its receptor (Rapraeger et ai, 1991; Yahon et ai, 1991). 
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Various cytokines have also been shown to directly influence the synthesis and 
degradation of a number of proteoglycans providing a stronger link between these two classes of 
molecules in modeling tissues (Niefled, 1993). In addition several proteoglycans possess EGF-
like domains and may possess cytokine activity themselves. These proteoglycans include 
aggrecan (Doege et ai, 1987; Doege et ai, 1990), versican (Zimmermann and Ruoslahti, 1989), 
the basement membrane proteoglycan, perlecan (Noonan et ai, 1993), thrombospondin (Engel, 
1989)), and a HSPG-form of the J3-amyloid precursor protein (Schubert et ai, 1988). 
Tumor Development 
Carcinomas are characterized by transformed cells which exhibit altered morphology and 
uncontrolled growth, and an altered surrounding matrix which aids in the tumor growth and 
invasion of the surrounding tissues. Studies have demonstrated altered proteoglycan expression 
in neoplastic tissues (Iozzo, 1988; lozzo and Cohen, 1993). In general, transformed cells express 
a lower amount of cellular HSPG than their counterparts (Chiarugi and Vannucchi, 1976). 
Furthermore, the surrounding tumor stroma in carcinomas of the breast, liver, colon, and 
prostrate show increased levels of CSPG and hyaluronate (cf. Steck et ai, 1989; refs 46-53). As 
stated previously, cellular HSPG has been linked to maintenance of cell contacts anq mature 
morphology. In addition, cellular HSPG has been linked to the control of cell proliferation, while 
CSPGs and hyaluronate in the ECM are associated with greater cell migration. The observed 
changes in proteoglycan composition during neoplastic transformation are therefore consistent 
with the known functions of these classes of proteoglycans. 
In addition, increased levels of the CSPG, decorin have been detected in the tumor 
stroma of human colon cancer (Iozzo and Cohen, 1993). Decorin has a negative modulatory 
effect on collagen fibrillogenesis, and therefore, increased levels contribute to the poorly 
organized invasive stroma matrix. Decorin also slows the degradation of other ECM 
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proteoglycans such as versican, biglycan, and perlecan. Since these proteoglycans are capable 
of binding growth factors, or may possess cytokine activity themselves, they may provide the 
tumor with local supplies of growth factors. 
Gene Transcription 
Recent stUdies have suggested that proteoglycans may directly regulate gene expression. 
Addition of proteoglycans and GAGs to cultured hepatocytes results in elevated levels of tissue-
specific mRNAs ( see Jackson et ai, 1991, and references within). Increased amounts of nuclear 
heparan sulfate have been linked to growth rates of cultured hepatocytes (Fedarko et ai, 1989). 
Most notably, nuclear GAGs have been identified which appear to regulate gene transcription by 
interacting with transcription factors (Busch et ai, 1992). 
Multiple Functionality 
The multidomains of several proteoglycan cores, the ability of proteoglycans to bind a 
number of different ligands, and the structural versatility displayed in a cell-specific and 
developmentally-regulated manner substantiate their role as multifunctional proteins capable of 
modulating numerous cell processes through development. This multifunctionality is well 
illustrated for the syndecan proteoglycan family (Fig 1.2). These proteoglycans are potentially 
capable of interacting with numerous disparate ligands and mediate a myriad of cellular 
processes (Bernfield et ai, 1992). 
Nervous SYstem Proteoglycans 
While increasing evidence points to the importance of proteoglycans in neura,1 
development, nervous system proteoglycans have yet to be well characterized. This is due, in 
large part, to the difficulty in purifying individual proteoglycans from the complex mixture of brain 
proteins and glycoproteins. Immunological and molecular studies suggest that nervous system 
proteoglycans are largely unrelated to those characterized outside the nervous system (Gowda et 
ai, 1989; MargoliS and Margolis, 1989; Herndon and Lander, 1990). Metabolic labeling studies in 
rat brain have demonstrated that there are a diverse number of proteoglycans which undergo a 
complex regulation pattern throughout neural development (Herndon and Lander, 1990). 
While very little is known about the primary structure of nervous system proteoglycans, 
studies have linked the different classes of proteoglycans to many functions of the developing 
nervous system. 
Structure and Localization of Nervous Tissue HSPG 
Brain HSPGs are primarily associated with the cell surfaces of neurons and glia. 
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Membrane fractions from brain, retina, peripheral nerve, as well as, cultured PC12 cells, and 
primary cultures of glia and neurons, are all enriched in HSPG (for reviews, see Margolis and 
Margolis, 1989a; Margolis and Margolis, 1989b). Hydrophobicity analysis suggest a majority of 
these HSPGs are integral membrane proteins, however, it was demonstrated that the addition of 
exogenous heparan to membrane fractions from various sources released up to 20% of the 
HSPG, suggesting that a significant proportion of the HSPGs are peripherally associated with the 
plasma membranes (Klinger et ai, 1985; Ripellino and Margolis, 1989; Herndon and Lander J 
1990). In addition several HSPGs from rat brain (Herndon and Lander, 1990; Karthikeyan et ai, 
1992» and Schwann cells (Carey and Evans, 1989; Carey et ai, 1990) have been shown to be 
covalently linked to the membrane via a GPI linkage. 
While the ubiquitous expression of HSPG in the nervous system is clear, biochemical 
characterization of individual HSPGs has been limited. The major HSPGs from adult rat brain has 
been partially characterized (Klinger et ai, 1985; Ripellino and Margolis, 1988). The major HSPGs 
01 rat brain have an average MW of around 220 kOa. One major species has been identified with 
a core protein molecular weight of 55 kOa. This proteoglycan has recently been cloned, and has 
been shown to be highly homologous to a HSPG found in lung fibroblast, glypican (Karthikeyan 
et ai, 1992). 
A recent analysis has identified at least seven different HSPGs in developing rat brain 
which have core protein sizes varying from 20 kOa to > 200 kDa (Herndon and Lander, 1990). 
These HSPGs have been only partially characterized, but display a dynamic pattern of expression 
throughout development. 
The major HSPGs have been characterized from cultured PC12 cells (Margolis et ai, 
1983; Gowda et ai, 1989). These HSPGs display an average MW of 100-170 kDa, and a major 
core size of 65 kDa has been identified. Approximately 25% of the HSPG is found secreted into 
PC12 conditioned media. Interestingly, NGF .. treatment of the PC12 cells resulted in a decrease 
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in the cell-associated HSPG fraction (Margolis et ai, 1983). The NGF-treated cellular HSPGs were 
more highly sulfated than the HSPGs from untreated cells. This is consistent with other studies 
linking increased HSPG sulfation to states of higher differentiation, while undersulfated species 
are linked to immature or transformed cells (Chiargui and Vannucchi, 1976; lozzo, 1985). 
A brain HSPG homologous to syndecan, named N-syndecan, has been partially cloned 
(Carey et ai, 1992). This HSPG shows strong homology to the membrane spanning and 
cytoplasmic domains of syndecan, but the partially cloned extracellular domain shares only 
around 25% identity to the corresponding syndecan domain. N-syndecan displays a 
developmentally restricted expression pattern, being abundant in neonatal rat brain and Schwann 
cells, but absent in embryonic and adult rat brain. Functional significance of N-syndecan awaits 
further study. 
Functions of Nervous System HSPG 
In general, HSPGs have been linked to the enhancement of cell-cell and cell-substratum 
interactions, as well as the stimulation of neurite outgrowth (Lander et ai, 1985; Cole et ai, 1985a; 
1985b; 1986; Hantaz-Ambroise et ai, 1987; Riopelle and Dow, 1990; Jackson et ai, 1991). These 
functions are usually mediated in part by interactions with heparan-binding proteins which include 
NCAM (Cole et ai, 1985a; 1985b; 1986; Cole and Akeson, 1989), fibronectin (Rogers et ai, 1983; 
1985), laminin (Rogers er ai, 1983; Lander et ai, 1985), and thrombospondin (Sun et ai, 1989; 
Neugebauer et ai, 1991; O'Shea et ai, 1991). 
ECM Interactions 
Laminin is a complex ECM glycoprotein found in the PNS and embryonic CNS (for review 
see Reichardt and Tomaselli, 1991). Numerous in vitro studies have demonstrated that laminin 
contains a protein domain which is a strong promotor of neurite outgrowth. Laminin also 
contains a heparan-binding domain, and has been shown to interact with both secreted and cell-
surface HSPGs from cultured Schwann cells, PC12 cells, and astrocytes (Reichardt and 
Tomaselli, 1991 »). Antibodies which disrupt the laminin-HSPG interaction were found to inhibit 
the neurite growth-promoting activity (Sandrock and Matthew, 1987), suggesting the importance 
of bound HSPG in laminin-mediated axon outgrowth. Immunohistochemical studies have 
demonstrated laminin to be present along growing axon pathways in developing (Rogers et ai, 
1986) and regenerating peripheral nerves (Chiu et ai, 1986; Hopkins et ai, 1985), as well as, a 
number of axon tracts in the developing CNS (Perris and Bronner-Fraser, 1989). Therefore, 
laminin-HSPG interactions may play an important role in axon growth and guidance in the 
developing nervous system, as well as in regenerating nerve. 
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Cell-surface HSPGs also interact with other ECM components which include fibronectin 
(Rogers et ai, 1983; 1985) and thrombospondin (Sun et ai, 1989; Neugebauer et ai, 1991; 
O'Shea et ai, 1991). These components are found in areas of the developing PNS and CNS 
where cells are actively migrating, most notably, neural crest cell pathways (Perris and Bronner-
Fraser, 1989), and preplate derivatives of the developing cortical plate (Sheppard et ai, 1991). 
Thrombospondin appears necessary for granule cell migration in the developing cerebellum 
(O'Shea et al,1990). In addition, these ECM components are found along axon tracts in the 
developing PNS and eNS (Reichardt and Tomaselli, 1991). HSPG interacting with these ECM 
components enhance cell-ECM interaction, thereby assisting in cell migration and axon tracking. 
Both fibronectin and thrombospondin contain neurite-outgrowth promoting epitopes (Reichardt 
and Tomaselli, 1991) so that the binding of HSPG may enhance these functions as well. 
Other Neurotrophic Interactions 
HSPG binding of FGF has been shown to potentiate the various functions associated with 
this cytokine in the developing nervous system (Damon et ai, 1988; 1989). These functions 
appear largely cell-specific, but include increased cell survival, growth, and differentiation. HSPG 
interaction may potentiate function by protecting FGF from proteolysis. Heparan was shown to 
increase the half life of FGF-treated PC12 cells from 7 to 39h (Damon et ai, 1989). " 
HSPG binding of the protease inhibitor, glial-derived nexin enhances neurite outgrowth 
(Manard et ai, 1973). HSPG binding to this inhibitor was found to accelerate degradation of 
thrombin, a protease shown to inhibit neurite elongation (Stone et ai, 1987). Interestingly, glial-
derived nexin mRNA is increased in distal segments of regenerating sciatic nerve (Meier et ai, 
1989), suggesting that this inhibitor, possibly in conjunction with HSPG, may be important for 
peripheral nerve regeneration. 
Other HSPG-neurotrophic interactions include a heparan-binding Schwann cell mitogen 
which binds a HSPG found on dorsal root ganglion neurons (Ratner et ai, 1988), a retina cell-
survival molecule, purpurin (Schubert and Lacorbiere, 1986), and the retinoic acid-stimulated 
HBNF (heparin-binding neurite-promoting factor) (Huber et ai, 1990). 
Interaction with Cell Adhesion Molecules 
15 
The interaction between the major adhesion molecule in the developing nervous system, 
NCAM, and HSPG has been extensively studied. Cole et ai, (1986) demonstrated that the 
addition of exogenous heparan or heparan sulfate inhibited NCAM-mediated adhesion in an in 
vitro assay. Other studies showed that blocking HSPG interaction with the heparin-binding 
domain of NCAM using monoclonal antibodies (Cole and Glaser, 1986), or synthetic peptides 
(Cole and Akeson, 1989), would inhibit NCAM-mediated adhesion. Furthermore, Kadmon et ai, 
(1990) has shown that heparan is required for aggregation of NCAM-coated beads. Together 
these studies suggest that NCAM binding to heparan, presumably in the form of HSPG, is 
required for NCAM-mediated adhesive function. 
While the NCAM-binding HSPG has not been isolated, Cole and Burg (1989) have 
characterized a HSPG which copurifies with NCAM in chick embryonic brain cells, and may 
represent a physiological ligand for NCAM. This HSPG has an average MW of 400-520 KDa 
based upon gel exclusion chromatography. The HSPG has a protein core of 120 kOa, and may 
be a membrane-associated proteoglycan due to its strong interaction with phenyl-Sepharose. 
Alzheimer's Pathogenesis 
Studies have linked HSPG to the pathogenesis of Alzheimer's disease. Increased levels of 
HSPG has been found associated with the neurofibrillary tangles and neuritic plaques.associated 
with the disease (Celesia, 1991; Perry et ai, 1991; Su et ai, 1992; Zebrower et ai, 1992). 
Evidence also suggests that a form of the J3-amyloid protein precursor is a HSPG (Shubert et ai, 
1988), while recent evidence suggests that another p-amyloid protein precursor protein is a 
CSPG (Shioi et ai, 1992). It has been theorized that increased levels of HSPG may lead to 
aberrant neurotrophic activity within the developing plaques, because of increased concentration 
of FGF, and other neurotrophic factors, including the J3-amyloid peptide itself, which has shown 
to bind to both bind to HSPG, and possess neurotrophic activity (Small et ai, 1992). 
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Structure and Tissue Localization of Nervous System CSPG\KSPG 
CSPG is the major proteoglycan found in late developing and adult brain (Margolis and 
Margolis, 1989a; 1989b). Like their non-nervous system counterparts, neural CSPGs are generally 
associated with the ECM of the developing nervous system. Some early immunohistological 
studies suggested that CSPGs of rat brain were located extracellularly in immature animals (Le. 
P7), but occupied a cytoplasmic location in adult animals (Margolis et ai, 1975; Aquino et ai, 
1984a; 1984b). The function of cytoplasmic CSPGs are unknown, and in general, CSPGs are 
thought to be primarily extracellular, or in some cases, associated with the plasma membranes of 
neuronal cells and processes (Stallcup and Beasley, 1987). 
Studies in rodent brain (Rauch et ai, 1991) have identified at least twelve CSPGs with 
protein cores ranging between 65 kDa to > 350 kDa; several of these CSPGs contain keratan 
sulfate chains, as well. In addition, several core proteins react with the HNK-1 monoclonal 
antibody f which recognizes a glucuronic acid 3-sulfate epitope found on a number of neural 
adhesion molecules which include NCAM, Ng-CAM, and tenascin (Kruse et ai, 1984; 1985). This 
result is interesting since the HNK-1 carbohydrate moiety is thought to enhance neuron-gUa 
interactions (Keilhauer et ai, 1985) while not affecting neuron-neuron adhesion (Kunemund et ai, 
1988). This epitope on CSPGs could potentially assist in processes such as neural migration 
along radial glia, and defasciculation of axon bundles. 
One of these HNK-1 reactive CSPGs has been recently cloned (Rauch et ai, 1992). This 
CSPG, named neurocan, contains a 136 kDa core protein, which is proteolytically cleaved to 68-
kOa in the adult brain. Neurocan contains N-terminal and C-terminal regions strongly . 
homologous to the proteoglycans aggrecan and versican, but the central region is unique. 
Neurocan does contain the immunoglobulin-like domain and hyaluronic-acid binding domains, 
and does aggregate with hyaluronic acid in brain. The C-terminal regions contains the EGF .. like, 
lectin-like, and complement regulatory protein-like domains found on aggrecan and versican. 
Preliminary studies suggest neurocan can inhibit NCAM and Ng-CAM mediated adhesion. 
The Cat-301 proteoglycan, which is associated with the cell surfaces of specific subsets of 
mammalian CNS neurons (Zaremba et ai, 1989), is also capable of binding hyaluroniC acid, and 
shares immunochemical determinants with aggrecan (Fryer et ai, 1992), and therefore may be 
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another member of this proteoglycan family. Expression of the Cat-301 proteoglycan on a subset 
of cells in the cat LGN (Guimaraes et ai, 1990; Hockfield and Sur, 1990) and the ventral horn of 
hamster spinal cord (Kalb and Hockfield, 1990a; 1990b) was found to be dependent upon 
neuronal activity during "critical periods" of the developing visual system and motor neuron 
pathways, respectively. The CAT-301 proteoglycan may help mediate the activity-dependent 
development associated with these neural circuits. 
The NG2 proteoglycan is an integral membrane CSPG found in developing neural and 
mesenchymal tissues (Nishiyama et ai, 1991 a). In neural tissues, it has been found on 02A glial 
progenitor cells in the rat optic nerve and cerebellum (Levine and Stallcup, 1987; Stallcup and 
Beasley, 1987). Its expression is highest during proliferation, but decreases as the cells 
differentiate. This proteoglycan is the only other CSPG identified in the nervous system to be 
cloned. The primary structure of NG2 encodes a 252 kDa protein with no homology to any other 
protein (Nishiyama et ai, 1991 b). The extracellular domain does contain two cysteine-rich 
domains and a region similar to the calcium-binding region of cadherins. 
Function of Nervous System CSPG\KSPG 
Neural CSPGs are a major component of the ECM, and contribute to both cell-ECM and 
ECM-ECM interactions (MargoliS and Margolis, 1989). Unlike HSPG, CSPGs have generally been 
found to be inhibitory to neurite outgrowth (Snow et ai, 1990a; Fichard er ai, 1991; McKeon er ai, 
1991; Oohira et ai, 1991). KSPGs are less abundant in the nervous system than the other 
sulfated PGs. Recent evidence suggests that KSPGs colocalize with CSPGs and have similar 
functions during development of the nervous system (Snow et ai, 1990a; 1990b; Cole ~nd 
McCabe, 1991; McCabe et ai, 1992; McCabe and Cole, 1992). 
Significantly, CSPG and KSPG have been reported to be associated with proposed barrier 
structures. These barriers, which include the spinal cord roof plate, the brainstem midline, and 
the cortical subplate, are thought to prevent growing axons from following aberrant paths during 
development ( Silver et ai, 1987; Snow et ai, 1990b; Cole and McCabe, 1991; McCabe et ai, 
1992; McCabe and Cole, 1992). Snow et ai, (1990b) have detected CSPG and KSPG in the glial 
roof plate of chick spinal cord during developmental times in which dorsal column axons are 
growing to their ipsilateral targets. In addition, dorsal commissural axons avoid the glial roof 
plate, but cross the midline at the floor plate, which does not express KSPG or CSPG (Snow et 
ai, 1990b) Once the commissural and dorsal column axons have reached their proper targets, 
the level of these PGs are down-regulated. KSPG has also been found in the "glial-knot" of the 
border between the telencephalon and diencephalon in the developing chick, during times in 
which both the olfactory and optic pathways are developing (McCabe et ai, 1992). The knot is 
thought to segregate these two pathways, and again, the proteoglycan disappear once the 
pathways are established. 
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Studies in avian neural crest migration have shown that CSPGs\KSPGs are distributed 
preferentially in posterior somites and the perinotochordal mesenchyme (Oakley and Tosney, 
1991; Perris et ai, 1991). These regions are inhibitory to neural crest migration, as well as, 
subsequent formation of peripheral ganglia. Neural crest cell migratory pathways, including the 
anterior somites, contain little CSPG\KSPG, but contain HSPG and other ECM components, such 
as laminin and fibronectin, which are considered "permissive" for neural crest migration and axon 
extension (Loring and Erickson, 1987). Previous studies have shown that CSPGs\KSPGs would 
inhibit neural crest cell locomotion on motility-promoting matrix molecules in vitro (Newgreen et 
ai, 1986). 
Claustrin 
Recently, our laboratory has characterized a neuronal KSPG which appears to inhibit 
adhesion, and has been immunohistochemically localized to several of the glial barrier structures 
mentioned above (Cole and McCabe, 1991; McCabe and Cole, 1992; McCabe et ai, 1992). This 
KSPG has been named claustrin. 
Claustrin is a 320 kDa KSPG, preferentially expressed in developing chick brain. Claustrin 
is produced and secreted by cultured glia, although the possibility remains that neurons produce 
low levels of the proteoglycan. Keratanase digestion results in the appearance of two putative 
core proteins of 100 and 70 kDa. The relationship between the two cores is presently unknown, 
although antisera produced against each protein core cross-reacts with the other core, 
suggesting the two cores are related. Alternatively claustrin may represent more than one KSPG, 
with keratanase digestion producing two separate but related protein cores. 
Claustrin was shown to prevent cell attachment and neurite outgrowth of neural cells to 
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laminin-coated dishes. In addition, neurons plated onto plates coated with alternating stripes of 
laminin and laminin plus claustrin, would not extend neurites onto the laminin-claustrin 
substratum. This inhibition was overcome by keratanase digestion of claustrin, or by the addition 
of monoclonal antibodies directed against claustrin's keratan sulfate chains. Other experiments 
showed that claustrin inhibited cell attachment to NCAM, as well as laminin. 
An immunohistological analysis was performed to determine if claustrin was expressed in 
any of the glia barrier structures of the developing chick nervous system. Claustrin expression 
was detected in embryonic spinal cord roof plate, and extended to the midline of the hindbrain 
and midbrain. Additionally, claustrin was expressed in the "glial-knotl region of the developing 
diencephalon, as well as diffusely staining the surrounding optic chiasm. This spatiotemporal 
expression pattern for claustrin is consistent with previous localization of CSPG\KSPG to these 
barrier regions of the developing chick CNS. In all cases, high magnification analysis of 
claustrin's expression pattern suggested a diffuse ECM localization. 
Claustrin is also present in the optic fiber layer of the developing retina, and its 
expression extends into the optic stalk. CSPG has been previously localized in these structures, 
and is thought to help channel axons into the optic nerve. Claustrin's expression pattern 
suggests it may playa similar function. 
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While these studies establish the overall importance of proteoglycans in neural 
development, these molecules are poorly characterized in developing nervous tissue. The 
research outlined in this dissertation focused on the biochemical and molecular characterization 
of proteoglycans in the developing chick nervous system. Two general approaches were used to 
fulfill this research objective: 
1. The isolation and biochemical characterization of the major proteoglycan species of the 
developing chick retina and brain. These broad surveys were used to establish the diversity, 
dynamic expression patterns, and possible functions of this complex group of macromolecules. 
These studies were also a necessary prerequisite for the production of proteoglycan antisera, 
which allowed us to more fully examine specific nervous system proteoglycan functions. 
2. The molecular cloning of a nervous system proteoglycan, Claustrin. Isolation and 
molecular characterization of claustrin enabled us to examine the primary structure, tissue 
distribution, and temporal expression pattern of this nervous system KSPG. 
FIGURE 1.1: Proteoglycan core protein families. The figure groups a number of well-characterized 
proteoglycans into core protein families based upon similar structure and function (from Kjellen and 
Lindahl, 1991). 
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FIGURE 1.2: Multifunctional properties of syndecan. This figure illustrates the numerous functional 
interactions proposed to mediated by the syndecan family of proteoglycans. These interactions 
include the binding of growth factors, ECM components, soluble enzymes, and viruses (from 
Bernfield et ai, 1992). 
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II. CHARACTERIZATION OF PROTEOGLYCANS IN 
THE EMBRYONIC CHICK RETINA 
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ABSTRACT 
In order to begin unraveling the complex expression pattern of proteoglycans in the chick 
nervous system, we have analyzed proteoglycans synthesized by dissociated embryonic retinal 
cells in culture. The study emphasized the identification of putative integral membrane 
proteoglycans, by assessing the ability of isolated retinal proteoglycans to bind to phenyl-
Sepharose. Proteoglycans capable of binding to phenyl-Sepharose consisted of 60% heparan 
sulfate proteoglycans (HSPG) and 40% chondroitin sulfate proteoglycans (CSPG). These putative 
membrane-associated HSPGs have an average molecular weight of 360 kOa, contain heparan 
sulfate chains (HS) of 40 and 20 kOa, and contain multiple core proteins with the major core 
protein of 130 kOa. The putative membrane-associated CSPGs have an average molecular weight 
of 520 kOa, contain chondroitin sulfate (CS) chains with an average molecular weight of 20 kDa, 
and also contain multiple protein cores ranging in size between 90-220 kOa. 
Since HSPGs have previously been shown to interact with the neural cell adhesion 
molecule, NCAM, we tested the ability of endogenous retinal HS chains to interact with NCAM, 
and modify NCAM-mediated function. We demonstrated that retinal HS chains are capable on 
interacting with the heparan binding domain of NCAM, and are capable of inhibiting NCAM-
mediated adhesion of retinal cells to a NCAM substratum. 
INTRODUCTION 
Proteoglycans are a diverse family of macromolecules abundant in the extracellular 
matrices (ECM) and associated with the plasma membranes of numerous tissues. Their varied 
functions include control of cell proliferation, migration, adhesion, and differentiation. These 
processes typify the morphogenesis of many mesenchymal tissues (Ruoslahti, 1988; Margolis 
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and Margolis 1989a; 1989b; Kjellen and Lindahl, 1991; Jackson et ai, 1991; Hardingham and 
Fosang, 1992). Neurogenesis is similarly characterized by a distinct series of events, which 
Include cell proliferation, migration, differentiation, neurite extension, and synaptagenesis 
(Jacobson, 1978). Increasing evidence suggest that the developing nervous system contains an 
abundant number of distinct proteoglycans which are involved in these processes (Gowda et ai, 
1989; Margolis and Margolis, 1989; Herndon and Lander, 1990). However, these nervous system 
proteoglycans have been poorly characterized due to their relative low abundance, molecular 
heterogeneity, and difficulty in adequately purifying them from a complex mixture of glycoproteins 
found in developing nervous tissue. 
Analysis of the neural retina offers several advantages in characterizing the molecules 
involved in neural development. The neural retina is a relatively simple neural structure 
containing a limited number of well-characterized neural cell types (Barnstable, 1987; Dowling, 
1987). In addition, retinal development is characterized by development of a distinct laminated 
architecture common to more complex brain regions, including the optic tectum, cerebellum, and 
mammalian cortex. The embryonic chick retina is particularly attractive for characterizing nervous 
system-specific proteoglycans since it is relatively avascular and free of contaminating connective 
tissue. 
Early characterization of retinal proteoglycans established that the developing vertebrate 
retina contains proteoglycans; retinal chondroitin suHate proteoglycans (CSPG) are particularly 
abundant in the interphotoreceptor matrix (Tawara et ai, 1988; 1989; Landers et ai, 1991) and in 
ECM of the plexiform layer (Hewitt, 1986) , while heparan sulfate proteoglycans (HSPG) are 
mainly localized to retinal cell surfaces (Cole et ai, 1985; Schubert and LaCorbiere, 1985) and 
basement membranes (Reh et ai, 1987). In addition, proteoglycans have been identified from 
cultured retinal cells grown in monolayers (Adler et ai, 1982; Needham et ai, 1988; Threlkeld et 
ai, 1989), organ cultures (Morris et ai, 1977; 1984: 1987), or dissociated retinal cell cultures 
(Morris and ring, 1981; Morris et ai, 1984). 
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The interaction of isolated retinal cells with numerous ECM components and cell 
adhesion molecules has been extensively studied, and has helped explain the processes of 
neural cell-adhesion and neurite elongation (Cole et ai, 1985; Schubert and LaCorbiere, 1985; 
Carri et ai, 1988; Neugebauer et ai, 1991). Cultured retinal cells will attach and extend neurites 
on purified laminin or thrombospondin (Neugebauer et ai, 1991). These interactions can be 
inhibited by the addition of exogenous heparin, suggesting that retinal cell surface HSPGs may 
be mediating some of these adhesive and growth-promoting effects. Both laminin and 
thrombospondin have been shown to have heparan binding domains (Reichardt and Tomaselli, 
1991), and the binding of a HSPG to laminin has been shown to be necessary for laminin .. 
mediated neurite elongation (Rogers et ai, 1983; Sandrock and Matthew, 1987). Cell-surface 
HSPG has also been implicated in mediating the binding of retina cells to purpurin, a retinol-
binding cell survival molecule isolated from conditioned media of cultured retinas (Schubert and 
Lacorbiere, 1986). 
Retinal cells have been used to study the adhesive functions of NCAM. Retina cell-cell 
adhesion has been demonstrated in both aggregation and monolayer adhesion assays. This 
adhesion is inhibited by the addition of NCAM antisera (Cole et ai, 1985; Cole and Glaser. 1986; 
Cole at ai, 1986). In addition, retina cells will bind to a substratum conSisting of purified NCAM 
(Cole and Glaser, 1986). Cole et ai, (1986) demonstrated that the addition of exogenous 
heparan or heparan sulfate inhibited NCAM-mediated adhesion. Other studies showed that 
blocking HSPG interaction with the heparin-binding domain of NCAM using monoclonal 
antibodies (Cole and Glaser, 1986) or synthetic peptides ( Cole and Akeson, 1989). could also 
inhibit NCAM-mediated adhesion. These studies suggest that NCAM binding to heparan, 
presumably in the form of HSPG, may be required for NCAM-mediated adhesive function. 
While specific NCAM-binding proteoglycans have yet to be identified, we have 
characterized a HSPG from embryonic chick brain which copurifies with NCAM, and may 
represent one physiologically relevant ligand for NCAM (Cole and Burg, 1989). This HSPG has a 
MW of 400-520 kOa with a protein core size of 120 kOa, and may be an integral membrane 
proteoglycan based upon its ability to bind to phenyl .. Sepharose. 
The present study undertakes the characterization of the major proteoglycans found in 
the developing chick retina. While previous studies have begun characterization of these 
molecules, our study emphasizes the identification of membrane-associated proteoglycans, and 
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In particular J examines the ability of isolated retina proteoglycans to bind to a hydrophobic matrix, 
In an attempt to identify putative integral membrane proteoglycans. In addition, the interaction of 
endogenous retinal HSPGs with NCAM, and their ability to affect NCAM-mediated functions, will 
be examined. 
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MATERIALS AND METHODS 
Materials 
Sulfate, leucine-free Dulbecco's Modified Eagles Medium (OME) and fetal calf serum were 
from Flow Laboratories. [35S]N82S0. (carrier-free, 1200-1400 Ci/mol), [3H]leucine (143.7 Ci/mol), 
and [35S]methionine (600 Ci/mol) were obtained from New England Nuclear; DEAE-Sepharose, 
Sepharose CL-68 and phenyl-Sepharose were from Sigma Chemical Co.; chondroitinase ABC, 
heparinase and heparitinase were obtained from ICN, and 8io-gel A-1,5m was from Sio-Rad. 
Extracti-gel 0 was from Pierce, and centricon-30 microconcentrators were from Amicon. All other 
reagents were purchased from Sigma Chemical Co. 
Retinal cell culture and labeling 
Embryonal chicken retinas (E10) were mechanically dissociated using a fire-polished 
Pasteur pipet, and were incubated either 5h or 18h at 3r in sulfate, leucine-free DME containing 
10% dialyzed fetal calf serum, penicillin-streptomycin, and 50 pCi/ml of [35S]N~S04' 20-30 retinas 
were usually used in each experiment. For double-labeling experiments, retinas were incubated 
as described above with 25-50 J.ICi/ml of e5S]N~SO. and 50 J.lCi/ml of [3H]leucine. 
Isolation of proteoglycans 
Following labeling cells and conditioned medium were separated by centrifugation, and 
cells were processed for isolation of proteoglycans as described by Bretscher (1985). Briefly J the 
washed cell pellet was lysed in 0.15 M NaCL, 0.01 M Tris-HCL pH 8.0,5 mM M92SO., 1 mM 
PMSF, 100 units of aprotinin, 2% Trition X-100 (Buffer A) by incubation at room temperature for 
15 min, and insoluble material was removed by centrifugation. The extract was then applied to a 
1.0 ml DEAE-Sepharose column, and washed successively with a series of buffers (B-F) as 
described by Bretscher (1985). Proteoglycans were eluted in buffer F (1.0 M NaCL. 0.01 M Tris-
HCL pH 8.0, 0.01% Triton X-100). The proteoglycans were then passed directly onto an 0.5 ml 
phenyl-Sepharose column equilibrated in buffer G (buffer F lacking Triton X-100). After washing 
with buffer H (0.01 M Tris-HCL pH 8.0) the putative integral membrane proteoglycans were eluted 
with buffer I (0.01 M Tris-HCL pH 9.0, 1% Trition X-100). To remove detergent from the fraction I 
proteoglycans, this fraction was passed over an Extracti-gel 0 column and then concentrated in 
an Amicon centricon-30 microconcentrator. Fraction G molecules were concentrated in a similar 
manner. Proteoglycans from the conditioned medium were also isolated as described above. 
Characterization of proteoglycans 
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The molecular weight of proteoglycans from each fraction was estimated by gel exclusion 
chromatography on a 1.5 X 50 cm Sepharose CL-6B column equilibrated with Tris-buffered saline 
containing 0.1 % SOS. One ml fractions were collected and counted in a LKB rack beta counter 
equipped with software to correct for isotope spillover. 
Classes of proteoglycans were identified by analyzing susceptibility to chondroitinase 
ABC or nitrous acid treatment. To quantitate CSPGs, fraction G or I molecules were incubated 
with 1 U/ml of chondroitinase ABC in phosphate-buffered saline (PBS) containing 0.5 mg/ml BSA, 
1mM PMSF, and 5 mM EOTA at 3-r for 4 h, and then applied to the Sepharose CL-6B column. 
HSPGs were quantified by treatment with nitrous acid at 4° for 15 min, followed by gel exclusion 
chromatography. 
AnalysiS of glycosaminoglycans 
The molecular weight of GAG chains was estimated by gel exclusion chromatography on 
a 1.5 X 75 cm Bio-gel A-1.5m column equilibrated in Tris-buffered saline, 0.1% SOS. GAG chains 
were isolated by sequential alkaline treatment and papain digestion according to published 
protocols (Morris et ai, 1897), with modification. Briefly, cell-associated fraction G and I 
molecules (free of Trition X-100) were incubated at 45° in 0.5 M NaOH for 48h and neutralized 
with acetic acid. The sample buffer was then adjusted to a final buffer consisting of 0.5 M Tris-
HeL, 20 mM EDTA, 20 mM cysteine-HCL pH 6,8, and incubated with 0.5 mg of papain at 55° for 
24h. A second aliquot of papain was then added for an additional 24h, the sample volume was 
adjusted to 0.5 ml with column elution buffer, and the samples were chromatographed on the 
8io-gel column. These digest conditions were found to yield GAG chains that did not contain 
any [3H]leucine radioactivity when double-labeled proteoglycans were employed. Shorter digest 
conditions (24h versus 48h) did not remove all [34H] radioactivity. 
To identify chondroitin sulfate and heparan sulfate GAGs, proteoglycans from many 
experiments were pooled until 5 X 105- 1 X 108 cpm of [35SOJ radioactivity was obtained. The 
isolated proteoglycans were then treated as described above to generate GAGs, and dialyzed 
against distilled water. Aliquots of GAGs (50,000-100,000 cpm) were treated with heparitinase 
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and heparinase (Cole and Burg. 1989) or chondroitinase ABC prior to chromatography on Sio-gel 
A-1.5m. 
AnalYSis of HSPG protein core 
To estimate the size of the protein cores of the membrane-associated HSPGs, fraction I 
proteoglycans were isolated from retinal cell cultures labeled with [35S] methionine. The 
proteoglycans were then treated with heparitinase and heparinase in the presence of protease 
inhibitors as previously described. Digested samples were chromatographed on Sio-gel A-1.5m, 
and 1.15 ml fractions were collected and counted. This allowed the identification of the 
rS]methionine-labeled protein cores. following removal of the GAG chains. Experiments were 
. also conducted using [8H] leucine- and ~S]S04-labeled proteoglycans to confirm removal of 
GAGs from the protein cores (data not shown). 
Dinding of GAG chains to NCAM 
To determine whether endogenous neural HSPGs were capable of interacting with NCAM, 
sulfate-labeled heparan sulfate chains were isolated from embryonal retinal cells. Fraction G 
molecules were treated with 0.5 M NaOH and papain as previously described, dialyzed against 
water, and lyophilized. In addition, Fraction G molecules that flowed through a Centricon-30 
membrane, and likely represent free heparan sulfate chains, were also employed. Binding to 
NCAM was measured using an in vitro assay previously used to quantify [3H]heparin binding to 
NCAM (Cole et ai, 1985). However, a significant change in the present experiment was the use 
of a synthetic peptide that encodes the heparin-binding site of NCAM (Cole and Akeson, 1989), 
in place of NCAM. This peptide binds significantly higher amounts of heparan, and was therefore 
employed in the present study as a means of quantifying heparan sulfate binding to NCAM. In 
the present experiments, 10 J.lg/ml of the HBD-1 peptide (Cole and Akeson, 1989) was incubated 
1h at 3'7' with 10,000 cpm aliquots of sulfate-labeled GAG chains from the cell-associated fraction 
G. The samples were then applied to nitrocellulose, washed with PBS, and dissolved in 
scintillation fluid and counted. Nitrous acid degradation of the labeled heparan sulfate chains 
was used to demonstrate specificity of binding to the HBD-1 peptide. The effect of heparitinase 
and heparinase, or chondroitinase ABC, was also determined by incubation of the aliquots of 
radioactive GAGs with the enzymes as described above. 
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Effect of retinal GAG chains on cell adhesion 
To determine if retinal GAGs would inhibit cell adhesion to NCAM, we measured retinal 
cell adhesion to the 25 kDa amino-terminal fragment of NCAM in the absence or presence of cell-
associated fraction G HSPGs. We have shown previously that the 25 kDa fragment of NCAM 
contains the heparin-binding site on NCAM (Cole et ai, 1986a). The 25 kDa fragment was 
Isolated according to published protocols (Cole and Glaser, 1986), and was covalently coupled 
to glass scintillation vials (Cole et ai, 1985) or nitrocellulose-coated petri dishes (Cole and 
Akeson, 1989). Embryonic day 10 retinas were then mechanically dissociated and labeled in 
leucine-free OME containing 10% dialyzed fetal calf serum and 10 JlCi/ml of HSPG was added to 
the dishes immediately prior to the addition of ceUs. The HSPG was isolated from unlabeled 
retinal tissues as described above, and was quantitated as described by Heimer and Sampson 
(1987), using CSPG as a standard. To demonstrate that the HSPG was responsible for inhibition 
of cell adhesion, 20 Ilg/ml aliquots of HSPG were treated with nitrous acid for 15 min before 
being used in the adhesion assay. Nitrous acid buffer alone was used to control for any effect of 
the acid in the assay. 
RESULTS 
Subcellular distribution of retinal proteoglycans 
Proteoglycans are most commonly associated with one of two subcellular distributions, 
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the plasma membrane and the extracellular space. Our analysis of cultured retinal cells 
concentrated on these cell-associated and secreted proteoglycans. Accordingly, the soluble 
cytoplasmic fraction of the cultured retina cells was not analyzed, while the membrane-solubilized 
fraction was analyzed using a DEAE-extraction procedure (Bretscher, 1985). The ability of these 
cell-associated proteoglycans to bind to phenyl-Sepharose was tested in order to distinguish 
putative integral membrane proteoglycans from those peripherally associated with the plasma 
membrane. Secreted proteoglycans contained in the retinal conditioned medium (CM) was 
similarly analyzed. 
Analysis of a 5-h pulse label with 35SO. and eH]leucine demonstrate that approximately 
60% of the 8OS0 4-labeled proteoglycans are found in the cellular fraction while only 40% is found 
in the eM. Of the cell-associated proteoglycans, a little over a third is found in the phenyl-
Sepharose bound I fraction. and therefore represent potential integral membrane proteoglycans, 
while the remainder of the 35S04 radioactivity is found in the phenyl .. Sepharose unbound G 
fraction, suggesting that these molecules do not contain a hydrophobic polypeptide tail capable 
of membrane intercalation. The [3H]leucine-labeling of the cell-associated proteoglycan protein 
cores is found almost exclusively in the I fraction. Together, these data suggest that the majority 
of the larger cell-associated proteoglycans are contained in the I fraction. These would include 
Integral membrane proteoglycans. GPI-linked proteoglycans, and other larger proteoglycans 
which contain hydrophobic regions on their protein cores. The G fraction appears enriched in 
smaller proteoglycans and\or free GAG chains, and these proteoglycans probably associate with 
the membrane via GAG-binding to cell-surface proteins. 
Interestingly, the majority of proteoglycans found in the 5-h pulse CM are also capable of 
binding to phenyl-Sepharose. Nearly 60% of the 35SO. radioactivity, and over 75% of the rsH] 
radioactivity is found in the eM fraction I. This result was somewhat surprising since the eM 
would not be expected to be enriched in ·membrane" proteoglycans. While some of these 
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proteoglycans may represent partially clipped integral membrane proteoglycans, the majority 
probably represent secreted proteoglycans containing hydrophobic protein cores. Clearly, 
phenyl-Sepharose binding represents only a first step in identifying integral membrane proteins. 
Further studies, which include hydrophobic partitioning and the ability to insert into liposomes, 
are necessary to properly identify integral membrane proteins. 
Analysis of the 18-h pulse labeling revealed an enrichment of eM proteoglycans over cell-
associated proteoglycans, which would be expected due to proteoglycan turnover, cell death, 
and proteolysis. However, while normal turnover and degradation would favor the accumUlation 
of eM fraction G proteoglycans, a large increase in CM fraction I proteoglycans is also observed. 
In addition, the ceU-associated G proteoglycan fraction remains stable for this labeling period. 
These data suggest that the GAG-enriched cellular proteoglycans, as well as, the CM fraction I 
proteoglycans, have a longer half-life and may be more resistant to proteolysis than the cell-
associated I proteoglycan fraction. This may be suggestive of different functions for these classes 
of proteoglycans (see discussion). 
The GAG composition of the cell-associated proteoglycans was then determined. Both 
cell-associated fractions were enriched in HSPG as compared to CSPG. The majority (81.5%) of 
cell-associated fraction G proteoglycans are HSPGs, while the cell fraction I proteoglycans show 
a more modest enrichment of 60% HSPG. These numbers are consistent with previous studies 
done on embryonic chick retinal cells (Morris et ai, 1977; 1984; 1987). In general, HSPGs have 
been localized to plasma membranes. and the majority of characterized integral membrane 
proteoglycans are HSPGs (Fransson, 1987). However, a number of CSPGs have been found to 
form tight associations with cell-surface proteins (Hoffman et ai, 1988; Herndon and Lander, 
1990;Zaremaba et ai, 1989, and a number of integral membrane CSPGs have been recently 
Identified (Bourin et ai, 1986; Jalkanen et ai, 1988; Nishiyama et ai, 1991; Kugelman et ai, 1992). 
Our study indicates two separate population of cell-associated HSPGs, one being a GAG-
enriched stable cell-associated population, while a second population is capable of interacting 
with a hydrophobic matrix, contains a greater protein\GAG ratio, and may have a shorter half-life. 
Proteoglycan Size Analysis 
Size analysis of cell-associated G fraction proteoglycans using Sepharose CL-68 
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chromatography revealed an average MWof 150 kOa. Nitrous acid treatment of this fraction 
eliminated a majority of the 36SO 4 radioactive peak, with the resulting degraded GAG chains 
migrating in the total volume of the column. This confirms the earlier results indicating the low 
protein\high heparan sulfate composition of this fraction. In addition, a majority of the fraction G 
molecules pass through a Centricon-30 microconcentrator, suggesting that this fraction may be 
aviched in free GAG chains. 
Size analysis of the membrane-enriched fraction I proteoglycans revealed an average MW 
of 450 kOa. Following nitrous acid treatment, the resulting CSPG peak migrated at an apparent 
MW of 520 kOa. Chondroitinase ABC treatment revealed the remaining HSPGs have a smaller 
WI of about 360 kOa. The relative percentage of CSPG and HSPG as revealed by this size 
analysis is consistent with previous analysis (Table IJ). Size analysis of the HSPGs from 
membrane-associated G and I fractions further establish that two separate populations of HSPGs 
are found associated with the plasma membrane. The broad peak profiles revealed by the 
Sepharose CL-68 chromatography are indicative of the heterogeneity of the proteoglycans in the 
various fractions, and is consistent with proteoglycans characterized from other tissues (see 
Ruoslahti, 1989). This heterogeneity is due to differences in individual protein core sizes, but also 
may be due to heterogeneity of the GAG chain population. 
A similar size analysis of retinal CM proteoglycans was performed. The CM fraction I 
proteoglycans were somewhat smaller than their cell-associated counterparts, with an average 
WI of approximately 300 kOa. Conditioned media fraction G proteoglycans displayed a very 
broad profile with an average MW of 450 kOa. Since this fraction incorporated very little 
['H]leucine during the pulse chase experiments (Table I), the large average MWand 
heterogeneity is suggestive of a highly GAG-substituted population of proteoglycans. In addition, 
association of free GAG chains with intact proteoglycans in the eM may account for the broad 
profile. 
Glycosaminoglycan Size Analysis 
The size of the glycosaminogJycan chains of the various proteoglycan species were 
determined by degradation of the protein cores with sequential treatments of 0.5 M NAOH and 
papain, followed by size analysis of the remaining GAG chains on a Sio-Rad A-1.5m 
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chromatography column. Two populations of GAG chains with average MWs of 40 and 20 kOa 
wwe identified for the cell-associated G fraction proteoglycans, which primarily represent heparan 
lulfate chains. The 20 kDa heparan sulfate chains are similar in size to those obtained from 
analysis of cell-associated G proteoglycan fraction which passes through Centricon-30 
microconcentrators (data not shown), further suggesting that a percentage of cell-associated 
proteoglycans occur as free GAG chains. 
Analysis of the GAG sizes of cell-associated fraction I proteoglycans indicated a broad 
range of sizes with an average MW of around 40 kOa. Digestion of heparan sulfate chains 
revealed a heterogeneous population of chondroitin sulfate chains, with a peak MW of 20 kDa. 
The predominant heparan sulfate chains in the cell-associated fraction are larger, with an average 
tIN of 40 kOa, with a shoulder of smaller sizes ranging between 30 and 10 kOa. As a whole, the 
cell..associated I heparan sulfate GAG chains are more heterogenous than the heparan sulfate 
GAGs found in the cell-associated G fraction, although both extracts contain two predominant 
species averaging 40 kOa and 20 kOA. 
Protein Core Analysis 
In order to identify specific protein core(s) of the retinal HSPGs and CSPGs characterized 
In this study,[36S]methionine-labeled proteoglycans were electrophoresed on SOS polyacrylamide 
gels following enzymatic removal 01 their GAG chains. Analysis of cell-associated HSPGs 
revealed multiple protein cores with a major core of 130 kOa, and minor cores of 150 and 60 
kOa. 
A similar analysis of CSPG cores also indicated multiple protein cores. Four major CSPG 
cores were identified with MWs of 220, 185, 155, and 120 kDA. Two minor protein cores 
between SO-90 kDa were also detected. 
Interaction of Retinal HSPG with NCAM 
Previous studies have established that NCAM contains a heparan binding domain, and 
that addition of exogenous heparan could inhibit the binding of retinal cells to substrata of either 
purified NCAM or the isolated NCAM heparan-binding domain (Cole and Glaser, 1986), thus 
suggesting that retinal HSPGs may potentially interact with, and modify, NCAM function. In order 
to test whether exogenous retinal HSPG could interact with NCAM, two experimental approaches 
were used. First, a binding assay was performed to test the ability of retinal heparan sulfate 
chains to bind to a synthetic peptide, HBD-1, corresponding to the heparan .. binding domain of 
NCAM (Cole and Akeson, 1989). 35504-labeled heparan sulfate chains obtained from the cell-
•• ociated fraction G proteoglycans were used instead of those from the cell-associated I 
taction, since any residual detergent has been found to interfere with the binding in these 
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The results (Table III) show that approximately 30% of the 35SO 4-labeled heparan sulfate 
GAG chains will bind to the HBD-1 peptide under the assay conditions. Treatment of the GAGs 
with nitrous acid abolishes the binding, while incubation of the GAGS and peptide in the 
prtsence of the nitrous acid buffer alone has no effect on binding. In addition, treatment of the 
labeled-heparan sulfate chains with heparitinase similarly abolishes binding to the peptide, while 
chondroitinase ABC treatment has no effect. The results demonstrate that retinal heparan sulfate 
chains are capable of specifically binding to the HBO-1 peptide. 
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To further establish the ability of retinal H5PG to modify NCAM function a cell adhesion 
assay was performed. In this assay, the adhesion of [3H]leucine-labeled retina cells to various 
substratum was tested. In this case, the substratum consisted of the 25 kDa N-terminal fragment 
of NCAM containing the heparin-binding domain (Cole and Glaser, 1986). As seen in Fig. 7, 
retinal cells attach to the 25 kDa NCAM fragment, and this adhesion is inhibited by the addition 
of unlabeled retinal heparan sulfate chains obtained again from the cell-associated G 
proteoglycan fraction. This inhibition is concentration dependent upon the concentration of added 
heparan suHate GAGs. This inhibition can be partially neutralized by nitrous acid degradation of 
the GAG chains. 
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DISCUSSION 
In this study we have examined the cellular distribution and biochemical characterization 
of the major proteoglycans synthesized by dissociated cultured embryonic chick retinal cells. 
While previous studies have provided initial characterization of proteoglycans produced from 
cultured retinal cells and retinal explant, our study focuses on characterization of membrane-
associated proteoglycans, and in particular, examines the proteoglycans capable of binding to 
phenyl-Sepharose, which may represent integral membrane proteoglycans. In addition, we have 
examined the ability of retinal HSPG GAGs to associate with NCAM and modify NCAM-mediated 
adhesion. 
Our studies have confirmed others which have established that embryonic retinal cells 
produce HSPGs and CSPGs, with HSPG being the predominant cell-associated species and 
CSPGs being enriched in the conditioned media (Morris et ai, 1977; 1984; 1987). Approximately 
one-third of the cell-associated proteoglycans (based upon [355]50" incorporation) were capable 
of binding to phenyl-Sepharose. These proteoglycans contained the majority (> 80%) of the 
rH]leucine incorporation found in the cell-associated proteoglycan fraction, and a majority may 
represent integral membrane proteoglycans. Approximately 40% of this fraction represents 
CSPGs. These CSPGs are approximately 520 kDa, and contain chondroitin sulfate chains of with 
an average MW of 20-25 kOa. The remaining 60% of the phenyl-Sepharose bound proteoglycan 
fraction are HSPGs with an average MW of 350 kOa, and containing two pools of heparan sulfate 
GAG chains of 20 and 40 kOa. These sizes are comparable to those previously reported for 
guanidium chloride-extracted retinal proteoglycans ( Morris and Ping, 1981), although these 
proteoglycans had reported GAG sizes of 6O-SO kDa for CSPGs and only one pool of heparan 
sulfate chains of 20-25 kOa. It is unclear whether differences in extraction procedures or size 
analysis account for these differences. 
We have identified an additional cell-associated HSPG fraction which does not bind to 
phenyl-Sepharose. These HSPGs incorporate little to no eH]leucine and may largely consist of 
free GAG chains, since a majority of this fraction is capable of passing through a Centricon-30 
membrane. These HSPGs migrate with an apparent MW of 150 kDa on a Sepharose-CL68 
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column, however. this estimation of MW may be inaccurate due to the excessive sugar content of 
.. fraction. The size of the heparan sulfate GAG chains of this fraction are similar to that 
obtained for the larger phenyl-Sepharose bound HSPGs, although the 40 kOa GAG population is 
II. predominant GAG size in these fraction G proteoglycans. Morris et al. (1987) identified a 
.Imllar low molecular weight HSPG fraction from cultured retinal cells. These HSPGs contained 
little to no rH]serine-labeled protein, and a majority of these molecules could only be released 
from the cells by lysis of cells prior to membrane solubilization. A majority of these GAG-
enriched or free heparan sulfate chains may therefore be localized within cytoplasmic and 
nuclear membranous compartments. In support of this idea, we find that only a third to one-half 
01 cell-associated heparan sulfate is released from retinal cells upon incubation with heparan or 
heparinase\heparitinase treatments (data not shown), suggesting an intracellular pool of heparan 
sulfate. Free heparan sulfate chains have been found in nuclear and cytoplasmic compartments 
. of various cell-types (Busch et ai, 1992; Su et ai, 1992). While the function of these intracellular 
GAGs are largely unknown, nuclear GAGs are thought to control gene transcription by interacting 
with transcription factors (Busch et ai, 1992). Intracellular GAGs, as well as those associated with 
the cell-surface, may serve to protect various proteins from proteolysis, a function normally 
associated with highly substituted intracellular granule proteoglycans. In support of this idea, this 
fraction 01 proteoglycans\GAGs was found to be a relatively stable fraction in the study by Morris 
at II. (1987), as well as in our current study (Table I). 
We have identified multiple protein cores for the cell-associated retinal proteoglycans. Six 
different CSPG cores with molecular weights between 80-220 kDa were observed. Fewer HSPG 
cores were detected; a major core of 130 kOa and minor cores of 150 and 60 kOa were 
observed. Morris at at (1987) had previously reported only one HSPG core size of 65 kOa, and 
several large CSPG cores of about 220 kOa. The diversity of protein cores identified in our study 
is consistent with similar patterns found in adult rat brain (Gowda et ai, 1989), and supports the 
idea that the various neural cell-types may produce distinctive proteoglycan species to perform 
different functions. This idea is further supported by the observation that protein core expression 
displayed a dynamic pattern of expression when embryonic, postnatal, and adult rat brain 
proteoglycans were analyzed (Herndon and Lander, 1990). Specific antisera which react to 
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IndMdual proteoglycan cores will be needed to fully examine the temporal and spatial expression 
pattern of individual nervous system proteoglycans. 
Previous experiments have determined that both heparan and heparan sulfate are 
capable of binding to NCAM (Cole et ai, 1985; Cole and Glaser, 1986a; Cole et ai, 1986b). 
Furthermore, these substances were capable of inhibiting adhesion of retinal cells to various 
lubstrates including retinal cell monolayers (Cole et ai, 1986), retina-secreted adherons (Schubert 
and LaCorbiere, 1985) , and purified NCAM. Other studies also suggested that heparan binding 
to NCAM was actually required for NCAM-mediated adhesion (Cole et ai, 1985; Kallapur and 
Akeson, 1992). Since these studies suggested that endogenous retinal HSPGs were capable of 
Interacting with and modifying NCAM, we were interested in determining if retinal HSPGs and 
GAGs could bind to NCAM and modify its adhesive function in an in vitro assay. We 
demonstrated that endogenous retinal heparan sulfate chains were capable of binding to a 
synthetic peptide corresponding to the heparan binding domain of NCAM. Furthermore, we 
showed that these same retinal GAGs could inhibit adhesion of embryonic retinal cells to a 25 
kDa fragment of NCAM containing the heparin binding domain of NCAM. This inhibition was 
dose-dependent, and could be partially overcome by degradation of the heparan sulfate chains 
by nitrous acid treatment. While these experiments fall short of identifying a specific retinal HSPG 
which binds to an intact NCAM, they do establish that endogenous HSPG GAGs are capable of 
interacting with NCAM domains, and modifying NCAM-mediated adhesion, presumably by 
Interfering with cell-surface HSPG interaction with the heparan binding domain of NCAM. 
Determination of how specific modifications along the heparan sulfate GAG chains, such as chain 
length and sulfation, may affect NCAM-binding is still unknown. While these studies fall short of 
Identifying a specific cell-surface NCAM-binding proteoglycan, we have characterized a HSPG 
from embryonic brain cells which copurifies with NCAM, and may represent a relevant ligand in 
brain (Cole and Burg, 1989). This HSPG has a core MWof 120 kDa and GAG chains of 40 kDa, 
which is similar in size to a subpopulation of membrane-associated HSPGs capable of binding 
phenyl-Sepharose which we have characterized in the present study. 
Characterization of retinal proteoglycans from this study and others have begun to 
unravel the manner in which neural proteoglycans function in the developing retina, and other 
regions of the developing CNS and PNS. The number of unique proteoglycans, as revealed by 
their distinctive protein cores, is reflective of the number of different cell-types found in 
developing nervous tissue, and contrasts the limited number of different proteoglycans found in 
more homogeneous organ systems. While analysis of the retina has identified 8-10 protein 
cores, analysis of rat brain has revealed at Jeast 20 distinctive cores which display a dynamic 
expression pattern throughout development (Herndon and Lander, 1990). Our preliminary 
analysis of proteoglycans in embryonic chick brain reveals a similar level of complexity (Chaper 
III of thesis). 
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HSPGs and CSPGs of developing retina display a distinct spatial and temporal pattern of 
expression which is reflective of their corresponding expression in other brain regions (Margolis 
and Margolis, 1989a; 1989b). HSPGs are primarily associated with the cell-surface and are 
preferentially expressed in early retinal development. CSPGs are primarily localized 
extracellularly and become enriched in late developing retina. Morris et al. (1977) demonstrated 
that this shift from HSPG to CSPG occurred in the developing chick retina primarily between E7 
and E14. This period is characterized by decreased proliferation and the formation of the definite 
laminated arrangement of the mature retina. Other studies in developing rat brain have observed 
a similar shift from HSPG to CSPG throughout development, although this phenomena has not 
been examined in relation to development of specific laminated regions of the brain such as the 
cortex, optic tectum, or cerebellum. Preliminary examination of the proteoglycan composition of 
developing chick brain suggest a similar shift from HSPG to CSPG during development of the 
chick optic tectum and cerebellum (Chapter 111;thesis). 
Finally. the study of retinal proteoglycans has elucidated their function in axonal growth 
and guidance. Proper axon guidance is believed to result from an appropriate distribution of 
adhesive and repulsive molecules associated with the growing axons and surrounding 
environment (Tosney, 1991). HSPGs are generally found to enhance adhesion and neurite 
outgrowth, in part, by interaction with ligands such as NCAM (Cole et ai, 1985; 1986) I laminin 
(Rogers et ai, 1983: Lander et ai, 1985), vitronectin ( Neugebauer et ai, 1991), and 
thrombospondin (Sun et ai, 1989; Neugebauer et ai, 1991; O'Shea et ai, 1991). CSPGs, on the 
, other hand, have been found to be inhibitory to axon growth. In the developing retina, HSPG 
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and NCAM are associated with the fasciculation of retinal ganglion cells axons, and their directed 
growth through the optic nerve toward their eventual target in the optic tectum (Rutishauser, 
1986). Recently, a developmentally and spatially controlled wave of CSPG has been identified in 
the developing rat retina which appears to control the time of ganglion cell differentiation, and 
appears to polarize their cell bodies and axons in the proper orientation toward the optic fissure 
(Brittis et ai, 1992). This interrelationship between HSPG and CSPG function in the developing 
retina may parallel similar functional interactions in other brain regions. 
In summary, we have characterized the major proteoglycans found in the embryonic chick 
retina. Analysis has revealed multiple HSPG and CSPG species reflective of the diverse cell-types 
found in the retina. In vitro experiments using retinal-derived heparan sulfate GAG chains have 
demonstrated that these endogenous GAGs are capable of interacting with the heparan binding 
domain of NCAM, and are capable of modifying NCAM-mediated cell adhesion. 
Table I: Cellular distribution of retinal proteoglycans. Embryonic day 10 chick cells were pulse-
labeled with [3H]leucine and [35S]S04' and retinal proteoglycans were isolated from DEAE-
Sepharose as described under IIMaterials and Methods·. Proteoglycans were then fractionated 
into phenyl-Sepharose nonbinding (G) and binding (I) fractions. The percentage of radioactivity 
in individual fractions is shown. The mean ± SO of three experiments are shown for the 5h 
pulse, and the mean of two experiments is shown for the 18h pulse. 
cellular distribution of retinal proteoglycans 
Fraction % 3H-q:m % 35S-q:m 
A. 5 h p.llse 
Cell fraction" G 8.9 ± 1.7 37.5 ± 5.6 
Cell fraction I 71.6 ± 5.6 22.7 ± 4.6 
CM fraction G 4.3 ± 1.0 11.9 ± 0.5 
eM fraction I 15.3 ± 3.0 27.8 ± 1.6 
B. 18 h p.llse 
Cell fraction G 11.2 32.1 
Cell fraction I 44.1 18.0 
eN fraction G 13.1 29.2 
CM fraction I 31.6 20.7 
Table II: Glycosaminoglycan composition of cell-associated proteoglycan fractions. The 
percentage composition of heparan sulfate or chondroitin sulfate in the cell ... associated 
proteoglycan fraction was determined by treatment of proteoglycans with nitrous acid or 
chondroitinase ABC lyase prior to chromatography on Sepharose CL-6B. The mean ± SO of 
four experiments is shown. 
Glycosaminoglycan CXJIuposition of cell-associated 
proteoglycan fractions 
Fraction % HSIG % CSFG 
cell fraction G 81.5 ± 9.7 18.5 ± 9.7 
Cell fraction I 59.9 ± 8.4 40.1 ± 8.4 
Figure 1: Sepharose CL-68 profile of retinal proteoglycans from cell fraction G. Proteoglycans 
isolated from lysed 35SO.-labeled retinal cells that did not bind phenyl-Sepharose were 
chromatographed on a 1.5 X 50 cm Sepharose CL-68 column under dissociative conditions. The 
data is graphed as percent of total radioactivity recovered from the column. Solid circles denote 
untreated fraction G molecules and open circles show the elution profile after nitrous acid 
digestion. The average molecular weight of the fraction G molecules is 150 kOa. The data is 
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Figure 2; Sepharose CL-68 profile of cell fraction I proteoglycans. Sulfate-labeled fraction I 
proteoglycans were analyzed by Sepharose CI-68 chromatography as described in Fig. 2. AJ 
Untreated molecules migrate with a molecular weight of 450 kDa (closed circles), but exhibit a 
molecular weight of 520 kDa following nitrous acid treatment (open circles). S, treatment with 
chondroitinase ABC allows identification of HSPGs with an average molecular weight of 360 kDa 
(open circles). 

Figure 3: Sepharose CL-68 profile of conditioned medium proteoglycans. Conditioned medium 
proteoglycans were separated into fraction G and I molecules, and sized under dissociative 
conditions as described under Materials and Methods. A, conditioned medium fraction G; B, 
conditioned medium fraction I. 

Figure 4: Estimation of GAG molecular weight of cell fraction G by chromatography on Sio-gel A .. 
1.5m. 35S04-labeled proteoglycans from cell fraction G were subjected to alkaline hydrolysis and 
papain digestion, and then analyzed on 8io-gel A-1.5m under dissociative conditions. The 
fraction G GAGs were resolved into molecules with molecular weights of approximately 20 and 40 
kDa, although the major peak is at 40 kOa. 
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Figure 5: Estimation of GAG molecular weight of fraction I proteoglycans. Fraction I 
proteoglycans were treated to generate GAGs as described in Fig. 5, and separated under 
dissociative conditions. A, untreated fraction I GAGs. a, fraction I GAGs treated with heparitinase 
and heparinase to yield chondroitin sulfate chains. C, fraction I GAGs treated with chondroitinase 
ABC to yield heparan sulfate chains. The fraction I GAGs are characterized by a broad peak with 
an average molecular weight of 40 kDa (A). This fraction consists of a mixture of chondroitin 
sulfate chains with an average size of 20 kDa (8), and heparan sulfate chains with molecular 
weights of 40 and 20 kOa (C). The data is graphed as percent of total recovered radioactivity 
from the column. 
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Figure 6: Estimation of core protein molecular weight of membrane-associated proteoglycans. 
Cell-associated fraction I proteoglycans isolated from retinal cells labeled with either 
[
35S] methionine were treated with 2.5 units each of heparitinase and heparinase, or 20 mU of 
chondroitinase ABC lyase for 4h at 37', and then analyzed on a 10% polyacrylamide gel under 
reducing conditions. A, Chondroitinase treatment; Lanes: 1, untreated proteoglycans; 2, 
chondroitinase treated proteoglycans. B. Heparitinase and heparinase treatment; Lanes: 1, 
untreated proteoglycans; 2, heparitinase\heparinase treated. 
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Figure 7: Inhibition of retinal cell adhesion to a functional domain of NCAM by retinal HSPG. 
Glass vials or nitrocellulose-coated petri dishes were coated with the 25 kDa heparan-binding 
fragment of NCAM as described under Materials and Methods. Dissociated embryonic day 10 
retinal cells were then labeled with eH]leucine, washed in Earle's balanced salts solution 
containing 1 % BSA, and added to the protein coated vials or dishes. The binding of labeled 
retinal cells was then quantitated after 1 h. The effect of retinal HSPG on cell attachment to the 
NCAM functional domain was tested by isolating fraction G proteoglycans from embryonic day 10 
retinas. Aliquots of these proteoglycans, which are enriched in HSPG, were then added to the 
assay medium immediately prior to the addition of cells. Inhibition by HSPG was confirmed by 
treating the retinal proteoglycans with nitrous acid (HN02). HN02 that was first neutralized with 
NaOH had no effect on adhesion, while treatment of the proteoglycans with HN02 (shown as 
HSPG-HNOJ, followed by neutralization, could partially remove the inhibitory activity of the retinal 
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Table III. Binding of [35S]S04-labeled heparan sulfate to HBD-1 peptide. The binding of fraction G 
HSPG molecules to a synthetic peptide, HBD-1, corresponding to the heparin-binding domain of 
NCAM, was tested using an in vitro assay described in Materials and Methods. [35S]S04-labeled 
retinal HS GAG chains derived from fraction G proteoglycans (10,000 cpm aliquots) were 
incubated with aliquots of the HBD-1 peptide (10 Jig) for 1 h at 3r. The samples were then 
applied to nitrocellulose, washed with PBS, and dissolved in scintillation fluid and counted. 
Approximately 31% of the labeled-HS bound to the peptide (ContrOl). Nitrous acid digested HS 
chains did not bind to the HBD-1 peptide (Nitrous acid digest), thus demonstrating the specificity 
of the HS-NCAM binding. The addition of nitrous acid buffer had no effect on the ability of retinal 
HS GAGs to bind to the HBD·1 peptide (Nitrous acid buffer). The mean ± SD of three 
experiments is shown. 
Biming of 35S04-1abeled heparan sulfate to HBD-l peptide 
Treatment cgn bourrl % cpm bourrl 
Control 3134 ± 995 31.3 
Nitrous acid buffer 4051 ± 1621 40.5 
\ 
Nitrous acid digest 246 ± 43* 2.5 
III. ANALYSIS OF THE MAJOR PROTEOGL YCANS 
OF CHICK BRAIN DURING DEVELOPMENT 
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ABSTRACT 
Increasing evidence suggest that proteoglycans (PGs) play important and diverse 
functions in neural development. We have characterized the major PGs of chick brain, and 
begun to describe how the pattern of PG expression changes during development. The major 
chondroitin sulfate PGs (CSPG) are a heterogeneous group of molecules with an average MW of 
450 kDa. Protein core analysis reveal multiple protein cores between 100-350 kDa. The heparan 
sulfate PGs (HSPG) are somewhat smaller with an average MW of 380 kDa, and possess a 250 
kDa protein core. An antisera produced against a HSPG which copurifies with the neural cell 
adhesion molecule, NCAM (Cole and Burg, 1989), is capable of immunopurifying this HSPG core, 
suggesting that the major HSPG species identified in the present study may be related to the 
previously identified NCAM-associated HSPG. During development the relative percentage of 
HSPG decreases from nearly 50% at E6 to 25% by E10. Analysis of cerebellar development 
shows a similar developmental decrease between E11 and E20, corresponding to the delayed 
development of this brain region. 
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INTRODUCTION 
Proteoglycans represent a diverse class of macromolecules whose defining feature is the 
addition of one or more glycosaminoglycan (GAG) sugar chains. These GAG chains are highly 
negatively-charged, due to numerous sulfation and\or carboxylation substitutions along their 
length. Many of the known functions of proteoglycans appear, in fact, to be mediated by these 
unusual sugar groups (for reviews see Ruoslahti, 1988; Kjellen and Lindahl, 1991; Jackson et ai, 
1991). 
Proteoglycans are ubiquitously expressed, and are particularly abundant in mesenchymal 
connective tissues, epithelial basement membranes, and the cell surfaces of a wide range of cell-
types including epithelial cells, liver hepatocytes, endothelial cells, as well as neuronal and glial 
cell surfaces. In general, chondroitin sulfate proteoglycans (CSPG) are enriched in the 
extracellular matrix (ECM), while heparan sulfate proteoglycans (HSPG) have been shown to be 
enriched in plasma membranes and basement membranes of various tissues (Fransson, 1987; 
Kjellen and Lindahl, 1991; Jackson et ai, 1991). 
Much of the early characterization of proteoglycan function focused on the structural 
functions mediated by these molecules. Proteoglycans associated with the extracellular matrix of 
developing cartilage, and other mesenchymal tissues, serve to link many components of the 
matrix together, including collagens and fibronectins (Rich et ai, 1981; Oldberg and Ruoslahti, 
1982). Cell-surface proteoglycans, in contrast, were shown to mediate cell-cell and cell-ECM 
interactions (Gallagher et ai, 1986; Fransson, 1987; Yanagishita and Hascall, 1992). As more 
proteoglycans have been identified and characterized, the various functions attributed to 
proteoglycans have greatly expanded. Proteoglycans have been shown to be involved in a 
diverse number of cellular processes which include control of cellular proliferation, differentiation, 
matrix assembly. and gene transcription (Ruoslahti, 1988; KjeUen and Lindahl, 1991; Jackson et 
ai, 1991). 
While little is known about the primary structure of nervous system proteoglycans, studies 
have linked the different classes of proteoglycans to numerous processes associated with the 
developing nervous system. Brain HSPGs have been shown to be primarily associated with the 
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cell surfaces of neurons and glia, and in general, these molecules have been linked to the 
enhancement of cell-cell and cell-substratum interactions, as well as the stimulation of neurite 
outgrowth (lander et ai, 1985; Cole et ai, 1985; 1986; Hantaz-Ambroise et ai, 1987; Riopelle and 
Dow, 1990; Jackson et ai, 1991). These functions are usually mediated in part by interactions 
with heparan-binding proteins which include NCAM (Cole et ai, 1985; 1986; Cole and Akeson, 
1989), fibronectin (Rogers et ai, 1983; 1985), laminin (Rogers et ai, 1983; Lander et ai, 1985), and 
thrombospondin (Sun et ai, 1989; Neugebauer et ai, 1991; O'Shea et ai, 1991). 
Neural CSPGs are a major component of the ECM, and are thought to contribute to both 
ce"-ECM and ECM-ECM interactions (Margolis and Margolis, 1989). Unlike HSPG, CSPGs have 
generally been found to be inhibitory to neurite outgrowth (Snow et ai, 1990a; Fichard et ai, 
1991; McKeon et ai, 1991; Oohira et ai, 1991). Keratan sulfate proteoglycans (KSPG) are less 
abundant in the nervous system than the other sulfated proteoglycans, and recent evidence 
suggests that KSPGs colocalize with CSPGs and have similar functions during development of 
the nervous system (Snow et ai, 199Oa; 1990b; Cole and McCabe, 1991; McCabe et ai, 1992; 
McCabe and Cole, 1992). CSPG and KSPG have been reported to be associated with proposed 
barrier structures. These barriers, which include the spinal cord roof plate, the brainstem midline, 
and the cortical subplate, are thought to prevent growing axons from following aberrant paths 
during development (Silver et ai, 1987; Snow et ai, 1990b; Cole and McCabe, 1991; McCabe et 
ai, 1992; McCabe and Cole, 1992). 
While numerous studies have characterized the major proteoglycans in the developing 
rodent brain (Klinger et ai, 1985; Oohira et ai, 1988; Gowda et ai, 1989; Herndon and Lander, 
1990; Rauch et ai, 1991), only a few of the proteoglycans of developing chick brain have been 
described (Tan et ai, 1987; Crawford,1988; Hoffman et ai, 1988; Krueger et ai, 1992), although, 
proteoglycans in the embryonic chick retina have been well studied (Morris, 1984; Morris et ai, 
1984; Morris et ai, 1987; Burg and Cole, 1990). The present study describes an analysis of the 
major sulfated proteoglycans in the developing chick brain. An analysis of the pattern of 
synthesis of chick brain proteoglycans reveals a relative shift from HSPG to CSPG during critical 
periods associated with development of the chick optic tectum and cerebellum. Also, the 
predominant HSPG identified in this study specifically interacts with a synthetic peptide 
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corresponding to the heparan binding domain of the neural cell adhesion molecule, NCAM, and 
therefore, may represent a physiologically relevant NCAM-binding proteoglycan. 
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MATERIALS AND METHODS 
I,olation of proteoglycans 
Brains were removed from chicks at various ages between embryonic day 6 (ES) and 
embryonic day 20 (E20), cut into approximately 5-10 mm2 pieces, and incubated in Spinner 
culture for 4h at 3r in sulfate, leucine-free DME containing 10% dialyzed fetal calf serum, 
penicillin-streptomycin, and 50 pCi/ml of N~ 35SO. (NEN). Alternatively, brains were incubated in 
methionine-free DME containing 50 #-,Ci/ml of [35S]methionine. Following labeling, cells were 
removed from the medium by centrifugation, and proteoglycans were isolated using DEAE-
Sepharose chromatography as described by Bretscher (1985). Proteoglycans were eluted from 
the DEAE ... Sepharose with 1.0 M NaCl, 0.01 M Tris-HCL, pH 8.0, which included a protease 
inhibitor cocktail containing aprotinin (1.000 kallikrien inhibitor U/ml), phenylmethylsulfony fluoride 
(1 mM), leupeptin (0.5 ug/ml), and EDTA (1mM). The samples were then dialyzed overnight at 4° 
against PBS, and aliquots were frozen for further analysis. For analysis of chick cerebellar 
proteoglycans, cerebella were dissected from chick brains between E11 and E20, metabolically 
labeled, and the proteoglycans isolated as described above. 
Characterization of proteogtycans 
Classes of proteoglycans were identified by analyzing susceptibility to chondroitinase 
ABC or nitrous acid treatment CSPGs were identified by digestion of proteoglycan samples with 
1 U/ml of chondroitinase ABC in PBS. containing the protease inhibitor cocktail described above, 
at 3-r for 4 h. HSPGs were identified by treatment of proteoglycans with nitrous acid at 0° for 1-2 
h. The relative percentage of these two classes of proteoglycans was determined by 
centrifugation of the treated proteoglycan samples using Centricon-30 microconcentrators 
(Amicon). rsS]SO.",labeUed material contained in the Centricon flow-through, representing 
digested glycosaminoglycan chains. were compared to the undigested rS]S04-labelied 
proteoglycans contained in the Centricon retentate using a LKB rackbeta scintillation counter. The 
molecular weights of the proteoglycans was estimated using gel exclusion chromatography on a 
1.5 X 50-cm Sepharose CL-68 column equilibrated with Tris-buffered saline containing 0.1 % SDS. 
One-milliliter fractions were collected and quantified by liquid scintillation counting. 
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Analysis of proteoglycan protein cores 
To estimate the size of the HSPG and CSPG protein cores, brain proteoglycans labelled 
with rS] methionine were subjected to either nitrous acid treatment or chondroitinase digestion, 
electrophoresed on 7.5% polyacrylamide gels, and visualized using fluorography, as described 
previously (Burg and Cole, 1990). 
Interaction of proteoglvcans with the heparan binding domain peptide, HBD-1 
The HBD-1 peptide, a 28 residue peptide corresponding to the heparan binding domain 
of rat NCAM has been previously described (Cole and Akeson, 1989). The interaction of brain 
proteoglycans with the HBD-1 peptide was tested using affinity chromatography. HBD-1 peptide 
(0.5 mg) was coupled to CNBr-activated Sepharose CL-4B, and incubated overnight at 4° with 
aUquots of rS] S04-1abeled proteoglycans from E10 chick brains. The unbound fraction was 
saved for further analysis. After three washes with O.35M NaCI, the bound fraction was eluted 
with 1 M NaCL. Both bound and unbound fractions were sized on a 50 X 1.S-cm Sepharose eL-
sa column. Proteoglycan composition of the fractions was determined by chondroitinase ABC or 
nitrous acid treatments, as described above. 
In order to identify protein cores that may bind to NCAM, HBD-affinity chromatography 
was performed using rS] methionine-labeled proteoglycan fractions from E10 chick brains. 
Unbound and bound samples were then subjected to either chondroitinase ABC digestion or 
nitrous acid treatment. electrophoresed onto 7.5% polyacrylamide gels, and visualized by 
fluorography. 
Antibody production and immunoaffinity analysis 
A polyclonal antisera was produced against a HSPG which copurifies with NCAM (Cole 
and Burg, 1989). Isolation of this proteoglycan has been previously described (Cole and Burg, 
1989). The antiserum was prepared by injecting a female white New Zealand rabbit three times 
at three week intervals with purified HSPG (25-50 J.lg/injection) over a period of two months. 
Serum was subsequently isolated and stored at -70°. 
A separate antiserum was prepared against a membrane-enriched proteoglycan fraction 
obtained from embryonic day 10 chick brains (E10). To prepare this fraction, E10 chick brains 
were homogenized in calcium, magnesium-free Hank's containing the protease inhibitor cocktail 
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previously described. After centrifugation (48,000 X g; 30 min), the supernatant was discarded 
and the membranes were homogenized in phosphate-buffered saline (PBS) containing 0.5% NP-
40 and the protease inhibitor cocktail. Since previous attempts to produce proteoglycan antisera 
hive been hampered by NCAM contamination, NCAM was removed from the membrane fraction 
by affinity chromatography using NCAM MAbs coupled to CNBr-activated Sepharose as 
previously described. Proteoglycans were isolated from the NCAM-depleted fraction using the 
DEAE-Sepharose extraction procedure described by Bretscher (1989). Two fractions were 
obtained from this procedure. One fraction (MI) binds to phenyl-Sepharose while the other 
fraction (MG) is unable to bind to the hydrophobic matrix. Since we were primarily interested in 
HSPGs contained in the proteoglycan fraction, we further purified these fractions by 
chondroitinase ABC digestion (1 U/ml; 37' for 4h) followed by gel chromatography on a 1.5 X 75 
em 8io .. gel A-1.5m (Bio ... RAd) column under dissociating conditions (PBS containing 0.1% SOS). 
The void volume of the column, containing primarily undigested HSPG proteoglycans, as well as 
some of the large CSPG protein cores, was collected. The SOS was removed using Extractigel-D 
(Pharmacia), and the samples concentrated using Centricon-30 microconcentrators (Amicon). 
Approximately 25-50 JJg purified proteoglycans/injection were used for both the MI and MG 
proteoglycans. Female New Zealand rabbits were given three injections of either MG (MG) or Ml 
proteoglycans over a two-month period. 
Antisera prepared against the NCAM ... copurifying HSPG and the MG proteoglycan fraction 
were used to immunopurify HSPGs identified in the current study. Each antiserum, including 
normal rabbit serum. was coupled to CNBr-activated Sepharose (0.5 ml) using previously 
described methods (Cole and Glaser, 1985). 0.25 ml aliquots were incubated overnight at 4° with 
105 cpm of rS]methionine-labeled chondroitinase ABC digested or nitrous acid treated 
proteoglycans from E10 chick brains as described above. After extensive washing with PBS 
containing 0.5 M NaCl, the bound fraction was eluted with PBS containing 50 mM diethylamine 
(pH 11.5), electrophoresed on 6% polyacrylamide gels, and proteins visualized by fJuorography. 
Cell-substratum adhesion assays 
A cell adhesion assay was performed to test the differential adhesiveness of chick brain 
cells from different developmental ages to a HBD-1 peptide substrate, using a modification of the 
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assay of Lagenaur and Lemmon (1987). Briefly, a 0.25 X 0.25 cm piece of nitrocellulose was 
dissolved in 6 ml of methanol, and 0.25 ml aliquots were applied to 35 mm petri dishes and 
allowed to dry. Aliquots of HBD-1 peptide (25119 dissolved in 100 pi PBS) were added to the 
dishes for 15 minutes, and excess binding sites were then blocked with Earle's balanced salt 
solution (EBSS) containing 1% eSA. Chick brains were removed from E6 and E10 chick 
embryos, dissociated into single cells with a pasteur pipette, and incubated in Spinner culture in 
suHate, leucine-free DME containing 10% dialyzed fetal calf serum, and 50 J.lCi eH]leucine (NEN) 
at sr for 2h. The labeled cells were washed 3 times with EBSS, 1 % BSA, and resuspended in 
EBSS, 1 % BSA. Aliquots of the labeled cells were then applied to HBD-coated dishes containing 
EBSS, 1% eSA. After a 30 min incubation at 37', the unbound cells were removed by aspiration. 
and the plates were washed once with PBS. The bound cells were removed with PBS 
containing 1 % Triton, and cell binding was quantified by liquid scintillation counting. The effect 
of heparan and chondroitin sulfate on the cell-substratum adhesion was tested by the addition of 
either heparan (50 I1g/ml) or chondroitin sulfate (100 I1g/ml) prior to application of the labeled 
cells. 
Growth of neurons on substratum-coated petri dishes 
Petri dishes (35 mm; Nunc) were coated with nitrocellulose (Lagenaur and Lemmon, 
1987), and either laminin (1 I1g), HBD-1 peptide (5 J.lg), E6 chick brain membrane-solubilized 
protein (25-50 I1g), or E10 chick brain membrane solubilized protein (25-50 119) was spotted onto 
the plates (10111) and allowed to dry under a Laminar hood. Non-specific binding sites were 
eliminated by incubating plates with 1 % BSA in sterile EBSS. Dissociated E6 optic lobe neurons 
(Pettmann et al., 1989), in DME containing 10% fetal calf serum, were added, and the plates 
incubated at 37',5% CO2 for 24-48h. 
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RESULTS 
Changes in synthesis of sulfated proteoglycans during chick brain development 
We were interested in comparing the proteoglycans found in the developing chick 
nervous system to those previously characterized from the chick retina. Previous analysis of chick 
retinal proteoglycans identified numerous HSPGs and CSPGs synthesized by this relatively 
simple eNS structure (Morris, 1984; Morris et aI., 1984; Morris et ai., 1987; Burg and Cole, 1990). 
Morris et al. (1987) demonstrated that there was a relative decrease in HSPG compared to CSPG 
during development of the chick retina. Studies in rodent brain (Oohira et ai., 1986; Burkart and 
Wiesmann, 1987; Jenkins and Bachelard, 1988) detected a similar shift from HSPG to CSPG 
during postnatal development, however, a similar analysis of embryonic brain has not previously 
been reported. We were therefore interested in determining the developmental pattern of 
proteoglycan synthesis in the embryonic chick nervous system. 
The relative percentage of heparan sulfate (HS) and chondroitin sulfate (CS) contained in 
the [35S]S04-labeled proteoglycan fraction was determined in the developing chick brain between 
E6 and E17. The results (Figure 1) show a dramatic decrease in HS, with a concordant rise in 
CS, between E6 and E10. The relative percentage of HS drops from 50% to nearly 25% during 
this period. While developmental changes in sulfation of the individual HS and CS GAG chains 
may account for some of the observed changes, it is likely that most of the observed change 
represents a relative shift from HSPG to CSPG. This period of brain development is characterized 
by extensive prOliferation, migration, and formation of the different layers of the optic tectum and 
forebrain (LaVaile and Cowan, 1971; Jacobson, 1978). Previous studies in rodent brain (Oohira 
at ai, 1986; Burkart and Wiesmann, 1987; Jenkins and Bachelard, 1988) and chick retina (Morris 
et ai, 1977) has shown a similar developmental shift from HSPG to CSPG during embryonic 
development. 
The developmental pattern of proteoglycan expression was also determined for a specific 
brain region, the cerebellum. The development of the chick cerebellum is delayed with respect to 
the other major brain regions, with a majority of its development occurring between E10 and 
hatching E21 (Hanaway, 1967; Jacobson, 1978). The relative percentage of cerebellar HSPG and 
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CSPG was determined during this period. These data (Fig. 2) once again show a developmental 
shift from HSPG to CSPG that occurs between E11 and E15, and which parallels the change 
occurring in tota' brain between E6 and E10. This stage of cerebellar development is similarly 
characterized by extensive proliferation, differentiation, and early development of the laminated 
structure found in mature cerebellum (Hanaway J 1967; Jacobson, 1978). Thus, it appears that 
while these different brain regions are maturing at different times in development, both are 
characterized by a shift from HSPG to CSPG of a similar stage of their development. 
Molecular sizing of proteoglycans in chick brain 
The intact molecular masses of the two classes of sulfated proteoglycans were 
determined using Sepharose Cl-68 chromatography. Sulfate-labeled proteoglycans from E6 and 
E10 brain were subjected to either nitrous acid or chondroitinase ABC treatments and analyzed 
on a Sepharose CL-68 column (Figure 3). To size CSPGs, nitrous acid treatment was used to 
degrade the heparan sulfate chains of the HSPG. The resulting eSS]S04 radioactivity is observed 
in the total volume of the column. The remaining rsS]S04 peak represents a CSPG population 
with an average MW of 420 kOa. The HSPG population revealed after chondroitinase digestion 
was smaller in molecular weight. with an average MW of 350 kDa (Fig. 3). Comparisons between 
Ea and E10 brains show that while the relative percentage of CSPG/HSPG increases, neither 
population changes in its average molecular weight during this period. Similar analysis of 
proteoglycans from older embryos also showed no change in molecular weight for either 
proteoglycan species (data not Shown). These brain HSPGs are similar in size to those isolated 
from a membrane-enriched proteoglycan fraction of developing chick retina, while the chick retina 
CSPGs were somewhat larger, exhibiting an average molecular weight of 520 kDa (Burg and 
Cole, 1990). 
The average molecular weights of cerebellar HSPG and CSPG were also determined using 
Sepharose CL-6B chromatography. This analysis reveals that the chick cerebellum contains 
HSPGs and CSPGs of similar size as found for total brain (Figure 4). Comparison between E11 
~nd E15 cerebellar proteoglycans again show no shift in molecular weight for either the HSPGs 
or CSPGs, but does exhibit the Increase in CSPGs relative to HSPGs in the older embryos. These 
data also indicate that while chick cerebellar and total brain proteoglycans are similar in 
molecular mass, they do exhibit differences from chick retinal proteoglycans (Burg and Cole, 
1990). 
Proteoalycan core protein analysis 
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We have previously identified multiple HSPG and CSPG protein cores in the developing chick 
retina (Burg and Cole, 1990), and therefore were interested in determining if proteoglycans in the 
developing chick cerebellum and total brain showed a similar protein core pattern. To obtain 
Information about the protein core(s) associated with the proteoglycans characterized by gel 
titration, we analyzed by gel electrophoresis [35S]methionine-labeled proteoglycans isolated from 
E8 and E13 chick brains. While these DEAE extracts were enriched in proteoglycans, they were 
still significantly contaminated with nonproteoglycan components based on [35S] methionine 
labeling. However, proteoglycan cores could be identified by the appearance of bands in the 
digested lanes which were absent in undigested control lanes. Chondroitinase ABC treatment 
(Figure 5:lanes 3,6,9) show several cores with MWs of 350, 230, 185, 150, and 70 kOa. While 
the same cores appear at all examined stages of development, the relative contribution of the 
different cores change, with the 350 kOa core decreasing and the 230, 185, 150, and 70 kDa 
cores increasing between E8-E13. These data analyzing protein cores of CSPGs agree with our 
earlier studies in chick retina which indicated the presence of at least five CSPG protein cores, 
however, these studies in retina failed to detect the 350 kDa or 70 kOa CSPG protein cores 
identified in the above analysiS of chick brain. These studies are also in agreement with a similar 
analysis of CSPG protein cores found in embryonic and adult rat brains, which identified up to 12 
different CSPG protein cores in the rodent brain (Gowda et al., 1989; Herndon and Lander, 
1990). 
Nitrous acid treatment reveals a major HSPG protein core of 250 kDa (Fig. 5;lanes 2,5,8). 
Developmental analYSis of this major HSPG 250 kOa core indicates a marked decrease from ES-
E13, consistent with the developmental decrease of [35S]S04-labeled HSPG described above. 
These results are in contrast to previous studies in embryoniC chick retina (Morris et al. I 1987; 
Burg and Cole,1990) which identified several HSPG protein cores with MWs ranging from 65-150 
kOa, but failed to identify a 250 kDa protein core. Recently, however, a HSPG with an associated 
250 kDa protein core has been identified in chick nervous tissue, which is present in the chick 
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retina basal lamina and axon tracts of the developing chick eNS (Halfter,1993). Several lines of 
evidence suggest that this HSPG may be related to the proteoglycan identified in our current 
study (see below). The demonstration that our chick HSPG is enriched in brain conditioned 
medium, and therefore may be a secreted proteoglycan also supports the suggestion that our 
HSPG is related to the HSPG recently described by Halfter (1993). Our results are, however, 
contrary to similar analyses of rat brain HSPG protein cores (Gowda et aI., 1989; Herndon and 
lander, 1990). which identified several HSPG protein cores with MWs ranging from 230-35 kDa. 
The possibility, therefore, exists that other HSPG protein cores remain undetected in our studies. 
Unfortunately, analysis of proteoglycan protein cores of embryonic chick brains was hampered 
by contamination of rS]methionine-labeled nonproteoglycan contaminating proteins. Initial 
analysis of these nonproteoglycan proteins suggest that many are GAG-binding proteins which 
remain aSSOCiated with the proteoglycans during the proteoglycan purification (data not shown). 
This demonstration of contaminating GAG-binding proteins was also reported in the analysis of 
the HSPG identified in the developing chick retina basal lamina and eNS axon tracts (Halfter, 
1993). 
The 250 kOa HSPG protein core identified in the present study is also recognized by 
several antisera produced in our laboratory which react with brain proteoglycans. One antiserum 
was produced against a brain HSPG that copurifies with the neural adhesion molecule, NCAM 
(Cole and Burg, 1989). This HSPG contains a core protein of 116 kDa, but may represent a 
small percentage of brain HSPG since our current analysis does not detect significant amounts of 
this core protein in developing brain. Alternatively, the core proteins isolated in the previous 
analysis may have been subjected to proteolysis during isolation. The second antiserum was 
produced against a HSPG-enriched brain fraction (see -Materials and Methods-). When coupled 
to Sepharose, these antisera against are both capable of specifically immunopurifying the 250 
kDa HSPG core protein from a nitrous acid digested brain proteoglycan fraction (Fig. 6; lanes 
3,5). These data therefore indicate that those antisera are reactive to the core protein. In 
addition, the antiserum produced against the HSPG-enriched brain fraction also is capable of 
immunopurifying the 350 and 230 kDa CSPG core proteins (Fig. 6; lane 6); normal rabbit serum 
coupled to Sepharose does not immunopurify any proteins from these proteoglycan fractions 
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(Fig. 6; lanes 1,2). These data imply that the larger CSPG core proteins comigrated with the 
Intact HSPG on the gel filtration column. As described in -Materials and Methods·, this fraction 
was used to generate the antiserum to the HSPG-enriched brain fraction. 
We have also recently shown that MAbs to the 250 kOa core protein of the chick basal 
lamina HSPG (Halfter, 1993) recognize a 250 kDa core protein in both chick brain soluble and 
membrane fractions (data not shown). This pattern of reactivity is similar to that observed with 
our antisera, which therefore suggests that the HSPG described in this study is related, if not 
Identical, to the HSPG described by Halfter (1993). 
Cerebellar proteoglycan protein cores were also analyzed as described for total brain 
proteoglycans. Following nitrous acid and chondroitinase treatment, CSPG and HSPG protein 
core patterns similar to those found in total brain were observed (Figure 7). A major 250 kDa 
HSPG protein core was identified, which decreases in relative abundance during cerebellar 
development between E15 and E18 (Fig. 7; lanes 5,8). At least five different CSPG protein cores 
were identified similar in size to the CSPG protein cores identified in total chick brain (Fig. 7; 
lanes 3,6). While an equivalent amount of radioactivity was electrophoresed in each lane, some 
lanes visually appear to contain less radioactivity than others. However, the protein cores 
positively identified in the study were consistently observed in digested lanes and absent in 
undigested samples. 
INTERACTION OF CHICK BRAIN HSPG WITH A HEPARIN-BINDING DOMAIN PEPTIDE 
The above data suggest that HSPG and CSPG perform different functions during important 
stages of neural development, since they exhibit different developmental patterns of synthesis. 
HSPG has been shown previously to enhance cell-cell interactions, in part by interaction with cell 
adhesion molecules such as NCAM (Cole and Glaser, 1986; Cole et al., 1986; Cole and Akeson, 
1989; Kallapur and Akeson, 1992), and a HSPG that copurifies with NCAM has been 
characterized (Cole and Burg, 1989). In addition, an antiserum produced against the brain HSPG 
that copurifies with NCAM recognizes the major brain HSPG identified in the current study (Fig. 
6). One possibility regarding neural HSPG function is that interaction of HSPG specific cell 
adhesion molecules is critical during early stages of development, but this interaction is not 
necessary or detrimental to later development. The ability of HSPGs from total chick brain to 
74 
interact with a peptide corresponding to the heparin- binding domain of NCAM was, therefore, 
tested in order to obtain some insight into whether brain proteoglycans were capable of binding 
this NCAM domain. As shown in Fig. 8, we were able to demonstrate that a HBD-Sepharose 
affinity column could specifically isolate the major HSPG of chick brain. Sepharose CL-6B 
chromatography reveals the HBD-bound proteoglycan fraction to consist of 350 kDa proteoglycan 
fraction, which was completely digested by nitrous acid (Fig. 8). These data indicate that only 
brain HSPG was retained on the HBD-Sepharose column; brain CSPGs remained in the unbound 
fraction (Fig 8). The specificity of this interaction between HSPG and HBD-peptide was further 
confirmed by protein core analysis (Figure 9). The HBD-unbound fraction is observed to contain 
the complex CSPG core pattern described earlier (Figure 9:lane 3), while the HBD-bound fraction 
contains only the major HSPG core of 250 kDa (Figure 9:lane 5), and contains no CSPG cores 
(Figure 9:lane 6). 
One possibility raised by the above data is that an elevated level of HSPG at early stages of 
neural development may enhance cell-cell interactions which are important in this developmental 
period. The adhesion of metabolically-labeled brain cells to HBD-peptide coated dishes was 
used to test the differential adhesiveness of neural cells of different ages. Brains from E6 and E10 
chicks were dissociated and metabolically labeled with [3H] leucine. These cells were then added 
to dishes coated with HBD-peptide in the presence or absence of either chondroitin sulfate or 
heparan sulfate. These results (Figure 10) show that E10 brain cells were consistently less 
adhesive (55%) than their E6 counterparts, based upon the percentage of cells that adhered to 
the HBD substratum. This interaction was shown to be HSPG-specific by the ability of heparan 
sulfate to inhibit the adhesion, while chondroitin sulfate had no effect. 
To further explore differences between E6 and E10 neural cells, we observed the cell 
attachment and growth of neurons on various substrata. Dissociated E6 brain cells attach well to 
an E6 brain membrane protein fraction absorbed to nitrocellulose-coated dishes; these cells 
extend short neurites within 24h (Fig. 11A). In contrast, dissociated E6 brain cells display a 
markedly decreased ability to attach to an E10 brain membrane protein fraction (Fig. 11 B), again 
demonstrating the relative decrease in cellular adhesiveness associated with the E10 brain cells. 
Neural cells grown on cell-adhesion molecules display differences when grown on ECM 
I 
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molecules. E6 brain cells grown on HBD-coated dishes display the high cell attachment and 
short neurite outgrowth pattern that was seen when the cells were grown on a E6 brain 
membrane fraction (Fig 11 C). In contrast, E6 cells grown on the ECM molecule, laminin, are 
characterized by a decrease in cell attachment with an increase in neurite outgrowth. These 
studies suggest that modulation of cell-surface adhesion and ECM interactions can change the 




The present study describes the isolation and preliminary biochemical characterization of 
the major sulfated proteoglycans synthesized in the developing chick brain. This survey allows 
US to compare the diversity and complexity of proteoglycans found in the developing chick 
nervous system to those described in the mammalian brain , chick retina, PNS, as well as, 
cultured glia, neurons. and PC12 cells (Margolis and Margolis 1989a, 1989b; 1993). 
Furthermore, analysis of the developmental regulation of the HSPGs and CSPGs that occur 
during chick brain development may help gain insight into the diverse functions associated with 
these two classes of proteoglycans. 
We have identified several putative CSPG cores with varied MWs between 350 kDa and 
70 kDA. These results are consistent with previous studies identifying multiple CSPG cores in the 
rodent brain (Gowda et ai, 1989; Herndon and Lander, 1990). Previous characterization of chick 
retinal CSPGs also revealed multiple CSPG cores of 220 kDa, 180 kOa, 155 kOa and 120 kDa 
(Burg and Cole, 1990). Three of these CSPG protein cores are similar in MW to those described 
In present study of chick brain, and may be related or identical. Two CSPGs, with protein cores 
of 370 kOa and 340 kDa, have been recently identified in the developing chick brain (Krueger et 
al.,1992). The smaller CSPG was shown to be also substituted with keratan sulfate, and 
therefore would not appear in our analysis. The 370 kOa core of the larger CSPG is similar in 
size to the 350 kDa described in this study and may be related. This CSPG with the 370 kDa 
core was also shown to be developmentally regulated, however, while the 370 kDa core protein 
expression peaks at E13, the 350 kOa core described in the present study peaks around E10. 
In the present study, we are also able to identify unequivocally only one major HSPG 
. protein core which has a MW of 250 kDA. This is somewhat surprising since previous studies in 
rodent brain have identified numerous HSPG cores (Herndon and Lander, 1990). However, HSPG 
cores of relatively low abundance or those which incorporate only low levels of [35S]methionine 
during the relatively brief labeling period would also be difficult to detect, especially considering 
the relatively high contamination with non-proteoglycan proteins still present in the partially 
purified extract. Previous analysis of chick retina revealed several HSPG cores of 60 kDa, 130 
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kOs, and 150 kOa, with no indication of a large 250 kDa core (Burg and Cole, 1990). However, 
" ... studies were conducted on membrane-enriched proteoglycans, while the current studies 
characterized brain proteoglycans from total brain extracts. While the existence of other 
unidentified HSPG cores is possible, the identification of an abundant, developmentally regulated 
HSPG, capable of interacting with a heparin- binding domain peptide of NCAM, is a significant 
observation from these studies. Previously, an HSPG that copurifies with NCAM has been 
id.,tified in developing chick brain (Cole and Burg, 1989). This HSPG exhibited an average 
molecular weight 01 400-520 kOa, and contained a protein core of 120 kOa. Our analysis of the 
protein cores of developing chick brain (Fig. 5) suggest this HSPG may represent a minor 
proteoglycan in the developing chick brain, or that the 120 kDa core protein ia a proteolytic 
fragment of the 250 kDa HSPG core protein. Accordingly, the HBD-affinity purification of the 
relatively abundant HSPG identified in the present study, and the ability of an antiserum prepared 
against the NCAM-associated HSPG (120 kDa core protein) to immunopurify the 250 kDa HSPG 
core from a mixture of nitrous acid treated proteoglycans, suggest that this proteoglycan protein 
core may be homologous to the previously characterized NCAM-associated HSPG. Thus, this 
HSPG may be an important NCAM-binding proteoglycan, although this awaits further analysis. 
The cell-substratum adhesion assays performed in this study suggest that cell surface HSPG, 
capable 01 binding to the heparan-binding domain of NCAM, is enriched in chick brain cells of 
earlier ages, and may assist in enhancement of cell-cell interactions during early developmental 
periods. 
Recently, a HSPG with a 250 kOa core protein has been identified in the developing chick 
nervous system using MAbs (Halfter, 1993). This proteoglycan was identified using MAbs 
produced from chick retinal basal lamina and chick optic tracts. The HSPG is abundant in the 
extracellular matrix of developing nerve tracts, where it is believed to associate with the axon cell 
membranes via heparan-binding molecules. The similarity in size and developmental expression 
of this HSPG with the molecule characterized in our study suggest that these molecules may be 
identical or related proteoglycans. In addition, the expression of NCAM in developing nerve tracts 
(Rutishauser 1984; 1989). and our demonstration that this HSPG can bind speCifically to NCAM, 
raises the interesting possibility that this HSPG modulates NCAM function during nervous system 
development. Studies are currently in progress using these MAbs, as well as our polyclonal 
antisera, to obtain information regarding the cellular distribution and structure of this potentially 
Important HSPG core protein. 
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Our data also demonstrate a pronounced shift in proteoglycan expression from HSPG to 
CSPG in the developing chick brain during a critical developmental period involving cell 
proliferation, migration, and formation of the complex structures of the brain, and in particular, the 
optic tectum (LaVaile and Cowan, 1971; Jacobson, 1978). This period of development has also 
been described as the second phase of chick brain development characterized by the formation 
of definitive cytoarchitecture, and distinguishes it from the early formative phase characterized by 
early neural differentiation, and the development of the major brain subdivisions (Romanoff,1960). 
The results presented here suggest that while early chick brain development may rely more 
heavily on HSPG-mediated functions, development of more intricate brain structures, such as the 
optic tectum, require either a down-regulation of HSPG-mediated functions and/or an increase in 
CSPG function. The importance of HSPG-mediated cell-cell interactions during initial neural 
networking, and the corresponding importance of CSPG-mediated ECM-cell interactions, as well 
as barrier/guidance functioning mediated by CSPGs. may help to explain the observed shift. The 
observed shift from HSPG to CSPG during the period of chick cerebellum development Similarly 
characterized by cell migration lamination strongly suggests that the two classes of 
proteoglycans are performing similar functions in development of this brain region (Jacobson J 
1978). Morris et ai, (1977) determined that a major shift from HSPG to CSPG was observed in 
the developing chick retina at a developmental period associated with retinal lamination. While a 
developmental analysis of the type described in this study has not been used to study 
mammalian cortex lamination, restricted spatiotemporal patterns of CSPG expression has been 
observed during cerebral corticogenesis of the rat (Nakanishi, 1983; Sheppard and Pearlman J 
1991 ). 
Our data presented here are consistent with previous work which has associated HSPG 
with early events in neural development, including neurulation (Morris and Solursh I 1978; Tuckett 
and Morriss-Kay, 1989). while CSPGs have been linked to cells that are more differentiated, and 
cellular environments that are more complex (Morris et ai, 1977; Oohira et ai, 1986; Geschwind 
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and Hockfield, 1989; Kalb and Hockfield, 1990). While it is not entirely clear how these two types 
of proteoglycans function in these different environments, one may speculate that HSPGs are 
used early in development to tightly control cell number and promote growth and adhesive 
functions in the formation of early neural networks. Later in development, these HSPG functions 
.,.1 down-regulated, and rapid prOliferation and migration of neurons is modified by CSPGs found 
In the surrounding ECM. In support of this notion, increased levels of HSPG have been linked to 
• decrease in cellular proliferation for many different cell types including hepatocytes, smooth 
muscle cells, fibroblasts, as well as neural and glial cells (Chiarugi and Vannucchi, 1976). In 
addition, transformed cells, characterized by abnormal proliferation, underexpress surface 
heparan sulfate (Chiarugi et ai, 1974). Heparatinase-treated rat embryos display improper cranial 
neurulation which, in part, is characterized by an abnormal increase in cell number (Tuckett and 
Morris-Kay, 1989). A strict control of neural cell proliferation would therefore seem important for 
early stages of nervous system development. At later stages of development, such as 
development of the tectum, cerebrum, or cerebellum, rapid cell proliferation is required, and a 
corresponding decrease in cellular HSPG would be expected. 
Early nervous system development is largely characterized by the expression of neural 
adhesion molecules and extension ofaxons in a stereotypic pattern along other axons (Dodd and 
Jessel, 1988; Jessel, 1988). HSPGs have been clearly associated with enhancement of cell-cell 
adhesion and neurite outgrowth, and therefore, play an important role at thais stage of 
development. For example, many proteins with defined roles in neural development are heparin-
binding molecules, and include NCAM (Cole et ai, 1985; 1986; Cole and Akeson, 1989), laminin 
(Rogers et ai, 1983; Lander et ai, 1985), and thrombospondin (Sun et ai, 1989; Neugebauer et ai, 
1991; O'Shea et ai, 1991). Later stages of development, characterized by extensive cell migration, 
would require a decrease in cell-cell adhesion, and therefore, a decrease in cellular HSPG might 
be expected. Our data indeed demonstrate a decrease in heparan-mediated binding of 
embryonically older chick brain cells to a heparan binding domain SUbstratum in an in vitro study 
(Fig. 9). In addition, the behavior of neurons grown on an extract of E6 brain membrane proteins 
is similar to their growth on a synthetic peptide corresponding to the heparan binding domain of 
NCAM, and is characterized by strong adhesion and limited neurite extension (Fig. 10A,C), and 
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contrasts the relatively poor adhesion and rapid axon elongation of neurons growing on the ECM 
component, laminin (Fig. 100). A decrease in cell surface HSPG, NCAM, and other molecules 
which enhance cell-cell adhesion, would allow cellular interactions with ECM molecules to 
predominate, and may facilitate cell migration and axon elongation within the complex ECM 
environment characteristic of later stages of nervous system development. 
In sharp contrast to HSPGs, CSPGs are an important component of the extracellular 
matrix of developing connective and nervous tissues, and appear to promote cell detachment, 
cell-ECM interactions, and cell migration (see Ruoslahti, 1988). Increased CSPG levels have 
been linked to the migration of cultured aortic endothelial cells after wounding (Kinsella and 
Wight, 1986). Primary mesenchymal cell migration in the sea urchin (Solursh et ai, 1986), as well 
as the developing vertebrate cardiac mesenchyme (Funderburg and Markwald, 1986) has also 
been demonstrated. In addition, there are increased levels of CSPGs in developing tumor stroma 
(Iozzo and Cohen, 1993) which may be associated with both the increased proliferation and 
metastasis of tumor cells. 
The observed shift from HSPG to CSPG in the developing chick brain during 
developmental periods associated with an increase in cell proliferation and migration is therefore 
consistent with known functions of the two classes of proteoglycans. For example, CSPG has 
been localized to the subplate and marginal layers of the developing mammalian cortex 
(Nakanishi, 1983; Sheppard et ai, 1991). The subplate plays a critical role in corticogenesis, and 
migrating neurons must migrate through this layer before differentiating and forming the layers of 
the cortical plate (Shatz, 1992). Incoming afferents defasciculate and form temporary 
connections with subplate neurons before forming their final connections with appropriate cortical 
targets (Ghosh and Shatz, 1993). CSPGs contained in the subplate may help to create an 
environment favoring migration and decreased cell-cell interaction. Studies in the reeler mutant 
mouse cortex, in which the cortical laminar pattern is inversed, revealed that CSPG expression is 
absent in the subplate, while CSPG expression is abundant in the superplate region above the 
cortical plate (Nakanishi, 1983). This study suggests that CSPG may be important for proper 
axon targeting. Extracellular matrix GAGs, presumably CSPGs, have been shown to form 
channels in the chick optic stalk and on the optic tecta I matrix ahead of growing afferent optic 
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axons (Krayanek, 1980; Krayanek and Goldberg, 1981), suggesting they playa prominent role in 
guidance ofaxons. 
Figure 1: Proteoglycan expression during chick brain development. Chick brains were removed at 
various embryonic ages, metabolically labeled with (358)S04' and proteoglycans isolated using 
DEAE-Sepharose chromatography. Samples were then subjected to nitrous acid or 
chondroitinase ABC treatments. Samples were then centrifuged using Centricon-30 
microconcentrators, and the percentage of digested [35S]S04-radioactivity in the centricon flow-
through was used to calculate the relative amount of HSPG and CSPG. This analysis reveals a 
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Figure 2: Proteoglycan expression during chick cerebellar development. Chick cerebella were 
isolated at various embryonic ages, labeled with [35S] SO., and proteoglycans isolated and 
analyzed as described in Figure 1. The cerebellar pattern of proteoglycan expression is similar 
to that found in total brain, with a shift from HSPG to CSPG occurring from E11-E15. The mean 
+ SO of three experiments is shown. 
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Figure 3: Molecular weight analysis of chick brain proteoglycans. Brain proteoglycans were 
metabolically labeled with [355]504 and isolated as previously described. Samples were treated 
with either nitrous acid or chondroitinase ABC, and sized on a Sepharose CL-4B column. Intact 
CSPGs from nitrous acid treated samples exhibit a broad peak with an average MW of 420 kDa, 
Intact HSPGs from chondroitinase ABC treated samples are smaller, with an average MW of 350 
kOal The relative decrease of HSPG can be seen when comparing the 350 kDa peaks of day 6 
and day 10 brains. Protein standards (thyroglobulin, 660 kDa; ferritin, 440 kDa; aldolase, 158 
kDa) were chromatographed on the Sepharose CL-48 column, and used to estimate the MWs of 
the proteoglycans. 
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Figure 4: Molecular weight analysis of chick cerebellar proteoglycans. Cerebellar proteoglycans 
labeled with [355]504 were isolated as previously described. Nitrous acid or chondroitinase ABC 
treated samples were then sized on a Sepharose CL-48 column. The sizes of intact cerebellar 
proteoglycans are similar to those found in total brain, with CSPGs (as revealed by nitrous acid 
degradation of HSPGs) displaying an average MW of 420 kDa, and HSPGs (as revealed by 
chondroitinase ABC digestion of CSPGs) a MW of 350 kDa. A decrease in the relative 
percentage of the 350 kDa HSPG peak is evident when comparing day 11 to day 15. Protein 
standards were used to estimate the MW of the cerebellar proteoglycans as described in Figure 
3. 
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Figure 5: Protein core analysis of chick brain proteoglycans. Chick brains were removed and 
metabolically labeled with [36S] methionine. Proteoglycans were isolated as previously described, 
and subjected to either nitrous acid or chondroitinase ABC treatments. Samples were then 
analyzed using autoradiograms from 7.5% polyacrylamide gels. Lane 1 t E8: Untreated; Lane 2, 
E8: Nitrous acid treated; Lane 3, E8: Chondroitinase treated; Lane 4, E10: Untreated; E10: 
Nitrous acid treated; Lane 6, E10, Chondroitinase treated; Lane 7, E13: Untreated; Lane 8, E13: 
Nitrous acid treated; Lane 9, E13: Chondroitinase treated. A major HSPG protein core of 250 
kOa can be seen (lanes 2, 5, 8); the relative amount of this HSPG protein core appears to 
decrease between E8-E13. Several CSPG protein cores with MWs of 350, 230, 185, 150, and 70 
kDa are also evident (lanes 3, 6, 9). The relative percentage of several of these CSPG protein 
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Figure 6: Immunoaffinity purification of proteoglycan core proteins. Antisera prepared against 
brain proteoglycans (see IIMaterials and Methodsll) or normal rabbit serum (NRS) were coupled to 
CNBr-activated Sepharose, and incubated at 4° overnight with aliquots of either nitrous acid 
treated or chondroitinase ABC treated eSS] methionine-labeled chick brain proteoglycans. After 
extensive washes, the bound proteins were eluted with 1 M NaCL and electrophoresed on 6% 
polyacrylamide gels. The antiserum against the HSPG which copurifies with NCAM (Cole and 
Burg, 1989) immunopurifies the 250 kOa HSPG protein core (lane 3), but does not significantly 
react to any other protein from the nitrous acid (lane 3) or chondroitinase treated (lane 4) 
proteoglycan fractions. The antiserum produced against a HSPG-enriched brain proteoglycan 
fraction, MG, also immunopurifies the 250 kOa HSPG protein core from a nitrous acid treated 
proteoglycan fraction (lane 5); this antiserum also immunopurifies the 350 and 230 kOa CSPG 
protein cores from chondroitinase treated proteoglycans (lane 6). NRS does not significantly 
immunopurify any protein from either the nitrous acid treated (lane 1) or chondroitinase treated 
(lane 2) proteoglycan fractions. Molecular weight markers are as previously described. 
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Figure 7: Protein core analysis of chick cerebellar proteoglycans. Chick cerebella were isolated, 
labeled with [35S]methionine, and processed as described in Figure 5. Lane 1, E15: Undigested; 
Lane 2, E15: Nitrous acid treated; Lane 3, E15: Chondroitinase treated; Lane 4, E18, Untreated; 
Lane 5, Nitrous acid treated; Lane 6, Chondroitinase treated. The cerebellar proteoglycan protein 
core pattern is similar to that found in total brain, with a major HSPG protein core of 250 kDa 
(lanes 2, 4) that decreases in relative percentage during cerebellar development, and several 
CSPG protein cores (lanes 3,6) which change in relative proportion during cerebellar 
development. Molecular weight markers are as previously described. 
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Figure 8: Molecular weight analysis of proteoglycans bound to the HBD synthetic peptide. 
[35S]S04-labeled proteoglycans isolated from E10 chick brains were incubated with a HBD 
synthetic peptide which had been coupled to CNBr-activated Sepharose. The unbound and 
HBD-bound proteoglycans were sized on a Sepharose CL-4B column. The unbound fraction has 
an average MW of 420 kDa, which corresponds to the size of CSPGs previously shown in Figure 
3. The HBD-bound fraction has an average MW of 350 kDa corresponding to the MW of HSPGs 
also seen in Figure 3. Nitrous acid treatment of the HBD-bound fraction resulted in complete 
digestion of the [35S1S04-radioactivity. thus confirming that the HBD peptide specifically binds the 
HSPG proteoglycan fraction. 
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Figure 9: Identification of HBD-binding HSPG protein cores. HBD peptide interactions with 
proteoglycans was analyzed by incubation of HBD peptide coupled to CNBr-activated Sepharose 
with [35S]methionine-labeled proteoglycans overnight at 4°. The unbound fraction was either left 
untreated (lane 1), nitrous acid treated (lane 2), or chondroitinase treated (lane 3), and 
electrophoresed on a 7.5% polyacrylamide gel. The HBD-bound material was eluted with 1 M 
NaCI, dialyzed, and was either left untreated (lane 4), nitrous acid treated (lane 5), or 
chondroitinase treated (lane 6). The HBD peptide specifically binds the HSPG with the 250 kDa 
core protein (lane 5), while not binding any CSPG (lane 6). Molecular wight markers are as 
previously described. 

Figure 10: Cell-substratum adhesion to HBD synthetic peptide. Aliquots of HBD-1 peptide (25 
J1g) were coupled to 35 mm dishes coated with nitrocellulose. Embryonic brain cells from E6 
and E10 chick brains were labeled with [3H]leucine for 2h and washed with EBSS, 1.0% BSA. 
Aliquots were added to either BSA-coated dishes, or peptide-coated dishes containing EBSS, 
1.0% BSA either alone, or in the presence of either heparan (50 J.lg/ml) or chondroitin sulfate (100 
J.lg/ml). Cell adhesion was determined after a 1 h incubation at 37' by dissolving bound cells in 
1 .0% Triton X-100 and determining the percentage of input cells bound after subtracting the 
background binding to the BSA-coated dishes. The data was then normalized to the adhesion of 
E6 brain cells to the HBD peptide, which displayed the greatest adhesion. The mean ± SD of 
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Figure 11: Cell adhesion and neurite outgrowth on various substrata. E10 chick optic lobe cells 
were plated on nitrocellulose-coated 35 mm dishes containing various substrata as described in 
"Materials and Methodsll • A. E6 brain membrane protein (20-25 Jig); B. E10 brain membrane 
protein (20-25 /19); C. HBD-1 synthetic peptide ( 5 /1g); D. laminin (1 /1g). Cells attach well to an 
E6 membrane protein substratum, and extend some short neurites (A), which resembles the 
pattern of growth seen on the HBD peptide substratum (e)f E10 membrane proteins provide a 
poor substratum for cell attachment and growth (B). The behavior of cells grown on laminin (D) 
contrasts that seen on the other substrata, and is characterized by moderate cell adhesion and 
extensive neurite outgrowth. 
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)t/. CLAUSTRIN, AN ANTI-ADHESIVE NEURAL KERATAN SULFATE PROTEOGLYCAN, 
IS STRUCTURALLY RELATED TO MAP18 
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ABSTRACT 
Our laboratory has recently identified a keratan sulfate proteoglycan (KSPG), named 
claustrin, that inhibits neural cell adhesion and neurite outgrowth in the chick nervous 
system. Antisera prepared against claustrin were used to screen a cDNA expression library 
from embryonic day 9 chick brain. Initial characterization of positive cDNAs revealed a high 
degree of homology to the mouse MAP1 B gene, although these cDNAs represent a 5' 
truncated fragment of MAP1 B. Protein sequencing of 3 peptides derived from a tryptic 
digest of purified, keratanase-treated claustrin also revealed strong homology to MAP1 B, and 
confirmed the authenticity of the 3.4 kb claustrin cDNA. To further determine the relationship 
between these two proteins, antibodies against MAP1 Band KSPGs were used in 
immunoblotting and immunohistochemical studies. These studies demonstrated 
cross reactivity between MAP1 Band claustrin antibodies, and that monoclonal antibodies to 
cartilage keratan sulfate react with MAP1 B in rat nervous tissue, and with claustrin in the 
chick nervous system. In addition, keratanase treatment of a taxor microtubule fraction from 
chick or rat brain eliminated MAP1 B, as detected by immunoblotting with the MAP5 
monoclonal antibody. These results suggest that MAP1 B and claustrin are highly related, if 
not identical, proteins. 
Keywords: proteoglycan; keratan sulfate; MAP1 B; neural development 
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INTRODUCTION 
Increasing evidence suggests that nervous system proteoglycans represent a diverse 
group of macromolecules involved in a wide array of functions in the developing nervous 
system (Cole and Burg, 1989; Herndon and Lander, 1990; for reviews see Ruoslahti, 1988; 
Margolis and Margolis, 1989; Kjellen and Undahl, 1991; Jackson, Busch, and Cardin, 1991). 
In general, heparan sulfate proteoglycans (HSPGs) have been linked to the enhancement of 
cell-cell interactions, as well as the stimulation of neurite outgrowth (Lander, Fujii, and 
Reichardt, 1985; Cole, Schubert, and Glaser, 1985; Cole, Loewy, and Glaser, 1986; Hantaz-
. 
Ambroise Vigny, and Koenig, 1987; Riopelle and Dow, 1990; Jackson et ai, 1991). These 
functions are usually mediated in part by interactions with heparan-binding proteins which 
include NCAM (Cole et ai, 1985; 1986; Cole and Akeson, 1989; Kallapur and Akeson, 1992), 
fibronectin (Rogers, Letourneau, Palm, McCarthy, and Furcht, 1983; Rogers, McCarthy, Palm, 
Furcht, and Letourneau, 1985), laminin (Rogers et ai, 1983; Lander et ai, 1985), and 
thrombospondin (Sun, Mosher, and Rapraeger, 1989; Neugebauer, Emmett, Venstrom, and 
Reichardt, 1991; O'Shea, Uu, and Dixit, 1991). Neural chondroitin sulfate proteoglycans 
(CSPGs) are a major component of the extracellular matrix (ECM), and contribute to both 
cell-ECM and ECM·ECM associations (Margolis and Margolis, 1989). Unlike HSPG, CSPGs 
have generally been found to be inhibitory to neurite outgrowth (Snow, Lemmon, Carrino, 
Caplan, and Silver, 1990a; Fichard, Verma, Olivares, and Saxod, 1991; McKeon, Schreiber, 
Rudge, and Silver, 1991; Oohira, Matsui, and Katoh-Semba, 1991). Keratan sulfate 
proteoglycans (KSPGs) are less abundant in the nervous system than the other sulfated 
PGs. Recent evidence suggests that KSPGs colocalize with CSPGs and have similar 
functions during development of the nervous system (Snowet ai, 1990a; Snow, Steindler, 
and Silver, 1990b; Cole and McCabe, 1991; McCabe et ai, 1992; McCabe and Cole, 1992). 
Significantly, CSPG and KSPG have been reported to be associated with proposed 
barrier structures. These barriers, which include the spinal cord roof plate, the brainstem 
midline, and the cortical subplate, are thought to prevent growing axons from following 
aberrant paths during development (Silver, Poston, and Rutishauser, 1987; Snow et ai, 
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199Ob; Cole and McCabe, 1991; Sheppard, Hamilton, and Pearlman, 1991; McCabe et ai, 
1992; McCabe and Cole, 1992). Snowet.aI. (1990b) have detected CSPG and KSPG in the 
glial roof plate of chick spinal cord during developmental times in which dorsal column 
axons are growing to their ipsilateral targets. In addition, dorsal commissural axons avoid 
. the glial roof plate, but cross the midline at the floor plate, which does not express KSPG or 
CSPG (Snowet ai, 1990b). Once the commissural and dorsal column axons have reached 
their proper targets, the level of these PGs are down-regulated. KSPG has also been found 
. in the IIgliai knor of the border between the telencephalon and diencephalon in the 
developing chick, during times in which both the olfactory and optic pathways are 
developing (McCabe, Thompson, and Colef 1992). The knot is thought to segregate these 
two pathways, and again, the proteoglycans disappear once the pathways are established. 
Recently we have described a novel neural KSPG, named claustrin, that is a 
developmentally-regulated 320 kDa proteoglycan expressed primarily in embryonic chick 
nervous tissue (Cole and McCabe, 1991). Immunohistological analysis has revealed its 
expression in CNS glial barrier structures along the midlines of the spinal cord and 
brainstem, including the glial roof plate (Cole and McCabe, 1991; McCabe and Cole, 1992). 
In addition, claustrin has been detected in the aglial knota region of the developing chick 
forebrain (McCabe et ai, 1992). Purified claustrin has also been shown to inhibit neurite 
outgrowth and cell adhesion on substrata comprised of laminin or NCAM (Cole and McCabe, 
1991). Together these data suggest that claustrin may play an important role in the 
modulation of axonal growth processes in the developing nervous system. 
In order to further characterize claustrin, we have screened an E9 chick cDNA expression 
library using two different antibodies; one prepared against the intact proteoglycan, and the 
second generated against a protein core of 70 kOa. Interestingly, initial sequence analysis of 
nine overlapping partial cON As revealed a strong (67% at the amino acid level) homology to 
the mouse microtubule-associated protein, MAP1 B (Noble, Lewis, and Cowan, 1989). 
However, these cDNAs represent 5' truncated fragments of MAP1 B. In order to further 
explore the relationship between MAP1 B and claustrin we carried out immunoblotting and 
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Immunohistological studies using antibodies to both MAP18 and claustrin. MAP18 (also 
called MAP5. MAP1, MAP1.2, MAP1 x) has been described as a 320 kDa MAP that is 
expressed early in development, and possibly associated with neurite outgrowth (Tucker, 
1990; Burgoyne, 1991). However, the exact nature of MAP18 itself has been somewhat 
elusive, since several different laboratories have produced MAbs against MAP1 B which show 
biochemical and histological differences between one another (Garner, Matus, Anderton, and 
Calvert, 1989). These data suggest that either differences in post-translational modification 
exist, or that several related proteins exist with MAP18 homology. While cDNA sequence 
analysis of mouse MAP1 8 predicted an encoded protein of approximately 250 kDa (Noble et 
ai, 1989), recent evidence suggests that MAP1 B may be synthesized as a polyprotein which 
is rapidly processed (Hammarback, Obar, Hughes, and Vallee, 1991). In addition, the 
identity of MAP1 B becomes further elusive in light of the recent isolation of a cDNA encoding 
a 94 kDa polypeptide corresponding to the 3' end of the MAP1 B gene, which was named 
neuraxin (Rienitz et ai, 1989). Our studies reported here show that antibodies against rat 
MAP1 B recognize chick claustrin, and that MAP18 and claustrin proteins exhibit similar, if not 
identical, biochemical properties. The distribution of MAP1 B in the embryonic rat brainstem 
is also similar to the distribution of claustrin in chick brainstem, further supporting the 
relatedness between these proteins. Thus, the data presented here support the hypothesis 
that MAP1 B and claustrin are related, if not identical proteins, and that MAP1 B is a keratan 
sulfate proteoglycan. 
MATERIALS AND METHODS 
Preparation of Antisera to Claustrin 
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Claustrin was isolated from E12 chick brain extracts by monoclonal antibody 
immunoaffinity chromatography, as described previously (Cole and McCabe, 1991). The 
Intact proteoglycan migrates as a 320 kDa band on polyacrylamide gels, and this band was 
excised and injected into female New Zealand white rabbits. Approximately 10-20 I1g of 
protein was injected at three week intervals, and reactivity of the antiserum to the 
proteoglycan was confirmed by immunoblotting of E12 brain protein. 
A second antiserum was prepared to a core protein of claustrin, with a molecular weight 
of 70 kOa. Purified claustrin was digested 4 h with 1 U/ml of keratanase (ICN) as described 
previously (Cole and McCabe, 1991). Following gel electrophoresis, the 70 kDa core protein 
was excised from the gel, and injected into rabbits at three week intervals. Reactivity of this 
antiserum with claustrin was confirmed by immunoblotting of undigested and keratanase 
digested brain protein or purified claustrin. 
A third antiserum was prepared to claustrin that was purified by two cycles of 
immunoaffinity chromatography with the AH10 MAb. Silver staining analysis of this 
preparation indicated that the proteoglycan had been purified to homogeneity (data not 
shown). Aliquots of the proteoglycan (10 I1g) were then digested with 1 U/ml of keratanase 
for 4h, and this mixture, which contains both core proteins, was injected into rabbits as 
described above. 
Isolation of Claustrin cDNA Clones 
Initial screening of claustrin eDNA clones used a lambda cDNA expression library 
prepared with the Uni-Zap XR cloning vector (Stratagene). Total RNA was isolated from E9 
chick brains by the method of Chomczynski and Sacchi (1987), and polyA+ RNA was 
isolated by absorption to oligo dT cellulose (Collaborative Research). 2119 of polyA+ RNA 
was used for first strand synthesis, and synthesis was primed using oligo dT oligonucleotide. 
After completion of second strand synthesis the eDNA was size selected by Sepharose CL-
48 chromatography, with an average insert size of approximately 1 kb. The cDNA was then 
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Hgated into the Uni-Zap XR vector in a sense orientation, with respect to the LacZ promoter, 
and packaged using Gigapack II Gold packaging extract (Stratagene). The library was then 
amplified once prior to use. 
For screening Escherichia coli cells, strain XL 1-Blue cells were infected with 
bacteriophage and plated on NZY agar plates. Nitrocellulose filter lifts were prepared from 
approximately 400,000 recombinants and incubated with a polyclonal antiserum (1 :200) 
generated against the intact claustrin proteoglycan. Seven positive clones rescreened 
positive and were plaque purified. Four of these clones were shown to be homologous to 
mouse MAP1B by dideoxy chain termination sequencing. An additional 400,000 
recombinants were then screened using a second antiserum, prepared against the 70 kDa 
core protein of claustrin. Five positive clones were isolated, each of which rescreened 
positive. These cDNAs were shown to be homologous to mouse MAP1 B by sequencing. 
Insert sizes of the claustrin cDNA clones ranged from 600 bp to 1.S kb. These inserts were 
excised from pBluescript according to manufacturer protocols, and sequenced by the 
dideoxy chain termination procedure (Sanger, Nicklen, and Coulson, 1977) using Sequenase 
version 2.0 (U.S. Biochemicals). Synthetic oligonucleotide primers were then prepared to 
facilitate complete sequencing of the inserts. 
Additional claustrin cDNA clones were obtained by screening an oligo dT-primed E13 
chick brain 19t10 cONA library ( kindly provided by Dr. Barbara Ranscht, LaJolia Cancer 
Research Foundation). An oligonucleotide probe (5' 
GATGAGTGGTTTCTCCTCIIIIIIAGAAAC) was synthesized from 5' sequence information 
contained within the 1.4 kb partial claustrin cDNA construct produced from the initial 
screenings (Fig. 2), and end-labeled with [32P] dATP. Filter lifts were prepared from 
approximately 400,000 plaques, and hybridized with the labelled probe overnight at 3r in 6X 
sse, 1 X Denhardt's solution, 0.1 % SOS, 100 J.lg/ml sperm DNA. Filters were then washed at 
60° with 6X SSC, 0.1 % SDS, and exposed to Kodak XAR-S film at -700 with intensifying 
screens. Positive clones were plaque purified and subcloned into the EcoRI site of the 
plasmid pGEMz7-f (Promega). One clone, named 6G5, was sequenced by the dideoxy chain 
termination procedure (Sanger et ai, 1977). A similar procedure was used to screen a 
random-primer generated E14 chick retina glia library ( kindly provided by Dr. Anthony 
Young, Ohio State Biotechnology Center). One clone, named 7G2, was subcloned into 
pGEMz7-f and sequenced. 
Northern Blot Analysis 
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RNA was extracted from E9 chick brains using the guanidium-isothiocyanate method 
(Chomczynski and Sacchi, 1987). Poly A+ RNA was purified using oligo [dT] cellulose 
chromatography (Pharmacia). 7.S J..Ig of poly A+ RNA was electrophoresed through a 1% 
agarose gel containing 2.2 M formaldehyde, and transferred to a nylon membrane (Nytran; 
Schleicher & Sehuell) using a posiblot pressure apparatus (Stratagene). Membranes were 
hybridized with a Fp] dATP-labeled cDNA probe, obtained from random-primed labelling of 
an EcoRI fragment of the 24-1 claustrin eDNA (Fig. 2), at 42° for 48h in 5X SSPE, 1X 
Denhardt's solution, 0.5% SOS, 100 J..Ig/ml sperm DNA, 50% formamide. The membranes 
were washed to a final stringency of 0.2 X SSC at 68°, and exposed to Kodak XAR-S film for 
autoradiography. 
Protein Microsequencing of Purified Claustrin 
Immunopurified claustrin was digested with keratanase (ICN) to yield the 70 kDa and 
100 kDa core proteins. Because of limited amounts of the 100 kDa protein, sequence was 
only obtained for the 70 kDa core protein. The 70 kOa core protein was visualized by 
Coomassie Blue staining of polyacrylamide gels, and 411 pmol of protein was isolated as 
determined by amino acid sequence analysis. The protein was then digested with trypsin, 
separated by HPLC, and sequenced directly by K Williams and K Stone of the W.M. Keck 
Foundation Biotechnology Resource Laboratory at Yale University. 
Preparation of Soluble Brain Proteins 
Rat brain tissue from E20 rat brain was homogenized in calcium, magnesium-free Hank's 
balanced salt solution (eMF) containing aprotinin (1,000 kallikrien inhibitor U/ml), 
phenylmethylsulfonyl fluoride (1 mM), leupeptin (0.5 ug/ml), pepstatin (1 J.lg/ml) , and EDT A 
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(1mM), and then centrifuged at 48,000 X g for 1 hr to obtain a soluble fraction. Embryonic 
chick brain tissue (E9) was processed similarly. Claustrin was immunopurified from E12 
chick brain as previously described (Cole and McCabe, 1991). Protein concentration of 
fractions was determined by the method of Bradford (1976). 
Isolation of Microtubules and Microtubule ... Binding Proteins 
Microtubules along with associated microtubule-binding proteins were isolated from 
chick and rat brain tissue following the taxol-dependent procedure of Vallee (1986) with 
some slight modification. Briefly, taxol and GTP (20 J.lM and 1 mM final concentrations, 
respectively) were added to 1 ml soluble brain protein fractions (20 ... 25 mg/ml) in CMF, and 
incubated at 3r for 30 minutes. Samples were centrifuged at 48,000 X g for 30 minutes in 
order to pellet the microtubules. The pellets were dissolved in CMF containing 1 M NaCI 
and recentrifuged. The soluble fractions containing the dissociated microtubules and 
microtubule-associated proteins were dialyzed overnight at 4° against CMF. 
Enzymatic Treatments 
Samples of soluble brain protein (generally 100 ... 200 J.lg) t purified claustrin (1-5 J.lg), or 
taxol-purified microtubules (2()...6() J.lg) were incubated with keratanase (1 U/ml) for 4 h at 37'. 
All samples were in PBS containing the protease inhibitor cocktail described above. 
Treatment of samples with endo-/3...galactosidase (Boehringer Mannheim) and\or keratanase II 
(Seikagaku Co.) were conducted at 100 mU\ml for 24h. 
Electrophoresis and Immunoblotting 
All samples were electrophoresed on 6% polyacrylamide gels using the buffer system 
of Laemlli (Laemlli, 1970). Gels to be stained were either soaked in 0.5% Coomassie Blue for 
several hours followed by destaining in 10% glacial acetic acid/10% methanol, or silver ... 
stained. Gels to be used for immunoblotting were electrophoretically transferred to 
nitrocellulose using a Hoefer Transblot apparatus (Hoefer Scientific Instruments, San 
Francisco, CA). Filters were blocked by soaking in 5% nonfat dry milk for 45 minutes. The 
filters were then incubated with primary antibodies diluted into 5% nonfat dry milk for 1 h. 
This was followed by 1 h incubations with biotinylated secondary antibody, and an avidin ... 
peroxidase complex (Vector Laboratories). Antibody binding was visualized using 
dlaminobenzadine (DAB). 
Metabolic Labeling of Chick Claustrin 
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Synthesis of claustrin was analyzed by metabolic labeling of glial cultures as described 
previously (Cole and McCabe, 1991). Briefly, E10 chick brains were trypsinized and plated 
for 4·5 days. Cells were then removed from the substratum by trypsinization and replated to 
yield pure glial cultures. For pulse-chase labeling of glia 35 mm dishes were washed with 
methionine-free Dulbecco's Minimal Essential Medium containing 10% dialyzed fetal calf 
serum and then incubated in the same medium for 2 hours prior to the addition of 150 pCi of 
FS]methionine (ceUlabeling grade, NEN). Cells were then incubated for 30 min, followed 
by removal of medium, washing with normal DME-10% FCS, and incubation with normal 
medium for 1-22 h. Cells were washed with PBS, followed by lysis with PBS-1% Triton X-
100. Conditioned medium and cell extracts were then incubated with 0.1 ml of Sepharose 
CL-4B to which AH10, AH11 and AH4 MAbs had been coupled. These MAbs recognize the 
claustrin molecule, but either do not react or only exhibit weak reactivity with the core 
proteins. Bound radioactivity was eluted from the affinity matrix by incubation with PBS-50 
mM diethylamine (pH 11.5). Equal aliquots of the purified cell and conditioned media 
fractions were then analyzed by polyacrylamide gel electrophoresis. To confirm that the 
immunoprecipitated protein was claustrin, aliquots of conditioned media or cell protein was 
treated with keratanase (1 U/ml) for 2h prior to gel electrophoresis. 
For purification of rH]glucosamine-labeled claustrin, chick glial cultures were labeled 
in low-glucose DMEM for 24 or 48h with 25 pCi\ml of rH]glucosamine. Isolation of claustrin 
from cell Iysates or conditioned medium was then conducted as described above, using 
AH10-coupled Sepharose. 
Immunohistochemical Analysis of MAP1 B in Rat Brain 
For immunohistological analysis of MAP1 B in rat brain, E20 rats were decapitated and 
brain tissue was fixed in 4% paraformaldehyde for 4h at room temperature. The tissue was 
then dehydrated, embedded in paraffin, and sectioned at 10 pm as described previously 
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(McCabe et ai, 1992). Sections were then incubated with MAPS MAb (1 :1000) for 2 h at 
room temperature, and antibody binding was visualized using biotinylated secondary 
antibody and an avidin-horseradish peroxidase conjugate (McCabe et ai, 1992; McCabe and 
Colet 1992). Similar analyses were conducted using the polyclonal antisera to chick 
claustrin, with identical results obtained when compared to MAPS MAb staining. However, 
staining with antibodies to claustrin was very weak (data not shown). 
114 
RESULTS 
Claustrin Protein Core Analysis 
In order to extend our characterization of claustrin, the protein cores of the KSPG were 
Identified by keratanase digestion of the purified intact molecule. Two major protein cores, 
of 100 kDa and 70kDa, were identified following silver staining of the electrophoretically 
separated digest (Fig. 1 A). These core proteins were reproducibly obtained when using 
different lots of keratanase, although variation in the relative proportions of these proteins is 
observed, raising the possibility that these core proteins are related, possibly by proteolytic 
cleavage of the 1 00 kDa core protein. The appearance of these two core proteins were also 
observed upon treatment of claustrin with endo.p-gaJactosidase (Fig. 1 B) and keratanase II 
(data not shown). Each protein core was excised from polyacrylamide gels (using the 
claustrin preparation shown in Fig. 1 A), and used independently to generate polyclonal 
antibodies. Antisera generated against either protein core reacted with both core proteins, as 
well as intact claustrin (data not shown), suggesting that the two core proteins are related. 
However, the exact relationship between the 70 kDa and 100 kDa proteins has yet to be 
determined. For example, it remains to be tested whether the 70 kDa core is a degradation 
product of the 100 kDa core protein, or whether the two proteins are the products of distinct 
mRNAs. 
Identification of Claustrin cDNA Clones 
Antisera generated against both intact claustrin and the 70 kDa protein core were 
used to screen an oligo dT -primed E9 chick brain expression library. The anti-70 kDa 
antiserum was selected since the anti-100 kDa antiserum exhibited a low titer, and weaker 
reactivity with claustrin. Each antibody was used to independently screen approximately 
400,000 recombinants. Positive plaques were picked and rescreened. A total of seven 
clones rescreened using the intact claustrin antisera, while five clones rescreened with the 
70 kDa protein core antiserum. These clones were plaque purified using standard protocols. 
Sequence analysis of these clones revealed that nine of the twelve clones were related to 
each other, and moreover, these clones were homologous to the mouse MAP1 B gene. 
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Sequence information from three of these overlapping clones (20-1,24-1,24-2) was combined 
to produce an approximately 1.4 kb partial claustrin cDNA (Fig. 2). Partial sequence 
Information for the other clones all map to a region contained within the 1.4 kb cDNA. 
Interestingly, these clones show identity in the coding region, but diverge in the 3' 
untranslated region, as indicated in the 24-1 and 24-2 cDNAs in Fig. 2. To extend our 
sequence information in the 5' direction, an E13 chick brain 19t1 0 library was then screened 
with an oligonucleotide probe generated from 5' sequence of the initial claustrin 1.4 kb 
eDNA. A resulting clone, named 6G5, was subcloned into pGEM7 and sequenced. The 
6G5 clone overlapped with the 1.4 kb claustrin eDNA, and extended the sequence 
approximately 2 kb, resulting in an apparent full-length 3.4 kb cDNA (Fig. 2). The complete 
sequence of the cDNA contains an open reading frame (ORF) of 3114 bp coding for 1038 
amino acids (Fig. 3). This amino acid sequence is 75% homologous to the published 
MAP1 B sequence (Noble et ai, 1989). The protein sequence contains five Ser-Gly repeats, 
known to represent potential glycosaminoglycan acceptor sites (Kjellen and Lindahl, 1991),3 
N-linked glycosylation sites, and numerous potential O-linked glycosylation sites. This latter 
observation is of significance since other KSPGs have been shown to contain O-linked 
keratan sulfate chains (Hascall,1983). In addition, the sequence contains an RGD sequence, 
a sequence common to many ECM components, which is involved in cell adhesion 
(Reichardt and Tomaselli, 1991). The deduced amino acid sequence encodes a protein with 
an estimated MW of 117 kOa, similar in size to the putative 100 kOa core obtained from 
keratanase digestion of claustrin (Fig. 1). Although the cDNAs encoding claustrin show 
strong homology to MAP1 B, the claustrin cDNA(s) appears to represent a 5' truncated 
version of the MAP1 B sequence (Fig. 4). Thus, the chick claustrin cDNA isolated by our 
laboratory corresponds to nucleotides 1-3149 of mouse MAP1 B, while the untranslated 
region appears unrelated to MAP1 B. The claustrin cDNA contains a stop codon and a short 
222 bp untranslated region which occurs nearly 4.3 kb upstream from the stop codon of the 
corresponding mouse MAP1 B sequence. While a 3' truncated version of MAP1 B, which was 
named neuraxin, has been previously identified in rat (Rienitz et ai, 1989), our claustrin clone 
Is not unique, as a 5' truncated version of MAP1 B has also been identified in Torpedo 
(Ngsee and Scheller. 1989) . Interestingly. the proposed microtubule-binding domain 
described for MAP1 B is contained within the claustrin sequence (Noble et ai, 1989). 
Northern Analysis of Claustrin mRNA 
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In order to gain preliminary information as to claustrin's message size and complexity, 
Northern blot analysis was performed. 7.5119 of poly A+ RNA isolated from embryonic chick 
brain was electrophoresed and hybridized using a[32PJ-labeled EcoRI fragment of the 24-1 
eDNA clone, which corresponds to coding sequence only. A 24h exposure revealed a major 
transcript of >10 kb, along with a less abundant transcript of approximately 8 kb (Fig. 5; 
lane 1). A longer exposure resulted in the appearance of smaller transcripts of 5.0 kb and 
3.2 kb (Fig. 5; lane 2, asterisks). No apparent degradation of the RNA was observed by 
analysis of residual 28S and 18S ribosomal RNA contained in the poly A + -enriched samples 
(data not shown). 
Claustrin Core Protein Sequencing 
In order to confirm that the cDNA clones isolated were authentic, the claustrin 
preparation shown in Fig. 1A was subjected to keratanase treatment, and the 70 kDa 
claustrin core protein was excised from a polyacrylamide gel, trypsin-treated, HPLC purified, 
and several peaks were partially sequenced. These data confirm that the 70 kDa claustrin 
protein core is indeed strongly homologous to mouse MAP1 B (Fig. 6). Two peptides of 5 
and 18 amino acids were identical to the corresponding mouse MAP1 B sequence, while a 
third 13 amino acid peptide shared 78% identity. All three claustrin peptides map to the 3.4 
kb claustrin cDNA (Fig. 3; double-underlined sequence). The peptide sequence data 
supports the hypothesis that claustrin and MAP1 B are structurally related proteins, and 
confirms the authenticity of the isolated cDNAs. 
A search of the Swiss Prot Protein Database reveals that claustrin and MAP1 Bare 
homologous to a protein found exclusively in the electric lobe and spinal cord of the ray, 
Torpedo califomica (Fig 6; ENP 1). The ENP 1 protein was identified by screening of a 
Torpedo cDNA library with an anti-synaptic vesicle antiserum. and the resulting cDNAs were 
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shown to represent a 5' truncated fragment of MAP1 B (Ngsee and Scheller, 1989). Thus, the 
possibility that claustrin and ENP 1 are related proteins is intriguing, but remains to be 
confirmed (see Discussion). 
Immunoblot Analysis of Rat and Chick Brain Proteins 
In order to further determine the relationship between claustrin and MAP1 B, we 
" carried out immunoblot studies of brain proteins using well-characterized antibodies against 
MAP1 B, as well as several KSPG antibodies. First, to determine the relationship between 
MAP1 Band claustrin, we conducted immunoblotting analysis using a MAb (MAPS) produced 
against the rat MAP1 B protein (Reiderer, Cohen, and Matus, 1986). As shown in Fig. 7, the 
MAPS MAb recognized only a 320 kDa band in both E20 rat brain homogenate supernatants, 
as well as E9 chick brain supernatants, which corresponds to the proper location of both 
MAP1 B and claustrin. To demonstrate that the MAPS MAb reactivity was directed against 
claustrin, we immunoblotted, using MAPS MAb, purified chick claustrin, which had been 
immunoaffinity purified from E12 chick brain using a claustrin MAb specific for the keratan 
sulfate moiety of the proteoglycan (Cole and McCabe, 1991). These data indicate that the 
MAP5 MAb reacts with purified claustrin (Fig. 7A). Interestingly, the MAP5 MAb 
immunoreactivity at 320 kOa was eliminated in these samples when digested with keratanase 
(Fig. 7A), an enzyme that specifically removes keratan sulfate chains from KSPGs. Our data 
suggest that the MAP5 MAb weakly recognizes the 100 kDa protein core in keratanase-
digested purified claustrin , as well as a putative protein core of similar size in the digested 
rat brain supernatants (data not shown). However, to observe this MAP5 MAb reactivity we 
had to analyze large amounts of purified claustrin. Since in these experiments the reactivity 
of the MAb with claustrin core protein was always significantly weaker than with the intact 
molecule, this suggests that the presence of keratan sulfate plays a role in recognition of the 
epitope by the MAPS MAb. Polyclonal antisera against both MAP1 Band claustrin strongly 
recognize the 100 kDa core (see below). Thus, not only does MAP1 B antibody react to 
purified claustrin and its polypeptide core, but these data suggest that the rat protein 
recognized by MAPS MAb is a KSPG. Furthermore, these data raise the interesting 
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possibility that the previously identified 11 kb MAP1 B cDNA does not encode for a 250 kDa 
protein, since a protein in this size range is not detected following keratanase treatment and 
immunoblotting with MAP1 B antibodies. 
To further explore the relationship between MAP1 Band claustrin, we carried out an 
analysis using a second MAb raised against rat MAP1 B, designated MAP1 B-4, which 
recognizes an epitope in the carboxyl terminal region of MAP1 B (Bloom, Luca, and Vallee, 
1984). This antibody reacts with the 320 kDa protein in rat (Fig. 78), but is only weakly 
reactive with chicken claustrin (data not shown). This immunoreactivity with MAP1 B-4 is 
eliminated after prolonged keratanase digestion. Comparisons between partial keratanase 
digests of rat brain supernatants using MAPS and MAP1 B-4 MAbs, which recognize epitopes 
in the amino- and carboxy-regions of MAP1 B, respectively (Bloom et ai, 1984; Zauner, Kratz, 
Staunton, Feick, and Wiche, 1992), reveal distinct immunoreactive patterns (Fig. 78). These 
data raise the possibility that distinct polypeptides are recognized by these MAbs. This is 
interesting in the light of recent studies which have identified MAP1 B-derived polypeptides 
corresponding to 5' and 3' regions of the cloned MAP1 B sequence (Ngsee and 
Scheller,1989; Rienitz et aI,1989; Hammarback et ai, 1991). This possibility remains to be 
tested, but experiments are currently in progress to generate polyclonal antisera that are 
specific for the two claustrin core proteins. 
A third MAP1 B antibody, 3d2, was also tested. This is a polyclonal antibody prepared 
against a fusion protein product from the 5' region of a MAP18 cDNA (Noble et ai, 1989). 
Once again, the 320 kDa protein recognized by this antibody is keratanase-sensitive (Fig. 
SA). In addition, a 100 kDa putative core protein can be seen in the keratanase-digested 
sample (Fig 88). This corresponds to one of the claustrin core protein sizes (Fig. 1). A 
recently prepared polyclonal antiserum made against purified chick claustrin was used in a 
parallel immunoblot. The results show that this antibody also recognizes a 320 kDa protein in 
the rat brain homogenates, as well as the 100 kDa protein core in the keratanase-treated 
sample (Fig 88). 
Although the data presented here suggest that MAP1 B is a keratanase-sensitive 
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KSPG, it remains possible that a contaminating protease in the keratanase is responsible for 
the molecular weight shift of MAP1 B. This possibility seems unlikely since no apparent 
degradation of any other protein was revealed by silver staining· of total rat brain soluble 
protein (Fig. 8C). In this experiment, 20l1g of E20 rat brain protein was analyzed either with 
or without a 1 U/ml, 1 hr, keratanase treatment. Our data indicate that little, if any, alteration in 
the protein profile occurs following keratanase treatment. Moreover, we have not detected 
degradation of EAP-300, a highly protease sensitive protein characterized by our laboratory 
that co-localizes with claustrin in barrier structures, following keratanase treatment (data not 
shown). Furthermore, treatment of immunopurifed claustrin with three different enzymes: 
keratanase (Fig. 1A), endo-l3-galactosidase (Fig. 1 B), and keratanase II (data not shown) all 
result in the appearance of the two protein cores of 100 kDa and 70 kDa core proteins. 
Technical specifications of all three enzymes report no detectable protease activity, and the 
protease cocktail used during our digestions is a commonly used mixture inhibiting all 
classes of proteases. 
Claustrin and MAP1 B display a similar developmental regulation in rat brain 
The above studies suggest that MAP1 B and claustrin are highly related, if not 
identical, molecules. To provide further support for this idea, we carried out immunoblotting 
analysis of rat brain protein during development using polyclonal antisera produced against 
intact chick claustrin. The antiserum to claustrin detects a developmental decrease in 
protein expression (Fig. 9A) which is very similar to the developmental decrease of 
expression revealed by the MAP5 MAb (Fig. 9B). Thus, antibodies to both MAP1 Band 
claustrin recognize keratanase-sensitive proteins which are identical in molecular weight and 
developmental expression in both the rat and chicken eNS. 
MAP1 B and Claustrin are recognized by antibodies to keratan sulfate 
To provide additional evidence that the MAP5 immunoreactive protein in rat brain was a 
KSPG, we immunoblotted rat brain supernatants with another MAb, named 504, which was 
raised against keratan sulfate chains from human cartilage, and binds to KSPG in many 
species (Caterson and Baker, 1983). These data show that the 504 MAb only reacts with a 
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320 kDa band in embryonic rat and chicken brain supernatants, as well as purified claustrin, 
thus confirming this protein as a KSPG (Fig. 10). The reactivity of this MAb with the 320 kDa 
band is also eliminated by keratanase treatment (data not shown). Analysis of Taxol-
Purified Brain Proteins 
The use of taxol to purify microtubules and microtubule-associated proteins is well 
established (Vallee, 1986; Diaz-Nido and Avila, 1989). In fact, this procedure was used as the 
source of MAP1 B antigen for the production of many of the MAP1 B antibodies currently 
available. We performed similar immunoblotting experiments on taxol-purified proteins, 
similar to those conducted on total brain homogenates, in order to further establish that 
MAP1B is a KSPG. Coomassie blue staining of a taxol-dependent microtubule preparation 
from E20 rat brain homogenates shows an enrichment for the high molecular weight MAPs, 
as compared to an aliquot of total brain homogenate (Fig 11A). When treated with 
keratanase, the 320 kDa band in the brain homogenate disappears, as well as the high 
molecular weight bands in the microtubule fraction (Fig 11A). No other proteins appear 
degraded in either preparation, again ruling out non-specific proteolysis. We did not observe 
the appearance of the claustrin core proteins in these experiments, but since our silver-
staining analysis of purified claustrin indicates greater staining intensity of the intact molecule 
(Fig. 1A), this may account for our inability to detect these cores by Coomassie blue staining 
of total protein. The Coomassie blue staining does reveal two high molecular weight 
proteins, both of which are sensitive to keratanase. While the lower of the two bands is 
usually identified as MAP2, we have not confirmed the identity of this protein by 
immunoblotting, and therefore cannot conclude whether MAP2 is also a keratanase-sensitive 
protein. 
To confirm that the keratanase ... sensitive antigen in the microtubule preparation was 
indeed MAP1 B, we carried out immunoblot analysis of the taxol fractions using MAPS MAb. 
These data show that the 320 kDa keratanase-sensitive antigen in both the total brain 
homogenate and the microtubule-enriched fraction is MAP18 (Fig 118). These data also 
show that the taxol treatment only removes a subfraction of MAP1 B from the total protein 
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fraction, which has been demonstrated previously, and is suggestive of weak interaction of 
MAP1 B with tubulin (Schoenfeld, McCerracher, Obar, and Vallee, 1989). 
Metabolic labeling analysis of chick claustrin 
In a previous study (Cole and McCabe, 1991), we established that claustrin is 
secreted into the conditioned medium of cultured glia. The secreted form of the molecule 
appears to be a 250 kDa keratanase-sensitive protein, while the 320 kDa claustrin molecule 
remains associated with the cell fraction (Cole and McCabe, 1991). Since MAP1 B has been 
described exclusively as a cytoplasmic protein, but our previous studies indicated secretion 
of claustrin into conditioned medium of glial culture, we were interested in determining 
whether cultured glia contained a stable cell-associated claustrin fraction which was not 
secreted into the medium. E10 chick glial cultures were labeled for 30 minutes with eSS] 
methionine, and subsequently chased with unlabeled medium for various times up to 22 
hours. Claustrin was immunopurified from these samples using a mixture of claustrin MAbs. 
As shown in Fig 12A, these results indicate that while the 250 kDa claustrin molecule is 
secreted into the medium during the first few hours of the chase, a stable pool of the 320 
kDa protein remains associated with the glial cells for the entire 22 hour period. These data 
also indicate that the secreted claustrin is more labile, possibly accounting for the disparity in 
amounts of the secreted and cellular fractions. It is interesting to note, however, that the 
claustrin MAbs were unable to immunopurify any labeled claustrin immediately after the 30 
minute pulse (Fig. 12A, time 0). Since the MAbs used appear to recognize epitopes 
contained within the keratan sulfate chains (Cole and McCabe, 1991) J these data may 
indicate that the post-translational addition of these glycosaminoglycan (GAG) chains has not 
yet been completed. A similar pulse-chase experiment (Hammmarback et ai, 1991) using rat 
C6 glioma cells demonstrated that the 184 MAb to MAP1 B was unable to immunopurify any 
labeled MAP1 B immediately after a 1 0 minute pulse, again possibly indicating that some 
post-translational processing is necessary for the MAb to recognize the protein. The 
keratanase-sensitivity of both the 250 and 320 kDa forms of the immunopurified claustrin, in 
both the conditioned medium and cell .. associated fractions, was also demonstrated (Fig. 
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128). Notably, the lower molecular weight (205 kOa) contaminating protein is unaffected by 
the keratanase treatment. and is present prior to the appearance of claustrin (see the time 0 
lane, Fig. 12A). 
The high degree of suffation and glycosylation common to proteoglycans enable them 
to be identified by the metabolic incorporation of either rsS] sulphate or [3H]-labelled sugars. 
Previously, we have demonstrated that FS] sulphate-labelled claustrin could be 
immunopurified from glial conditioned medium ( Cole and McCabe, 1991). To further 
demonstrate that claustrin is indeed a keratan sulfate proteoglycan we carried out metabolic 
labeling analysis of chick glial cultures using rH] glucosamine. As shown in Fig. 13, rH] 
glucosamine-Iabelled molecules, identical in size to those labelled with [35S] methionine (Fig. 
12) or [35S] sulphate ( Cole and McCabe,1991) were immunopurified from ceillysates and 
conditioned media using claustrin MAbs. rH]glucosamine-labelied claustrin was confirmed 
to be keratan sulfate proteoglycan by sensitivity to both endo-J3-galactosidase and 
keratanase ( Fig. 138, C). Thus, these data support the hypothesis that claustrin is a keratan 
sulfate proteoglycan, and further support our conclusion that MAP1 B/claustrin cONAs encode 
smaller protein cores that are post-translationally processed to yield a mature 320 kOa 
molecule. 
Immunohistological localization of MAP1 B 
As stated previously, CSPGs and KSPGs have been localized to areas of the 
developing nervous system which appear to act as physical and/or chemical barriers to 
growing axons (Snow et ai, 1990a; 1990b; Cole and McCabe, 1991; McCabe et ai, 1991; 
McCabe and Cole, 1992). In previous immunohistochemical studies, we have demonstrated 
claustrin expression in many of these same barrier structures of the developing chick CNS; 
these include roof plate and midline regions of the mesencephalon, rhombencephalon, and 
spinal cord, as well as the forebrain glial knot (Cole and McCabe, 1991; McCabe et al. 1992; 
McCabe and Cole, 1992). To further examine the relationship between MAP1B and claustrin, 
we analyzed expression of MAP1 B in the developing rat CNS using the MAPS MAb. A 
longitudinal section through an E20 rat brainstem revealed exclusive MAP1 B expression 
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within the midline regions of the pons and midbrain (Fig. 14A, arrows). This distribution 
pattern is identical to that observed for claustrin in the chick brainstem (McCabe and Cole, 
1992). Interestingly, the immunoreactivity does not extend into the region corresponding to 
the decussation of the superior cerebeUar peduncle (Fig.14A, asterisk). Thus, like claustrin, 
MAP1 B is expressed in midline structures which are inhibitory to axon crossing. but is absent 
, In areas where axons are crossing the midline. Similar immunoreactive patterns between 
claustrin and MAP1 B were also found in developing spinal cord, where the MAP5 MAb 
stained the glial roof plate and the funiculi (Fig 148) J a pattern identical to claustrin reactivity 
in chick spinal cord (Cole and McCabe, 1991; McCabe et ai, 1992; McCabe and Cole, 1992). 
We have also recently demonstrated that claustrin expression is limited to the marginal zone 
and subplate of developing chick telencephalon (G.J. Cole and D. Turner, unpublished 
observation). Examination of E20 rat occipital cortex revealed an identical immunoreactive 
pattern using the MAPS MAb (Fig. 14C, D). Both of these layers are preplate derivatives 
characterized by a relative absence of neuronal soma, as revealed by the lack of cresyl violet 
staining in these areas (Fig. 14C). Other studies have also localized CSPG to these regions 
of the developing cortex (Sheppard et ai, 1991). Polyclonal antisera against intact chick 
claustrin or the 70 kDa core protein, which were used to isolate the claustrin cDNAs, 
revealed staining identical to MAPS MAb on sister sections from E20 rat brain, although the 




The immunoblotting, immunohistochemical, and preliminary molecular cloning data presented 
... , support the hypothesis that claustrin and MAP1 8 are related, if not identical, proteins. For 
,example, the sequencing data from both the isolated claustrin cDNAs and the 70 kDa protein core 
establish that chick claustrin is homologous to the mouse MAP1B protein, although it appears to 
represent a 5' truncated form of the protein. The fact that the MAPS Mab reacts with purified chick 
claustrin further substantiates the relatedness of the two proteins. Even more interesting, however, 
was that the MAP1 8 antigen itself, as characterized by several MAP1 8 antibodies, appears 
Identical to claustrin as revealed by its electrophoretic mobility, keratanase-sensitivity, 
developmental regulation, and appearance of a 100 kDa putative protein core upon keratanase 
digestion. In addition, the MAPS MAb to rat MAP1B stains putative glial barrier structures in 
developing rat spinal cord and brainstem, which is identical to the expression of claustrin in the 
developing chick CNS (Cole and McCabe, 1991; McCabe and Cole, 1992). 
At this time, we are unable to conclude whether MAP1 B and claustrin are identical proteins, or 
whether they are two highly related KSPGs. The fact that initial characterization of claustrin shows 
that it is secreted by glia in culture, and has an extracellular appearance in tissue sections seems 
in conflict with the neuronal cytoplasmic location normally associated with MAP1 B. However, it is 
, quite possible that two separate pools of the protein exists. Our pulse-chase data suggest that 
both a cell-associated form, and a slightly smaller secreted form, of claustrin exists in cultured glia. 
The recent cloning of MAP1 B from a C6 glioma library (Zauner et al,1992) establishes that this 
cell-type does produce MAP1 a, and we have also detected a pronounced expression of claustrin 
mRNA by cultured chick glia (data not shown). 
The possibility has been raised that claustrin has been artifactually identified as a KSPG due to 
a contaminating protease in the keratanase. We feel this is unlikely for several reasons. Three 
different glycosidases keratanase, keratanase II, and endo-J3-galactosidase have all produced the 
same two core proteins of 100 kDa and 70 kDa. The protease cocktail employed is commonly 
used to inhibit all classes of proteases, and furthermore, we observe no apparent degradation of 
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",yother protein from a digestion of total rat soluble protein (Fig. 11 C). Claustrin was previously 
shown to be labeled by [35S]sulfate (Cole and McCabe, 1991), and we now have demonstrated 
rH]glucosamine-labeling of claustrin as well. Furthermore, taxol-purification of [3H] glucosamine-
labeled protein indicates an enrichment of the 320 KDa claustrin molecule in the taxol fraction 
(data not shown). Together, these data strongly suggest that claustrin is indeed a KSPG. 
Despite the accumulation of evidence in the present study that claustrin and MAP1 B are highly 
related, or even identical proteins, it is difficult to reconcile these data with the previous molecular 
cloning of mouse MAP1 B. A > 10 kb cDNA has been identified which encodes a 250 kDa MAP1 B 
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protein in mouse (Noble et ai, 1989). Thu$, it was unexpected when keratanase treatment 
completely eliminated MAP1 B immunoreactivity at 320 kDa on immunoblots. Our identification of 
a 5' truncated cDNA of MAP1 B, and the recent studies identifying ENP1 and neuraxin cDNAs 
(Ngsee and Scheller, 1989; Rienitz et ai, 1989), would appear to suggest the existence of 
polypeptides containing MAP1 B sequences which are much smaller than previously reported. It 
thus seems possible that MAP1 B is comprised of smaller protein cores that are glycosylated to 
yield the 320 kDa component. If so, our data suggest either post-transcriptional or post-
translational processing of MAP1 B. Recently, sequence information obtained from the cloning of 
the rat MAP1A protein has revealed that the 5' coding region of MAP1A is highly homologous to 
the 5' coding region of MAP1 B ( Langkopf, Hammarback, Muller, Vallee, and Garner, 1992). The 3' 
coding regions of the two MAP proteins diverge, however, and in fact, the 3' region of MAP1 B has 
been found to encode LC1, while the 3' region of MAP1A encodes LC2. These light chain proteins 
have been found to copurify with MAPs, and are thought to arise from post-translational 
processing of these larger MAP polypeptides (Hammarback et ai, 1991; Langkopf et ai, 1992). This 
hypothesis has yet to be proven, and the existence of our 5' truncated claustrin cDNA, as well as 
the 5' truncated cDNAs identified in Torpedo, raise the possibility that alternatively spliced 
transcripts may exist. Indeed, the fact that both MAP1 B and MAP1A contain 3' regions which 
encode different light chain proteins strengthens this idea. Alternative splicing of MAP1 A and 
MAP1 B transcripts has been downplayed based upon the inability to detect multiple messages by 
northern analysis (Hammarback et ai, 1991; Langkopt et ai, 1992). It has been shown, however, 
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that lower abundance transcripts often are difficult to detect, as an alternative transcript for the 
proteoglycan perlecan required long-term exposure of lanes analyzed using large amounts of poly 
A+ RNA (Noonan and Hassell, 1993). Accordingly, our preliminary northern analysis of E9 chick 
brain RNA reveals multiple transcripts when large amounts of polyA+ RNA are analyzed. This 
finding is in contrast to the earlier studies in which the 5' and 3' truncated MAP1 B cDNAs, ENP1 
and neuraxin, recognized only a single mRNA species of >10 kb (Ngsee and Scheller, 1989; 
Rienitz et ai, 1989). This identification of cDNAs that are Significantly smaller than the mRNAs they 
recognize by Northern blotting is difficult to reconcile, although one can speculate that the > 10 kb 
mANA represents an abundant, and possibly nuclear, precursor mRNA that is processed to yield 
less abundant transcripts represented by claustrin, ENP1 and neuraxin cDNAs. Accordingly, a 
recent study in chick brain has identified several neurofascin cDNAs of apprOXimately 4 kb that 
only recognize a single 8.5 kb mRNA (Volkmer, Hassel, Wolff, Frank, and Rathjen, 1992). 
Processing of this abundant, large mRNA to less abundant, smaller mRNAs was proposed to 
account for this observation. Future studies focussing on the genomic structure of the claustrin 
gene, as well as analysis of processing of its mRNA, will be required to address this intriguing 
question. 
It is unclear from our data what relationship exists between the 100 and 70 kDa claustrin core 
proteins, and which core protein would be encoded by our claustrin (5' MAP1 B) cDNA. Although 
an anti-70 kDa antiserum was used to screen the cDNA library, the antibody is also reactive with 
the 100 kDa core. In addition, an approximately 100 kDa protein would be expected to be 
encoded by our claustrin eDNA. Furthermore, we have shown that a polyclonal antiserum 
prepared against the 5' end of mouse MAP1 B (Noble et ai, 1989) reacts with a 100 kDa protein 
following keratanase treatment of rat brain protein. This same protein is recognized by an 
antiserum to claustrin. Thus, these data are suggestive of our claustrin eDNA encoding a 117 kDa 
core protein derived from claustrin. 
Claustrin is one of the few nervous system proteoglycans for which sequence information has 
been obtained. It is not entirely surprising that its sequence is unlike that of non-nervous system 
proteoglycans, such as those found in cartilage or fibroblasts. Initial biochemical analysis of brain 
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proteoglycans indicated they are a diverse group of proteins showing little immunoreactivity to 
proteoglycans found outside the nervous system (Gowda, Margolis, and Margolis, 1989; Margolis 
. and Margolis, 1989; Herndon and Lander, 1990). NG2, a proteoglycan found in both neural and 
non-neural tissues, has been cloned and sequenced, and found to share no homology to any 
previously sequenced proteoglycan (Nishiyama, Dahlin, Prince, Johnstone, and Stallcup, 1991) . 
. Recently, however, a cDNA has been isolated from a neonatal rat Schwann cell library which is 
homologous to the epithelial proteoglycan, syndecan (Carey, Evans, Stahl, Asundi, Conner, 
Garbes, and Cizmeci-Smith, 1992). Likewise, the Cat-301 CSPG of brain has been shown to be 
immunologically related to the cartilage proteoglycan, aggrecan (Fryer, Kelly, Molinaro, and 
Hockfield, 1992). At this time, the sequence of Cat-301 is unavailable, so the extent of the 
relationship with aggrecan is unknown. Also, several proteins have been identified which can exist 
as proteoglycans or as unsubstituted core proteins. These ·part-time proteoglycans· include the 
lymphocyte homing receptor (Jalkanen, Jalkanen, Bargatze, Tammi, and Butcher, 1988), the 
invariant chain of the class II antigen (Sant, Cullens, Giacoletto, and Schwartz, 1985), 
thrombomodulin (Bourin, Boffa, Bjork, and Undahl, 1986), the transferrin receptor (Schmidtchen, 
Carlstedt, Malmstrom, and Fransson, 1990), CD44 (Kugelman, Ganguly, Haggerty, Weissman, and 
Milstone, 1992), and collagen type IX (Yada, Suzuki, Kobayshi, Hoshino, Horie, and Kimata, 1990). 
This growing list suggests that many conventional proteins may contain GAGs which are not 
readily apparent. The recent identification in brain of a form of the amyloid precursor protein which 
exists as a chondroitin sulfate proteoglycan (Shiol, Anderson, Ripellino, and Robakis, 1992) is 
another example of the elusive identity of many proteoglycans. 
A CSPG, named neurocan, has been recently cloned from rat brain (RaUCh, Karthikeyan, 
Maurel, Margolis, and Margolis, 1992), and interestingly, this secreted proteoglycan contains a 
RGO sequence, and shares a region of homology to gelsolin, a cytoplasmic protein known to 
interact with the cytoskeleton. Previous studies identified cytoplasmic proteoglycans that have yet 
to be characterized (Aquino, Margolis, and Margolis, 1984; Su, Cummings, and Cotman, 1992), 
which raises the possibility that these molecules may be capable of interacting with the 
cytoskeleton. Interactions of proteoglycans with the cytoskeleton could serve many functions, 
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which may include contributing to the stability of the cytoskeleton by protecting cytoskeletal 
proteins from proteolysis, or by partiCipating directly in the assembly of the cytoskeleton. The 
possibility that both neurocan and olaustrin, two secreted proteoglycans. also may functionally 
interact with the cytoskeleton therefore needs to be tested. Interestingly) like neurocan, claustrin 
contains a RGD sequence. 
Analysis of proteoglycan core proteins which have been sequenced reveal that many of them 
'contain structural motifs often found in other proteins. Versican, for example, contains EGF .. like 
repeats, lectin-like repeats, complement regulatory protein-Uke repeats, and a hyaluronic acid .. 
binding domain (Krusius, Gehsen, and Ruoslahti, 1987). Different combinations of these motifs are 
found on many other proteoglycan cores (Kiellen and Lindahl, 1991). These motifs are thought to 
mediate many of the adhesive and mitogenic functions described for these proteoglycans (KjeUen 
and Lindahl, 1991; Reichardt and Tomaselli, 1991). The function ofclaustrin's "microtubule-
binding" region is unclear, but interestingly, this region of chick claustrin exhibits a lower degree of 
homology to mouse MAP1 B, when compared to the regions flanking the proposed microtubule-
binding domain. The microtubule-binding region of MAP1 B is unlike that found in other MAPs, 
and its microtubule .. binding has been described as relatively weak (Tucker, 1990). A database 
search reveals that this highly basic region is homologous to sequences contained in many other 
proteins, including neurofilaments, histones, DNA-binding proteins, and some heat .. shock proteins. 
This suggests that this basic motif may selVe to mediate the binding of an assortment of proteins 
to negatively-charged ligands. Many proteoglycan-binding proteins have a comparable basic 
region which is used to bind the GAG chains of the proteoglycan (Jackson et al,1991). Claustrin 
may use this basic region in order to associate with other proteoglycans. Alternatively, claustrin 
may bind to a cell-surface receptor via this region. We have partially characterized a novel protein 
found in the developing chick nervous system, EAP-300, that copurifies with claustrin, and is 
expressed in the same barrier-regions of the chick CNS as claustrin (Cole and McCabe, 1991; 
McCabe and Cole, 1992). Future studies will explore whether EAP-300 is a cell-surface receptor 
for claustrin, and if so, whether the interaction occurs between claustrin's protein core or keratan 
sulfate chains. 
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Our demonstration of homology between claustrin to the ENP 1 protein found in Torpedo 
electromotor neurons is interesting in light of recent evidence identifying a KSPG associated with 
the synaptic vesicles of Torpedo electric organ (Bahr, Noremberg, Rogers, Hicks, and Parsons, 
1992). The partial Torpedo cDNA clone for ENP 1 is 70% homologous to the 5' region of the 
mouse MAP1 B sequence, and appears to also represent a 5' truncated fragment of MAP1 B 
(Ngsee and Scheller, 1989). The Torpedo protein corresponding to this clone has only been 
partially characterized, but has been shown to be a 85-90 kDa protein. This is consistent with our 
observation that the truncated fragments of MAP1 B are lower in molecular weight, but are still 
recognized by antibodies to different regions of MAP1 B. This Torpedo protein has also been 
localized to intracellular membranes, including synaptic vesicles (Ngsee and Scheller, 1989). 
Several proteoglycans associated with synaptic vesicles and membranes in Torpedo have been 
characterized (Kiene and Stadler, 1987; Carlson and Wight,1987). Recently, it has been reported 
that the acetylcholine transporter-vesamicol receptor complex (AcChT-VR) of Torpedo synaptic 
vesicles is associated with a KSPG (Bahr et ai, 1992). While the exact identity of this KSPG has not 
been determined, it may be related to the cholinergic synaptic vesicle proteoglycan (SVPG) 
previously described (Stadler and Dowe, 1982; Carlson and Kelly, 1983). It will be interesting to 
determine whether any relationship between claustrin, ENP 1, and the AcChT-VR PG exists. 
In conclusion, we have presented the cDNA sequence and deduced amino acid sequence of 
one of the core proteins of a novel neural KSPG, claustrin. The authenticity of the clones has been 
established from amino acid sequence obtained from tryptic fragments of the 70 kDa protein core 
of claustrin. Surprisingly, the sequence is highly homologous to the 5' region of mouse MAP1 B. 
Analysis of MAP1 B using several different antibodies suggests that MAP1 B is itself a proteoglycan. 
Immunohistochemical analysis using one of these antibodies to MAP1 B reveals staining of eNS 
barrier regions in rat, which parallels similar expression of claustrin in the chick CNS. Together, 
these data establish that claustrin and MAP1 B are highly related, if not identical, proteins. 
Figure 1: Identification of claustrin protein cores. A, Aliquots of immunopurified claustrin were left 
untreated (0.3 pg; U), or treated with keratanase (1 U/ml) for 4h at 3T' C (1.5 119; D). The samples 
were then electrophoresed on a 6% polyacrylamide gel and silver-stained. Keratanase digestion 
reveals two protein cores of 1 00 kDa and 70 kDA. The lower molecular weight bands are 
contaminants present in both the undigested and digested lanes. The apparent enrichment of 
these contaminants in the digested sample is likely due to the five-fold excess of protein in the 
keratanase-treated lane. Two cycles of immunopurification of claustrin has recently been shown to 
eliminate these contaminating bands (data not shown). 8, Immunopurified claustrin (0.3 Jig) was 
incubated 24h with either 100 mU/ml of endo~-galactosidase (lane 3), or endo-/3-galactosidase, 
followed by keratanase for 2h (lane 4). Lane 2 shows endo~·galactosidase only, and lane 1 
contained claustrin only. This preparation of claustrin was partially degraded, and hence its 
heterogeneous appearance. The appearance of the 100KDa core protein, following endo-{3-





Figure 2: Structure of claustrin cDNA clones. The composite map of a set of overlapping claustnn 
cDNA clones was constructed from sequence information obtained from three of the nine cDNAs 
isolated from an E9 chick brain expression library (20-1, 24-1, 24-2). The complete sequence of 
24-1 and 24-2 were determined, but only a partial determination of 20-1 sequence is shown. The 
6G5 cDNA was isolated by screening an E13 lambda gt10 library with the 30 bp LIB 
oligonucleotide. The overlapping regions of the clones used to construct the 3373 bp composite is 
diagrammed below the open bar, which represents the open reading frame of the cDNA. The 
single line to the right of the TAG termination codon corresponds to the 222 bp 3' untranslated 
region of 24-1. Possible alternatively spliced regions of the cDNAs are indicated by open segments 
on the lines. These include a 12 bp segment at the 3' end of 6G5, and a 9 bp segment at the 5' 
end of 24-2, that are different from the corresponding sequence in 20-1. The cDNAs 24 .. 1 and 24-
2 also have distinct 3' untranslated regions, as indicated. Restriction enzyme sites are also 
indicated above the composite map: B, BamH I; P, Pst I; E, EcoR I; N, Nsi I. 
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Figure 3: Nucleic acid sequence and deduced amino acid sequence of claustrin eDNA. The 
sequence contains five Ser-Gly repeats (underlined), which represent potential glycosaminoglycan 
attachment sites (Kjellen and Lindahl, 1991). The nucleic acid sequence contains a stop codon (*), 
and consensus polyadenylation site (bold, underlined text). Also shown are potential N-Iinked 
glycosylation sites (bold type). Regions of deduced amino acid sequence corresponding to 
sequence obtained by protein sequencing is double underlined, and a single RGO site is indicated 
by a dotted underline. These sequence data are available from EMBLJGenBank/DDBJ under 
accession number X67778. 
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Figure 4: Comparison between chick elaustrin eDNA and mouse MAP1B. The full cDNA of chick 
claustrin is homologous to a 5' region of the published mouse MAP1 B sequence (Noble et ai, 
1989). Our 3.4 kb eDNA (Chick claustrin; boxed region) corresponds to the MAP1 B sequence 
between nucleotides 1-3149. This region includes the microtubule-binding region of MAP1 B 
located approximately between nucleotides 1800-2500. The poly(A) tails of the cDNAs are 
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Northern blot analysis of brain RNA using a claustrin eDNA. 7.5 J.19 of poly A + RNA from 
chick brain were separated on a formaJdehyde-agarose gel as described in Materials and 
Methods. A 550 bp EcoRI fragment of 24 .. 1, corresponding to the coding region of claustrin was 
hybridized to the blot for 48h, and then washed under high stringency. An overnight exposure is 
in panel A, indicating multiple transcripts, and a 1 week exposure (panel B) aHowed 
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Figure 6: Amino acid sequence comparison of claustrin, MAP1 B, and a Torpedo protein, ENP 1, 
Amino terminal sequencing of three tryptic fragments of the 70 kDa core protein of claustrin 
reveals that these regions of claustrin are highly homologous to sequences found in mouse 
MAP1 B (Noble et ai, 1989), and a protein found in Torpedo electric organ (Ngsee and Scheller, 
1989). The corresponding residues of these homologous proteins are indicated in the figure, with 
regions of homology indicated by shading. 
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Figure 7: Comparison of chick claustrin and MAP1B by immunoblotting analysis. A, Soluble 
proteins from E20 rat brain (150 I1g/lane) , E9 chick brain (150 11 gIl an e) , or purified chick claustrin 
(1 I1g) were either left untreated (-), or treated with keratanase (1 U/ml) for 4h at 3rC (+). 
Samples were then electrophoresed on 6% polyacrylamide gels, transferred to nitrocellulose, and 
immunoblot analysis was performed using a 1 :500 dilution of MAPS MAb, and biotinylated 
secondary antibody and an avidin-peroxidase conjugate. B. Soluble E20 rat brain protein (100 
pg/lane) was either left undigested (-), or partially digested with keratanase (0.5 U/ml) for 1 h at 
3rC (+). Samples were then electrophoresed and transferred to nitrocellulose as previously 
described, and then blotted with either MAPS MAb (1: 1000), or with MAP18-4 MAb (1: 1000). Note 
the different immunoreactive patterns in the partially digested samples. 
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Figure 8: Polyclonal antisera against both MAP1 Band claustrin recognize similar proteins in both 
undigested and keratanase digested samples. A. Soluble E20 rat brain protein (100 P9/lane) was 
either left untreated (.), or digested with keratanase (1 U/ml) for 4h at 3-rC (+), electrophoresed 
on a 6% polyacrylamide gel, and immunoblotted with 3D2 polyclonal antisera (1 :500). This 
antibody was made against a fusion protein from a mouse MAP1 B cDNA (Noble et ai, 1989). Note 
the appearance of a putative core protein of approximately 100 kDa in the keratanase digested 
lane (A; +). B. Soluble E9 chick brain protein (100 pg/lane) was treated as described for the rat 
tissue in A, except the protein was immunoblotted with a polyclonal antibody (1 :250) made against 
twice immunopurified chick claustrin (see Materials and Methods). The appearance of a 100 kDa 
core protein is again seen in the digested sample (B; +). The apparent difference in migration of 
the protein cores in A and B results from different gels being shown, and direct comparison on the 
same gel indicates that both antibodies recognize the same protein following keratanase treatment. 
C. Soluble E20 rat brain protein (20I19/Iane) was either left untreated (-), or keratanase treated 
(1 U/ml) for 4h at 3r C {+)t electrophoresed, and silver stained to visualize total protein. A faint 
protein band in the 320 kDa range disappears in the digested sample, while the overall protein 
pattern remains basically unchanged. These data are suggestive of proteolysis not being 
responsible for the shift in MAP1 B molecular weight with keratanase treatment. 
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Figure 9: MAP1 Band claustrin display a similar pattern of developmental regulation in rat brain, 
A. E20 rat brain protein (200 pg/lane) was isolated at the indicated developmental times, 
electrophoresed on 6% polyacrylamide gels, transferred to nitrocellulose, and blotted with 
polyclonal antisera prepared against purified intact chick claustrin (1 :200). The lower molecular 
weight bands in the adult lane represent biotinylated proteins that are detected in the absence of 
any antibody. B, E20 rat brain protein (100 1l9/lane) was isolated at the indicated developmental 
times and processed as in A, except this gel was blotted with the MAP5 MAb (1: 1 000). E20, 







Figure 10: MAP1B and claustrin are recognized by antibodies to keratan sulfate. Brain protein 
samples were electrophoresed on 6% polyacrylamide gels, transferred to nitrocellulose, and 
blotted with 5D4 MAb (1 :500), an antibody specific for karatan sulfate chains (Caterson et ai, 
1983). Lane 1, 200 119 E20 rat brain; Lane 2, 100119 E9 chick brain; lane 3, 5119 purified chick 
claustrin. 
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Figure 11: T axol-purified MAP1 B is keratanase-sensitive. A microtubule-enriched fraction was made 
from soluble E20 rat brain protein using a taxol-dependent method. The pelleted microtubule 
fraction was resuspended in 1 M NaCL, dialyzed, and aliquots were either left untreated ( .. ) or 
keratanase treated (+). The supernatant from the taxol preparation, representing the microtubule .. 
depleted fraction was also tested. A. Soluble E20 rat brain protein (100 Jig/lane) which was not 
taxol-processed was either left untreated (-), or keratanase treated (+), and electrophoresed on 6% 
gels along with the microtubule-enriched treated and untreated fractions. The gel was stained with 
Coomassie Blue to visualize total protein. These data again demonstrate the disappearance of a 
320 kDa band in the digested aliquot of total rat brain protein (Tot; + ), while the overall protein 
staining pattern remains basically unchanged. The high molecular weight bands in the taxol-
precipitated microtubule preparation (Pel), which represents the microtubule-associated proteins, 
are also digested by the keratanase enzyme, while the tubulin and other minor (lightly stained) 
bands remain unchanged. B. Aliquots from total rat brain protein, taxol-unbound fraction (Supe), or 
taxol-precipitated microtubule protein (Pel), were left untreated (-), or keratanase treated (+), and 
the electrophoresed samples were blotted with the MAP5 MAb (1 :500). These results show that 
the antigen detected by the antibody is digested by keratanase in each of the samples. The fact 
that a proportion of the MAP1 B is not precipitated with the taxol, and remains in the supernatant is 





















Figure 12: Pulse-chase analysis of metabolically-labeled claustrin in chick glial cultures. A. Chick 
glial cultures were labeled for 30 minutes with [35S] methionine, and then incubated with normal 
media for 1-22 h. Both the cellular fractions and conditioned media were analyzed at the indicated 
chase time points. Claustrin was immunopurified from these fractions (see Materials and Methods), 
and aliquots were analyzed by polyacrylamide gel electrophoresis. The single asterisk indicates 
the 320 kDa claustrin which is found associated with the cellular fraction, and appears relatively 
stable across the time course of the experiment. The double asterisk indicates the 250 kDa 
secreted form of claustrin that is mainly found in the conditioned medium. The 250 kDa secreted 
claustrin appears to reach its peak at around 3 hours, and is then rapidly degraded. The 
contaminating band at approximately 200 kDa is included to show that this protein, which binds 
Sepharose non-specifically, is present prior to immunoprecipitable claustrin. B. The keratanase .. 
sensitivity of the radiolabeled claustrin was also tested. Aliquots of immunopurified claustrin from a 
labelled glial cellular fraction was either left untreated (lane 1) or treated with keratanase (1 U/ml) 
for 2h at 3-r C (lane 2). The 320 kDa claustrin is digested, and a putative 100 kOa core protein 
appears in the digested lane (lane 2; arrow). Aliquots of immunopurified claustrin from glial eM 
also were left untreated (lane 3) or digested with keratanase (lane 4). The 250 kOa secreted form 
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Figure 13: rH] glucosamine labeling of claustrin in chick glial cultures. Purified chick glial cell 
cultures were pulse labeled 24h with 25 pCi/ml of fH] glucosamine. Celilysates and conditioned 
medium were then incubated with AH-10 Sepharose to isolate metabolically ... labeled claustrin. 
Aliquots of isolated protein were separated on a 7.5% gel (panel A), and show that proteins, 
similar in size to those isolated following [35S] methionine labeling, are isolated from conditioned 
media (eM) or cell Iysates. The asterisks denote bands that are sensitive to endo-~-galactosidase 
+ keratanase II digestion (panel St eM), or keratanase digestion (Panel B, cell). Only the higher 
MW region of the gels are shown in panel B, although it can be seen again that a lower MW 












Figure 14: Distribution of MAP1 B in the embryonic rat eNS. A, MAP5 MAb immunostaining of a 
longitudinal section of E20 brainstem. MAP1 B is expressed in the glial midline of the pons, with 
this expression extending along the midline into the mesencephalon (arrowheads). However, 
midline expression of MAP1 B in the mesencephalon does not extend into the region of the 
superior cerebellar peduncle decussation (asterisk) or the central gray substance. MAP1 B 
expression is also evident in occipital cortex (Oc). 4V, fourth ventricle; CA, cerebral aqueduct. 
(120X). B, In E20 rat cervical spinal cord, MAP5 MAb stains the developing funiculi as welJ as thf 
glial roof plate (arrowhead). (120X). C J CresyJ violet staining of E20 rat occipital cortex. MZ, 
marginal zone; CP, cortical plate; SP, subplate; IZ, intermediate zone. (180X). 0, MAP1 B 
expression in E20 occipital cortex is restricted to the marginal zone (MZ) and subplate (SP). 
These expression patterns of MAP1 B in the developing rat eNS resemble the distribution of 
claustrin in the chick eNS, and in addition, a polyclonal antiserum to chick claustrin stained the 












V.IN SITU LOCALIZATION OF A KERATAN SULFATE PROTEOGLYCAN, CLAUSTRIN, 
IN THE DEVELOPING CHICK NERVOUS SYSTEM 
157 
ABSTRACT 
Our laboratory has previously characterized a keratan sulfate proteoglycan, named claustrin, 
that is enriched in embryonic chick nervous tissue. In vitro and immunohistological studies both 
suggest that claustrin may function as an inhibitory molecule to axon elongation in the developing 
chick eNS. We have recently obtained the cDNA clone for claustrin. Interestingly, sequence 
analysis of the claustrin cDNA reveals a strong homology between claustrin and the mouse MAP1 B 
protein. To further our understanding of claustrin's possible role in neural development, the present 
study examines the spatiotemporal expression pattern of claustrin mRNA during chick development 
using in situ hybridization. We have determined that claustrin mRNA is expressed primarily by 
embryonic chick nervous tissue, and is found localized to several glial structures of the developing 
eNS, including the spinal cord dorsal columns, the IIglial-knot" region of the diencephalon, and the 
glial midlines of the developing chick midbrain and hindbrain. We have also localized claustrin mRNA 
to several discrete layers in the developing chick tectum and cerebellum. 
The current study also describes the cloning and molecular characterization of another 
eDNA that is also homologous to MAP1 S, but possesses sequence not contained within claustrin. 
We have named this cDNA, 3' MAP1 B-related clone (3' MRC), since it is homologous to the 3' region 
of the mouse MAP1 B sequence. This spatiotemporal pattern of mANA expression for this eDNA is 
similar to claustrin, and suggest that they may encode related gene products. 
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INTRODUCTION 
Proteoglycans have been well characterized outside of the nervous system, and have 
been found to be involved in a diverse number of cellular processes which include control of cell 
proliferation, differentiation, matrix assembly, and gene transcription (for reviews, see Ruoslahti, 
1988; KjeUen and Lindahl, 1991; Jackson et ai, 1991; Hardingham and Fosang, 1992). Nervous 
system proteoglycans have been less well characterized, but appear to have many important 
functions, which include enhancement of cell-cell and cell-ECM interactions, as well as the 
stimulation of neurite outgrowth, and guidance of growing neurons to their appropriate targets 
(Margolis and Margolis, 1989a; 1989b; 1993) . Interestingly, the different classes of proteoglycans 
function quite differently in the developing nervous system, and in many cases, appear to 
complement one another. Neural heparan sulfate proteoglycans (HSPGs) generally have been 
found to enhance cell-cell interactions and stimulate neurite outgrowth (Lander et ai, 1985; Cole 
et ai, 1985a; 1985b; 1986; Hantas-Ambroise et ai, 1987; Riopelle and Dow, 1990). These 
functions are, in part, due to binding of a number of different heparan binding molecules which 
include NCAM (Cole et ai, 1985a; 1985b; 1986), thromobospondin (Sun et ai, 1989; Neugebauer 
et ai, 1991; O'Shea et ai, 1991), fibronectin (Rogers et ai, 1983; 1985), and laminin (Rogers et al 
1983; Lander et ai, 1991). Conversely, neural chondroitin sulfate proteoglycans (CSPGs) and 
keratan sulfate proteoglycans (KSPGs) have been found to be disruptive to intracellular 
interactions, and instead enhance extracellular matrix (ECM)-cell and ECM-ECM interactions 
(Ruoslahti, 1988; Snow et ai, 1990a; 1990b; Fichard et ai, 1991; McKeon et ai, 1991). In vitro 
studies suggest that CSPGs and KSPGs inhibit neurite outgrowth, and are generally non-
permissive substrates for cell attachment and migration (Perris and Johansson, 1987; Pettway et 
ai, 1990; Snow et ai, 1990b; Cole and McCabe, 1991). 
Many studies suggest that cell migration and axonal guidance are largely controlled by 
positive and negative cues that cells encounter in their local migratory environments; 
proteoglycans appear to be important components of these pathways (for reviews, see Dodd and 
Jessel, 1988; Bixby and Harris, 1991; Tosney, 1991). Migratory pathways of neural crest cells, 
which include the anterior somites, are rich in HSPG, laminin and fibronectin, but contain little 
CSPG or KSPG. Conversely, areas of the nervous system which appear to act as barriers to 
159 
neural crest migration, including the posterior somites an perinotochordal mesenchyme, are rich 
in CSPG\KSPG but lack detectable amounts of HSPG (Bronner-Fraser, 1986; Tan et ai, 1987; 
Bonner-Fraser and Lallier, 1988; Pettway et ai, 1990; Perris et ai, 1991). 
Recently, a gradient of CSPG in the developing retina was shown to help orient retinal 
ganglion cell axons, and to direct growing ganglion cell axons toward the optic stalk (Brittis et ai, 
1992). From this pOint, these axons appear to be primarily guided to their tectal targets by 
adhesive molecules, such as NCAM, present in the developing optic nerve (Silver and 
Rutishauser, 1984). Interestingly, a KSPG recognized by a MAb, named Ted15, has been 
identified in mature optic nerve which is absent from developing nerve (Geisert et ai, 1992). This 
KSPG is found in species which are refractory to optic nerve regeneration, but is not detected in 
the goldfish or frog optic nerves, which are capable of regeneration. Other studies have indicated 
that many proteins isolated from mature astrocytes are IInon-permissivell for axonal growth, and 
may contribute to the reduced capacity for regeneration in the adult CNS of many species 
(McKeon et ai, 1991; Sagot et ai, 1991; Schwab et ai, 1993). The KSPG recognized by the Ted15 
MAb may function similarly in the mature optic nerve. 
CSPGs and KSPGs have also been localized to proposed glial barrier structures of the 
developing CNS. These barriers include the spinal cord roof plate, the brainstem and midbrain 
midlines, the ·glial-knot" between the diencephalon-telencephalon border, and the 
telencephalonic midline ·sling" which precedes development of the corpus callosum. These 
structures are inhibitory to axon crossing, and are thought to prevent growing axons from 
following aberrant paths during development (Silver et al. 1987; Snow et ai, 1990a; 1990b; Silver 
et ai, 1993;Steindler, 1993). 
Our laboratory has recently characterized a novel neural KSPG, named claustrin, which is 
a developmentally regulated 320 kDa proteoglycan expressed primarily in embryonic chick 
nervous tissue (Cole and McCabe, 1991). Immunohistological analysis has revealed its 
expression in CNS glial barrier structures along the midbrain and hindbrain midlines and the 
spinal cord roof plate (McCabe and Cole, 1992). In addition, claustrin has been detected in the 
"glial knot" region of the developing chick forebrain (McCabe et ai, 1991). Purified claustrin has 
also been shown to inhibit neurite outgrowth and cell adhesion on substrata comprised of laminin 
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or NCAM (Cole and McCabe, 1991). Together these data suggest that claustrin may play an 
important role in the modulation of axonal growth processes in the developing nervous system. 
We have recently obtained the cDNA clone for claustrin using expression screening of an 
E9 chick brain library. Our complete 3.4 kb cDNA contains an open reading frame of 3114 bp 
coding for 1038 amino acids (Burg and Cole, in press). Surprisingly, this amino acid sequence 
is highly homologous to the published mouse MAP 1 B sequence (Noble et ai, 1989), although the 
claustrin cDNA sequence appears to represent a 5' truncated version of the published mouse 
MAP1 B sequence. Subsequent immunoblotting and immunohistochemical experiments 
suggested that chick claustrin and mouse MAP1 B are highly related, if not identical, molecules 
(Burg and Cole, in press). 
The present study focusses on the further molecular characterization of claustrin through 
the use of northern, Southern, and in situ analyses in order to determine the spatiotemporal 
expression pattern of the claustrin mRNA during chick development. In addition, we have 
isolated a cON A clone whose sequence corresponds to 3' MAP1 B sequence not contained within 
our claustrin cDNA. A parallel analysis using this probe, referred to as 3' MAP 1 B-related clone (3' 
MRC), was performed in order to elucidate the relationship between these two MAP 1 B-related 
eDNA clones. 
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MATERIALS AND METHODS 
Preparation of Antisera 
Production of claustrin antisera has been previously described. Antisera prepared against 
intact claustrin and prepared against the putative 70 kOa core protein of claustrin were used for 
expression screening and isolation of claustrin cONAs. 
A separate antisera was prepared against a membrane-enriched proteoglycan fraction 
obtained from embryonic day 10 chick brains (E10). To prepare this fraction, E10 chick brains 
were homogenized in calcium, magnesium-free Hank's containing the protease cocktail 
previously described. After centrifugation (20,000 X g; 30 min), the supernatant was discarded 
and the membranes were homogenized in phosphate-buffered saline (PBS) containing 0.5% NP-
40 and the protease inhibitor cocktail. Since previous attempts to produce proteoglycan antisera 
have been hampered by NCAM contamination, NCAM was removed from the membrane fraction 
by affinity chromatography using NCAM MAbs coupled to CNBr-activated Sepharose as 
previously described. Proteoglycans were isolated from the NCAM-depleted fraction using the 
DEAE-Sepharose extraction procedure described by Bretscher (1989). Two fractions were 
obtained from this procedure. One fraction (I) binds to phenyl-Sepharose while the other fraction 
(G) is unable to bind to the hydrophobic matrix. Since we were primarily interested in HSPGs 
contained in the proteoglycan fraction, we further purified these fractions by chondroitinase ABC 
digestion (1 U/ml; 3r for 4h) followed by gel chromatography on a 1.5 X 75 cm Sio-gel A-1.5m 
(Sio-Rad) column under dissociated conditions (PBS containing 0.1% SOS). The void volume of 
the column, containing primarily undigested HSPG proteoglycans, and apparently some of the 
large CSPG protein cores, was collected. The 50S was removed using Extractigel-D 
(Pharmacia), and the samples concentrated using Centricon-30 microconcentrators (Amicon). 
Approximately 25-50 I1g purified proteoglycans/injection were used for both the fraction I and 
fraction G proteoglycans. Female New Zealand rabbits were given three injections of either 
fraction G or fraction I proteoglycans over a two-month period. 
Isolation of cDNA Clones 
Production of the E9 chick brain lambda cDNA library has been previously described 
(Burg and Cole, in press). Isolation of claustrin cDNAs has also been described previously. 
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Briefly, antisera produced against intact claustrin and against the 70 kOa claustrin protein core 
were used to independently screen approximately 400,000 recombinants from the E9 chick brain 
expression library. A total of nine related overlapping clones were isolated and sequenced. 
Authenticity of these claustrin cONAs was obtained from protein microsequencing information 
obtained from three tryptic fragments produced from the 70 kDa claustrin protein core. Additional 
elaustrin clones were obtained by screening of an oligo dT-primed E13 chick brain lambda gt10 
eDNA library and a random-primer generated E14 chick retina glia library, using an 
oligonucleotide probe synthesized from 5' sequence information obtained from the initially 
isolated clones. 
A polyclonal antiserum produced against the fraction G chick brain proteoglycans was 
used to screen the E9 chick brain lambda cDNA library. This antiserum was chosen over the 
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antisera produced against fraction I proteoglycans due to its greater avidity, as revealed by 
immunoprecipitation studies performed on [35S]SO.-labeled brain extracts (data not shown). 
Approximately 400,000 recombinants were screened as previously described for isolation of 
elaustrin cDNAs. A total of 23 clones were isolated, each of which rescreened positive. Since 
the fraction G antiserum cross-reacted with NCAM, NCAM-positive clones were identified using a 
previously characterized NCAM antibody. A total of 17/23 clones rescreened with the NCAM 
antisera and were not analyzed further. Sequencing of the remaining clones using the dideoxy 
chain termination procedure (Sanger et ai, 1977) revealed two related clones which were used in 
the current study. 
Northern and Southern Blotting 
RNA was extracted from various tissues and cultured glia using the guanidium-
isothiocyanate method (Chomezynski and Sacchi, 1987). Poly A+ RNA was purified using oligo 
[dT] cellulose chromatography (Pharmacia). 7.5 Ilg/Iane of poly A + RNA was electrophoresed 
through a 1 % agarose gel containing 2.2 M formaldehyde, and transferred to a nylon membrane 
(Nytran; Schleicher & Schuell) using a posiblot pressure apparatus (Stratagene). Membranes 
were hybridized with [32p]dATP-labeled cDNA probes, obtained from random-primed labeling of 
either an EcoRf fragment of the claustrin cDNA, or the 11-3 eDNA, which corresponds to 3' 
MAP18 related sequence (Fig. 1). The blots were hybridyzed at 420 for 48h in 5X SSPE, 1X 
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Denhardt's solution, 0.5% SDS, 100 Jlg/ml sperm DNA, 50% formamide, using a rotating 
hybridization oven (Bellco). The membranes were washed to a final stringency of 0.2 X sse at 
68°, and exposed to Kodak XAR-5 film for autoradiography. 
For Southern analysis, chick genomic DNA (10 J.lg/lane; kindly provided by Dr. Randy 
Buck) was digested with restriction enzymes (EcoRI or Hindlll),electrophoresed onto 0.5% 
agarose gels, and transferred to nylon membranes as described above for northern analysis. 
Labeling of probes, hybridization, and subsequent washes were also performed as described 
above for northern analysis. 
In Situ Analysis 
Chick brains were removed at various ages ranging between embryonic day 5 (E5) and 
hatching (approximately E21), fixed overnight in 4% paraformaldehyde in phosphate-buffered 
saline (PBS), cryoprotected overnight in 20% sucrose, and frozen at -85° C. Frozen cryostat 
sections (35 Jlm) were collected onto glass slides coated with Vectabond (Vector Laboratories), 
and slides were heated at 42° for 30-45 min to adhere sections to the slides. 
Oligonucleotide probes were labeled using [35S]dATP (NEN, NEG034H) and terminal 
deoxytransferase (TdT; NEN). Antisense 30-mer oligonucleotides were synthesized from claustrin 
(5' GATGAGTGGITTCTCCTCIIIIIIAGAAAC3') or 3' MRC (5' 
ATTCTGGAAAAGTAGGAGAGTATAGAGAG3') sequences. For a control, a sense 3D-mer 
oligonucleotide was constructed complementary to the claustrin sequence used to generate the 
antisense oligonucleotide. For labelling, the oligonucleotide (10 pmol), rS]dATP (75 J.lCi), TdT 
(75 units), TdT 5X buffer and water was mixed, and incubated at 37' for 2h. The labeled probes 
were further purified using a Sephadex G-50 column. 
Slides were prehybridized overnight at 3-r using prehybridization buffer (0.6 M NaGI, 0.01 
M Tris-HCI, pH 8.0, 2mM EDTA, 0.05% sodium pyrophosphate, 1X Denhardt's solution, 0.5 mg/ml 
yeast tANA, 0.5 mg/ml herring sperm DNA, and 50% deionized formamide). Labeled 
oligonucleotide prob~s were added to hybridization solution (prehybridization solution containing 
0.1 M DTT) at a final concentration of 1 X 107 cpm/ml. The prehybridization solution was removed 
from the slides, and approximately 100 J.l1/slide of hybridization solution containing the labelled 
oligonucleotide was applied, and slides were then incubated at 37' for 24-48h. Slides were then 
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washed 4 X 30' with 0.2X sse at 37', air-dried, and exposed to Kodak XAR-5 film for 3-7 days. 
RESULTS 
Description of claustrin cDNA and 3' MAP1 B-related clones 
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We have previously described the claustrin cDNA clones (Burg and Cole, in press). As 
indicated in Fig. 1, chick claustrin is highly homologous (75% protein sequence identity) to the 
published mouse MAP1 B sequence, however, claustrin represents a 5' truncated version of 
MAP1 B sequence. We have used an antiserum produced against a mixture of chick brain 
proteoglycans for expression screening, and subsequent isolation of other putative proteoglycan 
core proteins. Screening an E9 chick brain expression library using this antiserum resulted in the 
isolation of two overlapping cDNAs. Sequencing 01 these cDNAs revealed that they were also 
homologous to mouse MAP 1 a, however, the partial cDNA sequences of these clones matched 
sequence contained within the 3' region of mouse MAP1 B. The composite clone produced from 
sequence information obtained from complete sequencing of both clones (referred to as: 3' 
MAP 1 B-related clone or 3' MRC) shares 52% protein identity to the corresponding mouse MAP1 B 
sequence (Noble et ai, 1989). A 3' truncated version of MAP18, named neuraxin, has been 
previously identified in rat brain (Rienitz et ai, 1989). We are currently attempting to isolate 
additional 3' MAP 1 8-related clones which will enable us to establish the complete sequence of 
this cDNA clone. 
In order to identify what protein product(s) are encoded by this cDNA, fusion protein has 
been produced from 3' MAP18-related cDNA sequence, and has been used for production of 
polyclonal antisera. Preliminary studies suggest that the 3' MRC recognizes a keratanase-
sensitive protein of similar size to claustrin. Keratanase digestion of this protein, however, reveals 
a protein core pattern distinct to that seen for claustrin (data not shown). 
Northern Analysis 
Northern analysis was performed to determine claustrin's mRNA size, complexity, tissue 
distribution, and developmental expression. Preliminary studies had determined that the claustrin 
cDNA recognized at least four separate mRNAs in E9 chick brain, with sizes of >10 kb, 8 kb, 5 
kb, and 3.5 kb. although the smaller messages could only be detected using large amount of 
poly A + RNA and longer exposure times. These multiple messages are discrete, reproducible 
bands, suggesting that chick claustrin is encoded by multiple mRNA species in developing chick 
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brain. The large> 10 kb mRNA is the most abundant mRNA, and is similar in size to that 
reported for mouse MAP 1 B in developing rodent brain. Alternative splicing of MAP1 B has 
previously been thought unlikely based upon the inability to detect multiple messages by 
northern analysis. These later studies, however, were based upon the use of smaller amounts of 
electrophoresed RNA, as well as shorter exposure times, and therefore, may have resulted in less 
abundant mRNAs remaining undetected. 
Further analysis reveals claustrin's mRNA expression is largely restricted to developing 
chick nervous tissue (Fig. 2; Clau.). Multiple claustrin transcripts are abundant in chick brain 
between E9-E18. Claustrin expression is noticeably lower in E21 chick brain. Claustrin 
transcripts are also detected in chick retina and gut, but are expressed at lower levels in 
embryonic heart or liver. Claustrin's mRNA expression matches its protein expression pattern in 
developing chick (Cole and McCabe 1991) in both its restricted nervous tissue expression, and 
its temporal regulation in developing chick brain. The two larger claustrin messages of > 10kb 
and 8 kb are readily seen in all tissues expressing claustrin. The two lower claustrin transcripts 
of 5 kb and 3.5 kb are also detected with longer exposure (data not shown). 
We then compared claustrin's mRNA distribution to that of our 3' MAP 1 B-related clone, 
which is homologous to a 3' region of the mouse MAP 1 B sequence not contained within the 
claustrin sequence. These results (Fig. 2; 3' MRC) show that the 3' MAP1 B-related clone 
recognizes a > 10 kb mRNA similar to the largest claustrin transcript. The 3' MAP1 B-related 
clone's message also shows a similar developmental regulation and tissue distribution to that of 
claustrin. However, the 3' MAP18-related clone does not detect the smaller claustrin transcripts 
even upon long exposure times. These data suggest that the large > 10 kb transcript contains 
sequences common to both the claustrin cDNA and the 3' MAP1 B-related clone, while the 
smaller transcripts contain sequence unique to the elaustrin eDNA sequence. Since we have 
only isolated a partial eDNA for the 31 MAP 1 B-related clone, the possibility exists that a yet 
uncharacterized eDNA corresponding to the complete mouse MAP1 B clone exists which encodes 
the > 10 kb transcript, while the smaller messages are encoded by smaller 5' -truncated claustrin 
clones. Alternatively, the large > 10 kb transcript may represent a pool of precursor mRNA 
containing both elaustrin sequence and 3' MAP 1 B-related sequence. Subsequent processing of 
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this precursor may yield the smaller claustrin messages, and 3' MAP 1 8-related clone messages, 
which have yet to be identified. The higher background produced by the 3' MAP 1 B-related probe 
may contribute difficulty in detecting mRNAs of lower abundance. 
Southern Analysis 
Southern blot experiments were performed in order to determine the relative genomic 
expression pattern corresponding to our claustrin cDNA sequence, and to further explore the 
relationship between the claustrin cON A and the 3' MAP 1 B-related cDNA. Accordingly, chick 
genomic DNA samples, digested with either EcoRI or Hindlll, were probed with [32p]dATP-labeled 
claustrin or 3' MAP 1 B-related probes. The results (Fig. 3) show that both claustrin and 3' 
MAP1 B-related cONAs detect single restriction fragments in both digests. While both probes 
recognize an 8 kb fragment in the EcoRI digests (Fig. 3A; lanes 1,4), the claustrin and 3' MRC 
probes recognize slightly different sized restriction fragments in the Hindlll digests. The claustrin 
probe recognize a 2.5 kb fragment (Fig. 3A; lane 2), while the 3' MRC probe hybridizes to a 
smaller fragment of approximately 2 kb (Fig. 3A; lane 5). Due to high background using the 3' 
MRC probe, a second Southern blot is also shown which shows the size of the EcoRI and Hindlll 
fragment sizes recognized by the 3' MRC (Fig. 38). In addition, an EcoRI digest of genomic rat 
DNA was analyzed using the claustrin probe. The results (Fig. 3A; lane 3) reveal that claustrin 
recognizes a single fragment of approximately 14 kb in rat. These results suggest that both 
claustrin and the 3' MAP 1 B-related clones are probably encoded by a single copy gene, and 
furthermore, suggests that two cONAs may, in fact, be encoded by the same gene. 
In Situ Hybridization 
Previous immunohistological studies have demonstrated that the claustrin protein was 
expressed in several putative glial barrier structures in the developing chick nervous system, 
including the spinal cord roof plate, midline regions of the mesencephalon and hindbrain, and 
the IIglial-knof region of the developing diencephalon\telencephalon. In addition, a MAP 1 B MAb, 
named MAP5, displayed a similar immunoreactive pattern in the developing rat brain (Burg and 
Cole, in press), suggesting that these related proteins may be involved in similar functions in the 
developing nervous systems of the chick and rat. We were therefore interested in determining 
whether the claustrin mRNA displayed a similar spatiotemporal pattern of expression observed for 
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the claustrin protein. Furthermore, we wished to examine similarities and\or differences between 
claustrin mRNA expression and 3' MAP 1 B-related expression in the developing chick nervous 
system. 
Nervous system-specific expre8sion 
Our goal was to determine whether expression of claustrin mRNA was limited to 
developing nervous tissue, as was suggested by previous northern (Fig. 2) analysis and protein 
immunoblots (Cole and McCabe, 1991). Analysis of E5 chick parasaggital sections using a 
claustrin antisense oligonucleotide probe demonstrates that claustrin expression is indeed 
localized to developing brain, spinal cord. and spinal nerves during this stage of development 
(Fig. 4; Clau). Sister sections hybridyzed to 3' MAP1 B-related antisense oligonucleotide probe 
show an identical expression pattern (Fig. 4; 3' MRC). Sections probed with a sense 
oligonucleotide. produced from the corresponding antisense claustrin sequence, displayed no 
specific hybridization pattern (data not shown). The sense probe also displayed no hybridization 
signal to any of the other brain sections tested in this study (data not shown). 
Spinal cord expression 
Claustrin protein expression has been localized to the funiculi and roof plate of the 
developing chick spinal cord (McCabe and Cole, 1992). Preliminary in situ analysiS of E9 chick 
spinal cord reveals that both claustrin and 3' MRC mRNA expression is primarily localized in 
dorsal regions adjacent to the spinal cord roof plate (Fig. 5). This expression appears to 
correspond to the localization of the developing dorsal columns in the developing chick 
(Romanoff,1960). Since their are no neuronal cell bodies located in the dorsal columns, these 
data suggest that both claustrin and 3' MRC mRNA are being primarily produced by glia in this 
region of the developing spinal cord. These data support previous biochemical studies which 
demonstrated that claustrin was secreted by glial cells grown in culture (Cole and McCabe, 
1991). Putative inhibitory molecules to axonal growth, which include chondroitin sulfate and 
cytotactin, have been associated with astrocytes in the dorsal columns of developing rat spinal 
cord (Schwab and Schnell, 1991; Pindzola et al. 1993)J and it has been suggested that 
expression of these barrier molecules in this region may function to channel the axons of the 
corticospinal tract and to limit access of dorsal root fibers to this axon tract (Schwab and Schnell: 
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Pindzola et ai, 1993). Our data suggest that claustrin may playa similar inhibitory role in this 
region of the developing chick eNS. Interestingly, MAP18 protein expression has also been 
demonstrated in the corticospinal tract in the developing rat CNS (Schoenfeld et ai, 1989). We 
have also detected spinal cord roof plate signal hybridization at later developmental ages using 
both the claustrin and 3' MRC oligonucleotide probes (data not shown). 
Mesencephalon and diencephalon expression 
The midline regions of the developing rhombencephalon and mesencephalon are thought 
to represent barriers to axon growth, and claustrin protein expression has been detected in 
midline regions of the developing chick hindbrain and midbrain (McCabe and Cole, 1992). 
Additionally, we have also demonstrated that a MAP1 B MAb reveals protein expression in the 
midline regions of developing rat brain (Burg and Cole, in press). Claustrin and 3' MRC mRNAs 
are detected in the mesencephalic midlines of E9 chick brain (Fig. 6; E9). These in situ data 
support the previous immunohistochemical localization of claustrin and MAP1 B in the developing 
chick midbrain. 
Claustrin and 3' MRC mANAs are also found associated with discrete layers of the 
developing optic tectum (Figs. 6,7). At early developmental ages between E9-E15 (Fig. 6). both 
claustrin and 3' MRC probes hybridize to a discrete lamina contained within the stratum griseum 
et fibrosum superficiaJe (SGFS) strata of the developing tectum (see LaVaii and Cowan. 1971). 
This layer of the tectum lies immediately below the superficial stratum opticum (SO) layer, which 
is comprised of optic tract fibers. Retinal fibers invade the tectum between E6 and E15, and are 
limited to this superficial tecta I layer, although the mechanism which delineates this pathway are 
unknown (Goldberg, 1974; Vanselowet ai, 1989). Claustrin may represent a barrier to ingrowing 
retinal axons which restrict the growth of these axons to this tecta I stratum. As development 
proceeds, claustrin and 3' MRC mRNA expression decreases in the SGFS, but increases in the 
deeper, stratum griseum centrale (SGC), layer of the tectum (Fig. 7). 
Optic tract expression 
Claustrin and 3' MAC mRNA expression is also evident in the area bordering the optic 
chiasm (Fig. 6; E15). Putative barrier proteins, including claustrin, have been localized to a glial 
structure, the ·glial-knor region of the optic chiasm, and are thought to help prevent mixing of 
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optic and olfactory tract axons. Further analysis of the developing chick optic tract demonstrates 
that claustrin and 3' MAC mRNA expression appears to border the optic tract to the tectum (Fig. 
8). Mesencephalic midline claustrin message expression is also evident (Fig. 8; CLAU), while a 
more rostral section reveals 3' MRC mRNA expression in the optic chiasm (Fig. 8; 3' MRC,lower 
figure). 
Cerebellum expression 
Claustrin and 3' MRC mANAs are also detected in the developing chick cerebellum (Fig. 
9). At E15 and E18, expression appears to be largely limited to the external granule cell layer of 
the cerebellum. By E21, however, cerebellar mRNA expression increases greatly for both 
mRNAs, and becomes localized to internal layers of the cerebellum. The internal cerebellar fiber 
tracts, however, exhibit very little claustrin and 3' MRC mRNA expression. In addition, 3' MRC 
expression appears consistently higher than corresponding claustrin expression in late 
developing cerebellum, which is in agreement with our northern analysis which demonstrated that 
the 3' MRC mANA was enriched in E21 brain relative to claustrin (Fig. 2). 
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DISCUSSION 
In the present study we have examined the spatiotemporal expression of a nervous 
system keratan sulfate proteoglycan mANA. claustrin, in the developing chick CNS. Through the 
use of northern blotting we have shown that claustrin's mRNA distribution is mainly limited to 
developing chick brain, which is in agreement with previous immunoblot analyses demonstrating 
claustrin enrichment in embryonic chick nervous tissue (Cole and McCabe, 1991). In situ 
hybridization studies further localized claustrin's mRNA expression to specific regions of the 
developing chick CNS, and specifically, have localized claustrin mRNA to several proposed axon 
barrier regions of the developing eNS. Overall, these in situ studies support previous 
immunohistological studies which have characterized the spatiotemporal pattern of claustrin 
protein expression in the developing chick nervous system (McCabe and Cole, 1992), and are 
consistent with claustrin's proposed functional involvement in formation of axon barriers in the 
developing nervous system. 
Sequence analysis has established that chick ctaustrin is homologous to mouse MAP1 B, 
although claustrin represents a 5' truncated MAP1 B sequence (Burg and Cole, in press). The 
present study describes the molecular cloning and characterization of additional chick cDNAs 
which show strong homology to 3' mouse MAP 1 B sequences not contained within elaustrin. 
Sequence information from these cONAs were combined, resulting in a 1.4 kb partial cDNA which 
displays strong homology (52% protein identity) to a 3' region of mouse MAP1 B sequence; we 
refer to this eDNA as the 3' MRC (3' MAP1 B-related clone). This degree of homology is 
considerably less, however, than the 75% homology between claustrin and the 5' MAP1 B 
sequence. Because we have not obtained the complete 3' MRC cDNA, we are unable to 
determine whether claustrin and full-length 3' MRC cDNAs contain any overlapping sequence. 
However, the 3' untranslated region of 3' MRC is identical to the 3' untranslated sequence of one 
elaustrin cONA, which suggests alternative exon usage is involved in the generation of these two 
distinct mRNAs. 
In order to begin to establish the relatedness of these two gene products, northern, 
Southern, and in situ studies were performed using probes prepared from both elaustrin and 3' 
MRC sequences. These studies suggest that claustrin and 3' MAC are related, however, the 
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exact relationship between the two gene products is not clear. Probes prepared from both 
claustrin and 3' MRC sequences recognize a > 10 kb transcript enriched in embryonic chick 
brain. Claustrin probes also recognize several smaller transcripts in these northern blots, while 3' 
MRC probes hybridize to only the large > 10 kb transcript. This suggests that the > 10 kb 
transcript may contain sequence common to both claustrin and 3' MRC, while the smaller 
transcripts contain only claustrin sequences. One possibility is that the large transcript represents 
a pool of precursor mANA containing both claustrin and 3' MRC sequences. Subsequent 
processing of this primary transcript may produce smaller transcripts containing claustrin- and 3' 
MRC-specific sequences. High background observed with the 3' MRC probe may obscure the 
existence of smaller, less abundant messages on these blots. The observation that the > 10 kb 
transcript in E21 chick brain RNA extracts strongly hybridizes to a 3' MRC probe, but not to a 
claustrin probe, suggests that at this stage of development, the > 10 kb transcript contains 
primarily 3' MRC-specific sequence. Several related transcripts of similar size may be produced 
which differ in their relative abundance during development. In summary, northern analysis 
suggests that claustrin and 3' MAC are related gene products, however, their exact relationship 
remains unclear. 
Southern analysis of genomic chick DNA was also performed to obtain information about 
the genomic complexity of claustrin and 3' MRC. Probes produced from claustrin and the 3' MRC 
hybridize to single fragments of similar size in the EcoRI and Hindlll digested DNA samples, 
suggesting their respective genes may be highly related or identical. 
Using in situ hybridization, claustrin and 3' MRC mRNAs were shown to be expressed in 
several putative barrier regions of the developing chick CNS. These include the spinal cord roof 
plate (data not shown), and adjacent dorsal columns. The spinal cord roof plate consists 
primarily of modified astrocytes, and is thought to act as a barrier to growing somatosensory and 
dorsal commissural axons, which grow near, but do not cross, this region of the spinal cord. 
Claustrin mRNA expression in this structure confirms earlier stUdies which suggested that glia 
produce claustrin, and immunohistological analyses which indicated claustrin immunoreactivity in 
the developing spinal cord. Similarly, the dorsal column of rats has been shown to contain glial 
cells which synthesize inhibitory molecules to axon growth which include chondroitin sulfate and 
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cytotactin, These inhibitory molecules in the dorsal columns are thought to help properly 
channel growing dorsal column axons, and prevent mixing between somatosensory afferents and 
dorsal column axons. Claustrin mRNA expression in the analogous structure in the developing 
chick spinal cord is suggestive of a similar function. 
Claustrin mRNA is expressed in several locations in the developing chick visual system. 
Claustrin mRNA is expressed in the mesencephalic midline; this structure contains radial 
astrocytes, and is thought to maintain ipsilateral separation of afferent fibers in the optic tectum. 
The expression of claustrin this region of the midbrain is consistent with previous 
immunohistological localization of claustrin to this barrier structure (McCabe and Cole, 1992). 
Moreover, in vitro studies have demonstrated claustrin may be capable of acting as a barrier to 
growing axons, since the protein in vitro is inhibitory to cell adhesion and axonal growth (Cole 
and McCabe, 1991). 
Additionally, claustrin mRNA expression was detected in areas surrounding the optic tractf 
and then expression extended into the optic tectum. While it is not clear what cell-type is 
expressing claustrin mRNA in this region, the pattern of expression suggests that claustrin may 
help channel retinal afferents to their proper tectal targets in the external SO layer of the tectum. 
Furthermore, claustrin mRNA is strongly expressed in the layer just below the SO, the 5GFS, 
during the developmental period when retinal axons are invading the tectum. The mechanism by 
which ingrowing retinal afferents are restricted to the superficial layer of the tectum are currently 
unknown. The spatiotemporal pattern of claustrin mRNA expression in the developing tectum 
suggests that it could playa role in restricting the retinal afferents to the SO. At later stages of 
development, claustrin mRNA expression in the SGFS appears to be down-regulated, and is up-
regulated in a deeper layer of the tectum which corresponds to the SGC tectal layer. The layer 
below this, the SAC, contains tectobulbar efferents, which have been shown to form this layer by 
an unusual tangential migration pattern (Gray and Sanes, 1991). The mechanisms contrOlling 
this tangential migration are unknown, and one may speculate that claustrin may assist in 
directing this migratory path and subsequent guiding of tectobulbar efferents from the tectum. 
Claustrin protein was previously shown to be expressed in the optic fiber layer of the 
developing retina, as well as, the optic nerve (McCabe and Cole, 1992). In situ analysis fails to 
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detect any claustrin mRNA in the optic nerve, but appears to localize claustrin mRNA to the 
retina. These data may suggest that retinal ganglion cells may produce claustrin and transport 
the protein to their axons. The function of claustrin in retinal ganglion cell axons is unknown, but 
the function of claustrin in neurons may differ from glial-secreted claustrin, and may actually be 
involved with neurite extension, as has been proposed for the related MAP 1 8 protein. 
Claustrin mANA is also expressed in the internal layers 01 the late developing chick 
cerebellum, which corresponds to a developmental period following the majority of granule cell 
migration. At this time, it is difficult to speculate on the function of claustrin in the developing 
cerebellum. Studies determining which cell types actually express the claustrin mRNA, as well as 
a more detailed developmental analysis, will be necessary to ascertain claustrin's function in 
cerebellar maturation. It is important to note, however, that the 3t MRC mRNA generally appears 
enriched, as compared to claustrin mRNA in developing cerebellum. This observation is in 
agreement with northern analysis which establishes 3' MAC mRNA enrichment in late developing 
chick brain, when compared to claustrin mRNA. In this case, therefore, the functions of the 
protein product encoded by the full-length 3' MRC might be different than claustrin. 
In summary, we have characterized the mRNA distribution and spatiotemporal pattern of 
mRNA expression for claustrin in the developing chick nervous system. We have determined that 
claustrin mRNA is expressed primarily by embryonic chick nervous tissue, and is found localized 
to several glial structures of the developing eNS that are thought to serve as molecular barriers 
which help to guide growing axons along their proper pathways. In addition, we have described 
the cloning and molecular characterization of a cDNA that is homologous to MAP1 B, but 
possesses sequence not contained within claustrin. This spatiotemporal pattern of mRNA 
expression for this cDNA is similar to claustrin, and suggest that they may encode related gene 
products. 
Figure 1: Description of claustrin and 3' MRC cDNA clones. The full-length 3.4 kb claustrin 
cDNA is homologous to the published mouse MAP 1 B sequence (Noble et ai, 1989), and 
corresponds to MAP 1 B sequence between nucleotides 1-3149. Sequence information obtained 
from two other cloned cDNAs described in the current study were found to be homologous to 
sequence contained at the 3' end of the mouse MAP1 B sequence. This 1.4 kb partial cDNA 
construct, named 3' MAP 1 B-related clone (3' MRC), corresponds to nucleotides 5370-6708 of the 
MAP 1 8 sequence. 
1 Kb 
3149 5370 6708 
Mouse MAPIB AAAA 
Chick Claustrin 
L...--___ ~I~ll AAAA 
31 MRC - - - 1~ ___ ,---,1~': 1 AAAA 
Figure 2: Northern analysis of claustrin and 3' MRC mRNA distributions. 7.5 I1g of poly A + RNA 
isolated from various chick tissues were separated on a formaldehyde agarose gel, and 
transferred to nylon filters as described in Materials and Methods. Labeled claustrin (CLAU) and 
3' MRC probes were hybridyzed to the blots for 48h, and then washed under high stringency. 
Lane 1, E9 brain; Lane 2, E18 brain; Lane, 3 E21 retina; Lane 4, E9 heart; Lane 5, E9 liver; Lane 
6, E9 gut; Lane 7, E21 brain. The migration of the 28S ribosomal RNA is indicated. The bottom 






Figure 3: Southern analysis of claustrin and 3' MAC. Chick or rat genomic DNA (10 P9/lane) was 
digested with restriction enzymes and electrophoresed on 0.5% agarose gels, transferred to 
nylon filters, and labeled claustrin or 3' MRC probes were hybridized to the blots as described for 
northern blotting. A second Southern analysis using the 3' MRC probe was performed (8), in 
order to visualize bands obscured by high background (A; 3' MRC). A. Lane 1,4, Chick genomic 
DNA: EcoRI digested; Lane 2,5, Chick genomic DNA: HindUI digested; Lane 3, Rat genomic DNA, 
EcoAI digested. B. Lane 1, Chick genomic DNA: EcoRI digested; Lane 2, Chick genomic DNA: 










Figure 4: In situ localization of claustrin and 3' MAC transcripts in early developing chick nervous 
tissue. Parasaggital sections were prepared from E5 chick embryos and hybridized with labeled 
antisense oligonucleotide probes prepared from claustrin (CLAU) or 3' MAC sequences. 
Hybridization signal is localized to developing chick brain, spinal cord, and spinal nerves. 
CLAU 
Figure 5: In situ localization of claustrin and 3' MAC transcripts in E9 chick spinaJ cord. Cross-
sections of E9 chick cervical spinal cord were hybridized with claustrin and 3' MRC antisense 
probes, as previously described. Hybridization signal is localized to the dorsal columns, a region 




Figure 6: In situ localization of claustrin and 3' MAC transcripts in developing chick brain. Cross-
sections localized to the midbrain\diencephalon region of the developing chick brain were 
prepared from chick brains between E9-E15, and hybridized with claustrin or 3' MAC antisense 
probes as previously described. Hybridization is observed in the mesencephalic midlines, the 
SGFS layer of the tectum, and the ependymal linings of the third ventricle. Weaker hybridization 








Figure 7: In situ localization of claustrin and 3' MRC transcripts in late developing chick brain. 
Cross-sections localized to hindbrain and dorsal tectum were prepared from E18 and E21 chick 
brains, and hybridized with claustrin and 3' MRC antisense probes. Notice the absence of 
midline hybridization in the hindbrain, and increased hybridization signal in internal layers of the 





Figure 8: In situ localization of claustrin and 3' MRC transcripts in the developing chick optic 
tract. Longitudinal sections of E8 chick heads, which contain developing chick optic tract, 
diencephalon, and mesencephalon, were prepared and analyzed using the antisense probes 
described above. Hybridization signal is evident in the ganglion cell Jayer of the retina, the 
mesencephalic midlines, the SGFS layer of the optic tectum, and in areas bordering the optic 
pathway leading into the tectum. 
CLAU 
Figure 9: In situ localization of claustrin and 3' MRC transcripts in the developing chick 
cerebellum. Saggital sections of chick cerebella were prepared from E15, E18, and E21 
cerebella, and hybridized with claustrin or 31 MRC antisense oligonucleotide probes. These 
results demonstrate a developmental increase in both transcripts at E21, which are mainly 
confined to the internal layers of the cerebellum. 

VI. GENERAL DISCUSSION 
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The nervous system contains hundreds of different cell-types which arise in a precise 
temporal and spatial developmental pattern. The complex pattern of neural development is 
characterized by a distinct series of events, which include cell proliferation, migration, 
differentiation, neurite extension, and synaptagenesis (Jacobson, 1978). Proteoglycans have been 
implicated in being involved in many of these processes. but have been poorly characterized in 
the developing vertebrate nervous system (Margolis and Margolis, 1989a; 1989b; 1993; Herndon 
and Lander, 1989). The studies outlined in this thesis have focussed on the identification, 
biochemical characterization, and developmental regulation of the major proteoglycan species in 
the developing chick nervous system. This analysis has provided insight into the different 
functions mediated by nervous system HSPGs and CSPGs\KSPGs, and have enabled us to 
produce specific proteoglycan antisera that can be used to elucidate specific proteoglycan 
functions. 
We have also described the molecular cloning, sequence analysis, and in situ mRNA 
localization, of a nervous system keratan sulfate proteoglycan, claustrin. These analyses have 
determined that claustrin is highly homologous to the mouse MAP1 B protein, and furthermore, 
suggest that MAP 1 B itself may be a keratan sulfate proteoglycan. In situ localization of claustrin 
mRNA during chick development has reinforced previous studies (Cole and McCabe, 1991; 
McCabe and Cole, 1992; McCabe et ai, 1991) suggesting that claustrin may be an inhibitory 
growth molecule localized to many of the proposed glial barrier structures in the developing 
chick CNS. 
The diverse number of proteoglycan species identified in our studies of the chick retina 
and brain are in agreement with similar analysis of neural proteoglycans in the embryonic 
(Herndon and Lander, 1989) and adult rodent brain (RippeUno and Margolis, 1988; Gowda et ai, 
1989), and is reflective of the abundance of different cell-types in the nervous system. Many of 
these proteoglycans appear largely unrelated to non-nervous system proteoglycans based upon 
their poor immunoreactivity with antisera produced against proteoglycans isolated outside the 
nervous system (MargoliS and Margolis, 1989a; 1989b). Recent cloning of several neural 
proteoglycans, however, has demonstrated that a number of nervous system proteoglycans 
share homologous regions with their non ... neural counterparts (Margolis and Margolis, 1993). The 
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CSPG, neurocan, contains N .. and C .. terminal regions homologous to aggrecan, but contains a 
unique central region (Rauch et ai, 1992). Cytoplasmic and membrane-spanning regions of N-
syndecan are highly homologous to comparable regions of non-nervous system syndecans, 
however, the extracellular domain of N-syndecan is largely unique (Carey et ai, 1992). The NG2 
proteoglycan (Nishiyama et ai, 1991 a) and claustrin (Burg and Cole, in press) are unrelated to 
any other characterized proteoglycans. Together, these studies suggest that while some neural 
proteoglycans may contain regions homologous to non-nervous system proteoglycans, many 
nervous system proteoglycans are probably unrelated to those found in other tissues. This 
diversity of both number and structure exhibited by neural proteoglycans is consistent with the 
precise orchestration of events uniquely associated with the development of the nervous system. 
The different patterns of expression exhibited by HSPGs and CSPGs in the developing 
chick brain are in agreement with previous studies which have suggested that HSPG and CSPG 
perform different, and often complementary functions, in neural development. HSPGs have been 
linked to the enhancement of cell-cell interactions, and the stimulation of neurite outgrowth 
(Lander et ai, 1985; Cole et ai, 1985a; 1985b; 1986), while CSPG has been associated with cell-
ECM and ECM-ECM interactions, and is generally thought to inhibit axon extension (Margolis and 
Margolis, 1989a; 1989b; Snowet ai, 1990a). The relative shift from HSPG to CSPG in chick brain 
was associated with the formation of the laminated brain structures, the optic tectum and 
cerebellum. A similar shift from HSPG to CSPG was observed in the developing chick retina, and 
was correlated to the formation of the layered retinal cytoarchitecture (Morris et ai, 1977). 
HistogenesiS of these brain structures require an orchestrated series of events including 
proliferation, migration, and differentiation of neural cells. Numerous stUdies have correlated 
increased levels of cell-surface HSPG to a decrease in cell mitosis, migration and differentiation 
(see Chiarugi and Vannucchi, 1976), and suggests that a decrease in cellular HSPG during 
histogenesis may be important for functions associated with the lamination of certain brain 
regions. Similarly, an increase in CSPG during histogenesis may enhance cell-ECM interactions 
necessary for proper cell migration and proper axon targeting. CSPGs have been localized to 
the subplate and marginal layers of the developing mammalian cortex (Nakanishi, 1983; 
Sheppard et ai, 1991). This CSPG expression is absent in the subplate of the reeler mouse, a 
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mutant characterized by an inversed laminated cortex (Nakanishi, 1983). These studies suggest 
that CSPG plays an important role for proper cortical lamination. Immunohistological studies 
using specific proteoglycan antisera will be necessary to confirm the roles of HSPG and CSPG in 
the developing chick tectum and cerebellum. 
While numerous studies have examined the interaction of heparan and heparan sulfate 
with the neural cell adhesion molecule, NCAM, in vitro (Cole et ai, 1985a; 1985b; 1986), few 
studies have examined the interaction of endogenous heparan sulfate or HSPG with NCAM. We 
demonstrated that retinal heparan sulfate GAG chains were capable of binding to a synthetic 
peptide corresponding to the heparin-binding region of NCAM. Furthermore, we showed that 
these retinal HS GAGs could inhibit NCAM-mediated cell-substratum adhesion. Our laboratory 
has previously characterized a brain HSPG, containing a 130 kOa core protein, that copurifies 
with NCAM, and may be a relevant NCAM-binding ligand. The current studies have identified an 
abundant HSPG is chick brain, containing a 250 kOa core protein, that can be specifically 
immunopurified using either a NCAM peptide or NCAM antisera, suggesting that this HSPG, 
containing the 250 kDa core protein, may be related to the previously characterized NCAM-
associated HSPG. The similarity in size, abundance, and developmental expression between the 
250 kDa HSPG protein identified In our study and an HSPG identified in another recent study 
(Haltter, 1993) suggest that these two HSPGs may be related or identical proteoglycans. The 
HSPG characterized by Haltter (1993) is found in retinal basal lamina and CNS axon tracts of the 
developing chick nervous system. NCAM has previously been localized to these regions of the 
developing eNS (Silver and Rutishauser, 1984; Rutishauser, 1986), and the possibility that the 
HSPGs identified in these studies may interact with NCAM in these CNS areas of the developing 
nervous system is an intriguing possibility that awaits further study. 
Claustrin is one of the only nervous system proteoglycans for which sequence information 
has been obtained. While its strong homology to MAP 1 B is surprising, several lines of evidence 
suggest that the isolated claustrin cONAs are authentic, and that claustrin and MAP1B are related 
proteins. Amino acid sequencing of tryptic fragments derived from a claustrin protein core 
confirm that the claustrin protein is highly homologous to the MAP1 B protein. Antisera prepared 
against both claustrin and MAP1 B recognize keratanase-sensitive proteins of similar molecular 
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weight. The possibility that a contaminating protease has erroneously identified claustrin as a 
proteoglycan seems unlikely since we have also established the proteoglycan nature of claustrin 
by radioactive [36S}SO 4- and rH]glucosamine-labeling experiments, immunoblot analysis using a 
well-characterized keratan sulfate MAb (Catarson, 1983), and have localized claustrin protein and 
mRNA to eNS glial barrier structures known to contain CSPGs\KSPGs (Silver et ai, 1987; Snow et 
ai, 1990a; 1990b). Claustrin has been shown to be secreted by glia (Cole and McCabe, 1991), 
and appears to be an ECM component of the developing chick CNS (McCabe and Cole, 1992; 
McCabe et ai, 1991), while MAP 1 B is generally thought to exist primarily in the cytoplasm 
(Tucker, 1988). Our studies indicate that a stable, cell-associated pool of claustrin remains 
associated with cultured glial cells, suggesting that claustrin may exist in different subcellular 
compartments, and may help to explain the apparent discrepancy between claustrin and MAP1B 
subcellular localizations. Further studies are necessary in order to clarify the perplexing 
relationship between these two molecules. 
To further our understanding of claustrin's possible role in neural development, the 
spatiotemporal expression pattern of claustrin mRNA during chick development was determined 
using in situ hybridization. We showed that claustrin mRNA is expressed primarily by embryonic 
chick nervous tissue, and is found localized to several glial structures of the developing eNS, 
including the spinal cord dorsal columns, the Wglial-knor region of the diencephalon, and the glial 
midlines of the developing chick midbrain and hindbrain. These studies confirm previous 
immunohistological studies which identified the claustrin protein within these structures (McCabe 
and Cole, 1992; McCabe et ai, 1991). We have also localized claustrin mRNA to several discrete 
layers in the developing chick tectum. Claustrin mRNA is strongly expressed in the layer just 
below the SO, the SGFS, during the developmental period when retinal axons are invading the 
tectum. The mechanism by which ingrowing retinal afferents are restricted to the superficial layer 
of the tectum are currently unknown. The spatiotemporal pattern of claustrin mRNA expression 
in the developing tectum suggests that it could play a role in restricting the retinal afferents to the 
SO. At later stages of development, claustrin mRNA expression in the SGFS appears to be 
down-regulated, and is up .. regulated in a deeper layer of the tectum which corresponds to the 
SGC tectallayer. The layer below this, the SAC, contains tectobulbar efferents, which have been 
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shown to form this layer by an unusual tangential migration pattern (Gray and Sanes, 1991). The 
mechanisms controlling this tangential migration are unknown, and one may speculate that 
claustrin may assist in directing this migratory path and subsequent guiding of tectobulbar 
efferents from the tectum. Overall, the spatiotemporal pattern of claustrin mRNA in the developing 
chick eNS support the idea that claustrin may function as a barrier molecule which restricts the 
pathways of growing axon tracts. 
In summary, the studies reported in this dissertation have characterized the major 
proteoglycans of the developing chick nervous system, and have described the molecular 
cloning and in situ mRNA localization of a chick keratan sulfate proteoglycan, claustrin. These 
studies have helped to establish that nervous system proteoglycans are a diverse, structurally 
distinct, group of macromolecules, which have a well-defined spatiotemporal pattern of 
expression in the developing chick nervous system. Furthermore, the role of a specific 
proteoglycan, claustrin, in facilitating the accurate development of axon pathways is further 
supported by these studies. 
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